A Novel Asymmetric [2+2] Cycloaddition and Its Application to the Total Synthesis of 1233A by Dymock, Brian William
UNIVERSITY
of
GLASGOW
DEPARTMENT OF CHEMISTRY
A Novel Asymmetric [2+2] Cycloaddition and 
its Application to the Total Synthesis of 1233A
A thesis submitted in part fulfilment 
for the degree of Doctor of Philosophy
by
Brian William Dymock
September 1997
ProQuest Number: 13818597
All rights rese rv ed
INFORMATION TO ALL USERS 
The quality  of this rep ro d u c tio n  is d e p e n d e n t  u p o n  the quality  of the copy  sub m itted .
In the unlikely e v e n t  that the a u th o r  did not send a c o m p le te  m anuscrip t 
and there are missing p a g e s ,  these  will be n o te d . Also, if m ateria l had to be rem o v e d ,
a n o te  will in d ic a te  the d e le tio n .
uest
P roQ uest 13818597
Published by ProQuest LLC(2018). C opyrigh t of the Dissertation is held by the Author.
All rights reserved .
This work is p ro tec ted  a g a in s t u n au th o rized  copying under Title 17, United S tates C o d e
Microform Edition © ProQuest LLC.
ProQuest LLC.
789 East Eisenhower Parkw ay 
P.O. Box 1346 
Ann Arbor, Ml 4 8 1 0 6 -  1346
UNIVF.^'^
J ,TTP”
1 L *  h m
GLASGOW UNIVERSITY 
ilBRARY
Declaration
9
I declare that all of the work contained within this thesis was performed by 
myself unless otherwise stated. This thesis was submitted for examination in 
September 1997 and examined in December 1997.
Brian William Dymock 
signed
Glasgow, December 1997
[
I
I To my wife, Mei...
UNIVERSITY OF GLASGOW
ABSTRACT
FACULTY OF SCIENCE 
DEPARTMENT OF CHEMISTRY
Doctor of Philosophy
A Novel Asymmetric [2+2] Cycloaddition and 
its Application to the Total Synthesis of 1233A
by Brian William Dymock
The first enantioselective [2+2] cycloaddition of aldehydes with 
(trimethylsilyl)ketene is discovered and developed using chirally modified 
Lewis acids. In order to demonstrate the utility of the new methodology, the 
total synthesis of the cholesterol biosynthesis inhibitor 1233A was undertaken. 
Background biochemistry on cholesterol biosynthesis and coronary heart 
disease is discussed followed by previous syntheses of the target molecule.
The stereoselective synthesis of 1233A was completed using four key steps: (i) 
a cobalt semicorrin catalysed enantioselective reduction of an a,/Tunsaturated 
ester; (ii) a copper-mediated coupling of a vinyl iodide with a vinyl stannane;
(iii) a novel [2 +2 ] cycloaddition of an aldehyde with (trimethylsilyl)ketene and
(iv) a /J-lactone aldol-type reaction quenching with carbon dioxide to install the 
final carbon of 1233A.
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1Chapter 1
Introduction, Biological Background 
and Biosynthesis of Antibiotic 1233A
1.1 Introduction
2
Coronary heart disease (CHD) is the major cause of death in most industrialised 
nations, causing more deaths than all forms of cancer combined. 1 One of the 
main causes of CHD is atherosclerosis, a progressive disease of the major 
coronary arteries which is characterised by the formation of fatty plaques of 
cholesterol, lipids and other cellular debris in the arteries. In much the same 
fashion as water pipes in a heating system "fur-up" with old age, the cross- 
sectional area of the artery is reduced, the flexibility of the artery wall is 
diminished and the heart is forced to work much harder as a consequence. The 
disease is asymptomatic for many years as the lesion matures but the onset of 
symptoms can be rapid and fatal. Hypercholesterolemia is well recognised as a 
major independent risk factor for coronary disease2 and a number of studies 
have shown that reducing elevated levels of serum cholesterol in man leads to a 
reduction in the incidence of coronary-related deaths. 3,4
1 .1 .1.1 
CholesterolHO
Figure 1.1.1
1.2 Cholesterol Biosynthesis
In humans, 70% of cholesterol is derived from de novo synthesis in the liver 
and developments in the past decade have shown that one of the most effective 
approaches to lowering serum cholesterol levels is by inhibiting sterol 
biosynthesis. 5
Cholesterol is of interest both as a membrane component, modulating the 
fluidity of eukaryotic membranes, and as a precursor of many signal 
molecules.6 Steroid hormones such as progesterone, testosterone and cortisol 
are derived from cholesterol. The biosynthesis of cholesterol exemplifies a 
fundamental mechanism for the assembly of extended carbon skeletons from
3
five-carbon units. The "Jekyl and Hyde" nature of cholesterol is aptly 
expressed by Brown and Goldstein: 7
"Cholesterol is the most highly decorated small molecule in biology. Thirteen 
Nobel Prizes have been awarded to scientists who devoted major parts of their 
careers to cholesterol. Ever since it was isolated from gallstones in 1784, 
cholesterol has exerted an almost hypnotic fascination for scientists from the 
most diverse areas of science or medicine...
Cholesterol is a Janus-faced molecule. The very property that makes it useful 
in cell membranes, namely its absolute insolubility in water, also makes it 
lethal".
All 27 carbon atoms of cholesterol are derived from acetyl Coenzyme A. 
Coenzyme A is a central molecule in metabolism. The "A" stands for 
acetylation. It is a universal carrier of acyl groups. The structure of Coenzyme 
A is shown8 (Scheme 1.2.1).
OH
o
H H
O o  OHII
H3 C - C - S - C 0 A =  Acetyl CoA 0=fj>-0
1.2.1.2
Figure 1.2.1
HS-CoA.
1.2 .1.1
The terminal sulfhydryl group in CoA is the reactive site. The acetyl unit is 
linked to CoA by a thioester bond; this derivative is called acetyl CoA. The 
hydrolysis of a thioester bond is thermodynamically more favourable than an 
oxygen ester because sulfur is larger and more diffuse than oxygen and does not 
efficiently share the electrons of the carbonyl group. Consequently acetyl CoA 
has a high acetyl group transfer potential.
Cholesterol has been synthesised using acetate labelled in either its methyl or 
carboxyl carbon. Degradation of such labelled cholesterol allowed the origin of 
each atom of the cholesterol molecule to be determined9 (Scheme 1.2.2).
4-C
1.2 .2.1
Scheme 1.2.2
The biosynthesis of cholesterol starts with the formation of 3-hydroxy-3- 
methylglutaryl CoA (3-HMG CoA) from acetyl CoA and acetoacetyl CoA 
catalysed by the enzyme HMG CoA synthase. 3-HMG CoA is then reduced to 
mevalonate by HMG CoA reductase. The synthesis of mevalonate is the 
committed step in cholesterol formation6 (Scheme 1.2.3).
1.2 .2.2
Acetoacetyl CoA
1.2.3.1
+
Acetyl CoA
1.2.1.2
+
h2o
HMG CoA 
Synthase
-o2O d
HMG CoA 
Reductase HO
SCoA
-o2 OH
3-Hydroxy-3-methyl- 
glutaryl CoA 
1.2.3.2
Mevalonate 
1.2.3.3
Scheme 1.2.3
Mevalonate is converted into 3-isopentenyl pyrophosphate by three consecutive 
reactions involving ATP (Scheme 1.2.4).
ATP ADP HO /  -  ATP ADP
O"
Mevalonate 5-Phosphomevalonate
1.2.3.3 1.2.4.1
”V  O O ATPADP + Pf + C 02 I O O
O - O -  O O
5-Pyrophosphomevalonate Isopentenyl
1.2.4.2 pyrophosphate
1.2.4.3
Scheme 1.2.4
Isomerisation of isopentenyl pyrophosphate to dimethylallyl pyrophosphate is 
followed by condensation of these C5 units to form a C10 compound: geranyl
pyrophosphate . An allylic carbocation formed from dimethylallyl 
pyrophosphate is attacked by isopentenyl pyrophosphate. A similar reaction 
then occurs to convert geranyl pyrophosphate to the C15 compound famesyl
pyrophosphate (Scheme 1.2.5).
Isopentenyl 
pyrophosphate 
1.2.4.3
Allylic
substrate
PaOe3-
Allylic Condensed
carbocation
P2O63-
carbocation
Geranyl (or farnesyl) 
pyrophosphate
Scheme 1.2.5
Reductive condensation of two molecules of famesyl pyrophosphate leads to 
the formation of squalene, a C30 compound. This reaction proceeds through the
cyclopropane intermediate presqualene pyrophosphate10 (Scheme 1.2.6).
Farnesyl pyrophosphate 
1.2 .6.1
NADPH 
.^-N A D P+ + 2PP,
o. o^y  v xv—x0 X H 
X° ° '
0  0 “ Presqualene pyrophosphate
1.2 .6.2
V
Squalene 
1.2.6.3
Scheme 1.2.6
The final stage of cholesterol biosynthesis starts with the cyclisation of 
squalene. Squalene epoxide is formed from squalene in the presence of 
molecular oxygen, then a cyclase enzyme catalyses a remarkable cyclisation to 
form lanosterol. The squalene epoxide molecule is believed to be folded in a 
conformation which allows one double bond after another to react as a 
nucleophile with a cationic centre which develops nearby in the molecule. 6 A 
cationic centre behaves as a Lewis acid towards the 7C-electrons of an adjacent 
double bond which in turn creates a new cationic centre. This process 
continues until cyclisation is complete. Finally, lanosterol is converted into 
cholesterol by the removal of three methyl groups, the reduction of one double 
bond by NADPH and the migration of the other double bond (Scheme 1.2.7).
7H
Squalene Epoxide 
1.2.7.1
cyclase
HO' Lanosterol 
1.2.7.2
HO' Cholesterol
1.1.1.1
Scheme 1.2.7
Scheme 1.2.8 shows the general scheme for the biosynthesis of cholesterol.
1.3 Cholesterol Transport6
Cholesterol is transported in body fluids in the form of lipoprotein particles. 
The protein components of these macromolecular aggregates have two roles:
(i) They solubilise hydrophobic lipids for transport to cells.
(ii) They contain cell targeting apparatus, essential for molecular 
recognition on arrival at a cell.
Lipoproteins are classified according to density. Low-density lipoprotein
(LDL), the major carrier of cholesterol in blood, has a diameter of 22 nm and a
mass of approximately 3 million daltons. It contains a core of some 1500
esterified cholesterol molecules surrounded by a shell of phospholipids and
8
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Scheme 1.2.9
unesterified cholesterols. The role of LDL is to transport cholesterol to 
peripheral tissues and regulate de novo cholesterol synthesis at these sites. 
Although cholesterol is essential for the growth and viability of cells in higher 
organisms, high serum levels of cholesterol cause disease and death by 
contributing to the formation of atherosclerotic plaques in arteries throughout 
the body. It is evident that cholesterol metabolism must be precisely regulated. 
In general, cells outside the liver obtain cholesterol from the plasma, rather than
9
synthesising it de novo. Their primary source of cholesterol is the low density 
lipoprotein. The steps in the uptake of cholesterol by the LDL pathway are:
(i) The LDL particle binds to a specific receptor protein on the cell surface.
(ii) The receptor-LDL complex is internalised by endocytosis-the process 
by which a living cell takes up molecules bound to its surface.
(iii) Lysosomes, which carry a wide array of degradative enzymes, hydrolyse 
the protein component of the LDL to free amino acids and also hydrolyse 
the cholesterol esters. The receptor from the surface of the LDL is 
returned to the membrane and recycled.
(iv) The released unesterified cholesterol can then be used for membrane 
biosynthesis. Alternatively it can be re-esterified for storage inside the 
cell.
The LDL receptor on the surface of cells is subject to a feedback regulation: 
when cholesterol is abundant inside the cell, new LDL receptors are not 
synthesised, and so the uptake of additional cholesterol from plasma LDL is 
blocked. The cholesterol from these LDL particles may then be deposited as a 
component of plaques on arterial walls.
Pioneering studies of familial hypercholesterolemia by Brown and Goldstein 
revealed the physiological importance of the LDL receptor.11 The total 
concentration of cholesterol and LDL in the plasma is markedly elevated in this 
genetic disorder (300 mg/dL c.f. desirable level of 175 mg/dL). In familial 
hypercholesterolemia, cholesterol is deposited on various tissues because of the 
high concentration of LDL-cholesterol in the plasma. More harmful, however, 
is the deposition of cholesterol in atherosclerotic plaques causing arterial 
narrowing and leading to heart attacks. The molecular defect in most cases of 
familial hypercholesterolemia is an absence or deficiency of functional 
receptors for LDL.
The production of LDL receptors is controlled by the cell's need for cholesterol. 
When cholesterol is required, the amount of mRNA for LDL receptor rises and 
more receptor is found on the cell surface. This state can be induced by 
inhibiting cholesterol biosynthesis. Current drug therapy involves inhibition of 
HMG-CoA reductase by lovastatin (also called mevinolin, see scheme 1.4.1).12
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The consequent increase in the number of LDL receptors on liver cells leads to 
a decrease in the LDL level in blood. Plasma cholesterol levels decrease by as 
much as 50% in many patients.
1.4 Drug Therapy
There is much interest in drugs which inhibit cholesterol levels because 
atherosclerosis is the leading cause of death in industrialised societies.2 
Current drug therapy is dominated by inhibitors of 3-hydroxy-3-methylglutaryl- 
coenzyme A reductase (HMGR). In clinical studies such inhibitors effectively 
reduce serum cholesterol levels in a dose-related manner and a recent study has 
demonstrated that lowering raised cholesterol levels in patients with coronary 
heart disease improves survival.13
One such drug is lovastatin (also called mevinolin) which effectively blocks 
cholesterol biosynthesis (K\ = 1 nM) (Scheme 1.4.1). The consequent increase 
in the number of LDL receptors on liver cells leads to a decrease in the LDL 
level in blood.
Scheme 1.4.1
1.5 Antibiotic 1233A
Another suitable enzyme for inhibition is 3-HMG CoA synthase. Antibiotic 
1233A (1.5.1.1) (Figure 1.5.1) inhibits this enzyme specifically and 
irreversibly.1416 1233A was first isolated from Cephalosporium sp. in 1970.17’ 
19 However, since it has also been independently isolated from two other 
sources, it is also known as F-244 (isolated from Scopulariopsis sp.)20 and L-
Prodrug lactone 
1.4.1.1
Inhibitor lovastatin 
1.4.1.2
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o
.OH Antibiotic 
1233A
1.5.1.1
Figure 1.5.1
659,699 (isolated from Fusarium sp.). 21 The structure of 1233A has been 
known since its isolation but its relative and absolute configuration were only 
established in 1988 from a combination of chemical degradation and NMR 
spectroscopic studies. 22 The 2-oxetanone ring was shown to be essential for 
enzyme inhibitory activity since a series of y-lactone, cyclobutanone and 
oxetane analogues were found to be inactive. 23,24 This conclusion is in accord
with several reports concerning the mechanism of inhibition which involves 
acylation of the enzyme by ring opening of the 2-oxetanone moiety by an active 
site cysteinyl sulfhydryl group. 25-29 Not only has the /3-lactone moiety been 
shown to be essential for enzyme inhibition but the length of the side chain also 
plays an important role. 29,30
Very recently Omura et al reported a study which demonstrated that the specific 
absolute configuration (2R, 3R) of the 2-oxetanone 1.5.2.1 (DU-6622) was 
required for most potent inhibitory activity against HMG-CoA synthase. 31 
Omura synthesised all four possible diastereoisomers of 1.5.2.1 and tested each 
one separately.
Figure 1.5.2
Compound 1.5.2.1 is actually more active than 1.5.1.1 in vitro (IC50: 0.098 (iM 
and 0.20 |lM, respectively). Another interesting result is that the (25, 3R) 
isomer is more potent than the (25, 35) isomer which is more potent than the 
(2R, 35) isomer (IC50 values: 9.4 jiM, 31 \iM and 360 jiM, respectively). This
suggests that the C3 geometry of the 2-oxetanone is more important for 
inhibitory activity than the C2 geometry.
CO2M6
(2/7, 3/7) 
DU-6622
1.5.2.1
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Although 1.5.2.1 is very active, it induced a considerable increment in serum 
triglyceride levels. In an effort to find a more selective inhibitor, Omura has 
developed a number of other synthetic 2-oxetanones which retain the same 
lactone motif as the natural product but have similar activity in vitro and in vivo 
with little or no effect on triglyceride levels.32-34 Figure 1.5.3 shows
.OH
c o 2h
o h
1.5.3.1 1.5.3.2
IC50 = 0.74 (iM IC50 = 0.13 nM
Figure 1.5.3
two highly active compounds synthesised by Omura. 1.5.3.1 possesses a hexyl 
ether on the meta- position of the aromatic ring.33 This compound possessed 
good activity in vitro and in vivo (80.1% @ 500 mg/kg versus 83.0% @ 500 
mg/kg for 1233A) but also had no effect on triglyceride levels. An ethyl group 
spacer between the 2-oxetanone and aromatic system was required for good 
inhibitory activity on all analogues investigated. Compound 1.5.3.2 has a more 
complex aromatic system but possesses very high activity in vitro and 
significant in vivo inhibition (51.7% @ 200 mg/kg in the mouse liver versus 
83% @ 500 mg/kg for 1233A).34
The central tenet which underpins the design of these inhibitors lies in a 
hypothetical folded structure of the 1233A side-chain (for an example, see 
Figure 1.5.4). The high activities of some side-chain mimics suggest that these 
analogues may interact with the enzyme in a similar way to the 1233A side- 
chain.
.OH.OHh o 2c
1.5.4.1
Figure 1.5.4
1.5.4.2
13
The biosynthesis of antibiotic 1233A was studied by feeding 13C-labelled 
precursors to the producing organism Scopulariopsis sp. F-244.35 13C NMR 
spectroscopy established that 1233A is derived from 4 methionines and 7 
acetates (Figure 1.5.5).
Figure 1.5.5
Seven acetates are condensed to form a hexaketide and 4 methyl residues from 
methionine are introduced into the main skeleton. The 2-oxetanone is derived 
from the a-carboxylic acid of the hexaketide. Since methionine was efficiently 
incorporated into 1233A, radio labelled 1233A was prepared biosynthetically 
by feeding [ l4C]methionine to the producing organism. As a result, 
[14C]1233A was obtained with high specific radioactivity (27.2 |iCi/jimol). 
This enabled study of the direct interaction between HMG-CoA synthase and 
[14C]1233A which led to the conclusion that [14C]1233A specifically binds 
HMG-CoA synthase covalently.
1.6 Conclusions
In this chapter, the biological stage has been set for the total synthesis of the 
HMG-CoA synthase inhibitor 1233A. There is much known about the 
mechanisms involved in the formation of atherosclerotic plaques and the 
importance of this area will continue for many years with such high death rates 
attributable to coronary heart disease. Drug therapy appears to be a good 
alternative to surgical intervention and already analogues of 1233A are 
appearing in efforts to produce compounds which may one day become 
superior pharmaceuticals.
•—  [1-13C] acetate 
♦ [methyl-^3C] methionine
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Chapter 2
Previous Syntheses of 1233A
2.1 Introduction
15
To date there have been three total syntheses of 1233A and two formal 
syntheses published in the literature. The following discussion presents the 
salient points from these syntheses.
2.2 The Merck Total Synthesis
Antibiotic 1233A was first synthesised in 1988 by a group from Merck, Sharp 
and Dohme. 36
Retro synthetic analysis (Scheme 2.2.1) shows that 2-oxetanone formation could 
be effected via ring-closure and the diene could be constructed via a 
Reformatsky reaction. An Evan's aldol reaction should install the stereogenic 
centres of the 2 -oxetanone ring and the aldehyde (2 .2 .1 .2 ) could be made from 
(R)-pulegone (2.2.1.3).
Y < 3 p2 
\  C 02Me 
M Evan's AldolO
2.2.1.1
Adam's ring closure
,OH
1.5.1.1
Reformatsky
\ /  2.2.1.2
(R)-pulegone 
2.2.1.3
Scheme 2.2.1
Synthesis
Schemes 2.2.2 and 2.2.3 show the approach taken in practice. The key step was 
a highly diastereoselective Evans aldol37 reaction between an N- 
crotonyloxazolidinone (2.2.3.1) and aldehyde 2.2.1.2, Aldehyde 2.2.1.2 was 
prepared from (R)-(+)-pulegone (2.2.1.3) (Scheme 2.2.2). After ring-opening,
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DIBALH reduction, methyl magnesium iodide addition to the resultant 
aldehyde and oxidation with chromium trioxide-pyridine in dichloromethane, 
the methyl ketone 2.2.2.2 was obtained in 70% yield. Protection of the ketone 
as the ketal and ozonolysis revealed aldehyde 2.2.23 which was then chain 
extended with a Homer-Wadsworth-Emmons reaction followed by olefin and 
ester reduction.
(R)-pulegone 
2.2 .1.3
Scheme 2.2.2
Thus, upon treatment with dibutylboron trifluoromethanesulfonate (Bu2BOTf) 
and triethylamine, oxazolidinone 2.2.3.1 gave the corresponding boron enolate 
which smoothly added to aldehyde 2.2.1.2. After silylation (TBS) of the 
product GC analysis revealed 94% diastereoselection.
Removal of the chiral auxiliary in 2.23.2 gave a mixture of protected and 
unprotected ketones which were silylated together before treatment with 
hydrochloric acid. Methoxyethoxymethyl (MEM) protection gave olefin
2.2.3.4 in 30% overall yield. Conversion of the double bond in 2.2.3.4 to ester
2.23.5 was achieved via ozonolysis, oxidation with PDC and methylation with 
diazomethane in 54% overall yield. Lewis acid removal of the MEM protecting 
group to give 2.2.3.6 was followed by 2-oxetanone formation employing the 
classical Adams ring closure procedure: 38 sodium hydroxide cleavage of the 
methyl ester and conversion of the crude acid to a mixed anhydride with 
benzene sulfonyl chloride invited attack from the adjacent hydroxyl group 
forming four-membered ring compound 2.2.3.7 in 48% yield. This sequence is 
a common factor in all the total syntheses of 1233A detailed in the literature.
(i) h o c h 2c h 2o h
p-TsOH
(ii) H2, Pd/C
(iii) DIBALH
17% from 2.2.2.3
2.2.2.3
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Finally, the diene portion is attached with a Reformatsky reaction between 
lactone 2.2.3.7 and bromide 2.2.3.8 to give trans 2-oxetanone 2.2.3.10 and 
lactone 2.2.3.9. After separation of the desired 2.2.3.10, dehydration and
/ J ^ y  C ^
Bu2BOTf, Et3N 
CH2CI2> -78°C
> < ^  then 2.2
-78 -> 0°C
OH O O
66%
O' O
2.2.3.2
2.2.3.1 2.2.1.2
OMEM
O 2.2.3.4
(a) 0 3, CH2CI2i -78°C 
then Me2S, 0°C rt
(b) PDC, DMF, rt
(c) CH2N2> Et20 , rt
54%
(a) f-BuPh2SiCI, imid 
DMF, rt
Bu3B, AcOH 
THF, rt then 
LiBH4, THF, 0°C
OH
(b) HCI (aq)
(c) MEMCI, /-Pr2NEt 
CH2CI2, 0°C -> rt 
30% overall
2.2.3.3
R = J R='O^ ’ o
OMEM
OTBDPS
C 02Me
2.2.3.5
ZnBr2 
CH2CI2, rt 
 ►
mixture
OH
r4t
OTBDPS
2.2.3.6
(a) NaOH, /-PrOH, 60°C 
then 1 N HCI
(b) PhS02CI, pyr, 0°C 
33% overall0 2/-Bu
2.2.3.8
2.2.3.9 Zn, 2.2.3.8, THF, A OTBDPS
44% 2.2.3.7
O
C 02f-Bu
2.2.3.10
OTBDPS
SOCI2
c h 2ci2
pyr, A
C 02f-Bu ► 1.5.1.1
2.2.3.11
+ other isomers
50% HF (aq) 
THF, rt 
23% overall
Scheme 2.2.3
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simultaneous deprotection of the tert-butyl ester and rm-butyldimethylsilyl 
groups with aqueous HF gave 1.5.1.1 in an overall yield of <1%.
Although the initial key step to install the chiral centres of the oxetanone 
proceeded efficiently using Evans chemistry, subsequent manipulations resulted 
in mixtures of isomers and rather low yields. In particular, the last few steps 
are rather arduous: the Reformatsky reaction, in addition to being complicated 
by unreacted starting material, produced two products: the desired tertiary 
alcohol 2.2.3.10 and a,/3-unsaturated lactone 2.2.3.9. 2.2.3.10 is a mixture of 
four isomers which are subsequently separated, after dehydration, using 
preparative TLC which required seven elutions! At 23 steps this synthesis is 
also lengthy for a molecule containing 18 carbons and 3 stereocentres.
2.3 The Wattanasin Formal Synthesis
Scheme 2.3.1 shows an alternative synthesis, by Wattanasin et al, of advanced 
intermediate 2.2.3.7 from the Merck synthesis39 therefore constituting a formal 
total synthesis. Hence the first and key step uses the enolate of Braun's chiral 
acetate40 2.3.1.1. Condensation of this enolate with aldehyde 2.2.1.2 derived 
from (R)-(+)-citronellol led to /3-hydroxy ester 2.3.1.2 which was transformed 
to the desired rrarcs-2-oxetanone 2.2.3.7.
3h LiN(SiMe3)2
Ph --------------*
THF, -100°C
Ph 80%
(i) H2 (50 psi)
10% Pd/C, EtOAc(i) K2C 03> MeOH
(ii) LDA, BnOCH2CI 
THF, -78°C rt 
32%
OCH2Ph
|| 31%
°  2 .3 .1 .4  w
H Q (i) f-BuPh^SiCI, imid, DN
11 (ii) NaOH, /-PrOH, 60°C
Y  OMe ____________________
\  (iii) PhS02CI, pyr, 0°C -
Scheme 2.3.1
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Overall yield was 8 % (c.f Merck, above, with 0.4% overall yield for the same 
compound).
2.4 The Mori Total Synthesis
Mori has prepared 123 3A making use of the chirality generated from an 
enzymatic reaction.41
Retrosynthetic analysis starts with the classical Adam's ring closure of the 2- 
oxetanone ring (Scheme 2.4.1). A Homer-Wadsworth-Emmons reaction should 
furnish the desired olefin. Functional group addition of a phenyl vinyl sulfone 
in the position beta to the secondary alcohol to give 2.4.1.1 should allow an 
epoxide ring-opening disconnection hence revealing the key carbon-carbon 
bond forming process between sulfone 2.4.1.2 and epoxide 2.4.1.3,
^ .A dam 's ring closure
PhS02
£T\
w
Scheme 2.4.1
Synthesis
Mori's approach starts with the preparation of homochiral alcohol 2.4.2.2 
employing a pancreatic lipase-induced asymmetric hydrolysis of the meso- 
diester derived from the starting mesoacetylenic diol 2.4.2.1 (Scheme 2.4.2). 
After hydroxyl protection the terminal olefin is epoxidised with meta- 
chloroperbenzoic acid. Unfortunately this reaction produces two epoxide 
diastereoisomers 2.4.2.3 and 2.4.2.4 in a 1:1 ratio. Other epoxidation
" " " | ^ ^ S 0 2Ph CL, OP => U ,
''OH 0 X 0 * L
epoxide ring-opening '— ’ ^
>.4.1.1 2 -4 1 -2 2 -4 *1*3
O-'-
.OH
.OH
1.5.1.1
Horner-Wadsworth-Emmons
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conditions, such as the Sharpless epoxidation, were tried but no improvement in 
diastereoselectivity was found. However chromatographic separation was 
possible, after deacetylation with potassium carbonate in methanol, to give
(i) Ac20 , pyr,
CH 0°C -> rt JDAcH (ii) H2, Lindlar Pd
(i) f-BuPtfeSiCI, imid 
DMF, 0°C
2.4.2.1
H2, Lindlar Pd 
EtOAc, rt 
(iii) P. Lipase, 0.5 M 
pH 5 buffer, 0°C 
79%
2.4.2.2
(ii) m-CPBA, NaHC03
c h 2ci2, a
87%
TBDPS^
^ H
2.4.2.5
K2C 03i MeOH, rt
t---------------
then separation 
38%
EtMgBr, HMPA-THF 
—78°C then BuLi, 2.4.1.2 
THF, HMPA-THF, -78°C 
79%
2.4.2.6
(i) Na/Hg, EtOH, rt 
TBDPS ---------------------- ►
(ii) Me2C(OMe)2 
PPTS, Me2CO, A
91%
2.4.2.4 2.4.2.3
a 2.4.1.2
TBDPS
^DTBDPS
2.4.2.7
Me02'
1.5.1.1
(i) PhS02CI i { 
pyr, 0°C
(ii) 80%
AcOH, 50°C
18%
P(OMe)2
2.4.2.8
(i) 2.4.2.8, KH, THF, 0 40°C
(ii) TBAF, THF, 0°C
(ii) (COCI)2, DMSO, CH2CI2 
-78 -> 0°C then Et3N 
(iv) NaCI02, NaH2P 0 4 
2-methylbut-2-ene, f-BuOH-H20 , rt 
55%
(i) Amberlyst-15 
0 2H MeOH, rt
-----------------------
(ii) TrCI, pyr,70°C
(iii) LiOH, THF 
H20,30°C
85%
2.4.2.10 2.4.2.9
Scheme 2.4.2
alcohol 2.4.2.5. The key coupling reaction was then performed with addition of 
the anion of phenyl sulfone 2.4.1.2 (prepared in 6  steps from (/?)-citronellic 
acid) to the epoxide derived from 2.4.2.5. HMPA was required to effect 
smooth coupling in 79% yield. Desulfurisation and diol protection with
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concomitant removal of the ketal protecting group prepared the molecule for a 
Horner-Wadsworth-Emmons reaction. Hence, reaction of 2.4.2.7 with the 
potassium anion of phosphonate 2.4.2.8 produced a mixture of isomers 
containing 70% of the desired (E , E) diene and 30% of a mixture of other 
geometrical isomers.
Subsequent manipulations led to trityl protected /3-hydroxy acid 2.4.2.10 which 
was ring-closed as in previous examples using Adam's protocol. Separation of 
the various diastereoisomers and removal of the trityl group with acetic acid 
gave 1.5.1.1 in an overall yield of <1% over 19 steps.
This synthesis is similar in terms of efficiency to Merck's approach. It is long 
at 19 steps and complicated by mixtures of isomers at key points such as the 
epoxidation of 2.4.2.2 to 2.4.2.4 and the Homer-Wads worth-Emmons reaction. 
The key coupling between sulfone 2.4.1.2 and epoxide 2.4.2.5, although not 
directly forming any new stereocentres present in the natural product, was a 
noteworthy highlight.
At this juncture the difficulties experienced with these syntheses clearly 
demonstrate the deceptive complexity of 1233A and the challenges still 
remaining for the modem synthetic organic experimentalist.
2.5 The Wovkulich Total Synthesis
Of the three total syntheses to date the Wovkulich approach is the most recent, 
published in 1993, utilising two diastereoselective processes: a [2,3] Wittig 
rearrangement and a hydroboration.42
Retro synthetic analysis starts again with the Adam's ring-closure and a Heck 
reaction which should form the desired diene (Scheme 2.5.1). Classical Negishi 
carboalumination to form vinyl iodide 2.5.1.1 followed by some functional 
group manipulation may allow an opportunity to perform a diastereoselective 
hydroboration and a [2,3]-Wittig rearrangement, key steps in creating the motif 
in 2.5.1.2 to lay the stereochemical foundations for building 1233A.
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Adam's ring closure
/ jO
.OH
rr -
Heck Coupling
OP
2.5.1.3
>.5.1.1 0 ^ 0
OP
Carboalumination
OP
Hydroboration
2.5.1.2 ^
OH OH 
2P3]-Wittig rearrangement
Scheme 2.5.1
Synthesis
Asymmetric hydrogenation of diketo ester 2.5.2.1 gave /3-hydroxy ester 2.5.2.2 
in 99% ee and 81% yield (Scheme 2.5.2). Silyl protection, Wittig 
methylenation and DIBALH reduction of the ester led to olefin 2.5.2.3 which 
was further reduced with a rhodium catalysed hydrogenation. This last step 
resulted in the formation of two products: the desired alcohol 2 .5 .2 .5 
constituted 80% of the mixture and was separated from the undesired 2.5.2.4. 
Selenium induced elimination and acid catalysed desilylation gave the alcohol
2.5.2.6 in 27% overall yield for the 8 steps from 2.5.2.I.
O
h2, Ru(L*) ^ Y " C 0 2Me (i)TBSCI 
81%, 99%ee 0 ^ ^ Sss* ^ ^ 0 H
2.5.2.1 2.5.2.2
ii) Ph3P=CH2
iii) DIBALH
73%
OH
OTBS
Ru(L*) = {RuCI(C6H6)-[(S)-BINAP]}Cr
2.5.2.3
H2
Rh(PPh3)3CI
78%
OH
2.5.2.6
(i) ArSeCN 
PBu3
(ii) h 2o 2
(iii) TsOH 
58%
OH
I
OH
/ ’O ^ o T B S  OTBS
2.5.2.5 2.5.2.4
4 : 1
Scheme 2.5.2
The key transformation was a diastereoselective [2,3] rearrangement of bis- 
allylic ether 2.5.3.2 to allylic alcohol 2.5.3.3 (Scheme 2.5.3). Although the
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yield is only 40% and some unidentifiable by-products are also formed, the 
product is isolated as a single diastereoisomer. Some of the problems with this 
step may stem from a lack of regioselectivity at the initial deprotonation step 
(i.e. require selective deprotonation of CH  2 O C 6 v e r s u s  
CH2OTBS).Hydroboration of the rearranged compound with 9-BBN and 
hydrogen peroxide resulted in a 85:15 mixture of diastereoisomers in favour of
2.5.2.6
2.5.3.1
SiMe2/-Bu
D h NaH, TBAI, THF, 60°C 
60%
TBS
2.5.3.2
BuLi, THF 
-78  —» -20°C 
40%
(i) CUSO4 
Me2CO, rt
(ii) 0 3, MeOH 
CH2CI2, -78°C 
then NaBH4
56% overall
2.5.3.4
TBS
OH OH
9-BBN, THF 
0°C - » rt then 
<-------------
NaHC03, H20 2
2.5.3.3
TBS
85:15 (other diast.)
(i) PivCI, DMAP 
v /  pyr, 0°C X (ii) i-Pr2NEt, MsCI 
~  CH2CI2, 0°C
2.5.3.5 OTBS
LiEt3BH, THF, A 
76% '''OTBS2.5.3.6
2.5.3.9
H OH
(i) f-Bu-crotonate 
Ag2C 03 
Pd(OAc)2, Et3N 
CH2CI2, rt
(ii) 2.5.3.9, CH2CI2 
- 20°C then NaCI02 
NaH2P 0 4-H20
66%
-----------------------
(i) CP2Z1CI2 
Me3AI then 
l2. THF
0) (COCI)2 
DMSO, CH2CI2 
—50°C then Et3N 
(ii) f-BuOK 
N2CHPO(OEt)2 
THF, -78°C rt 
70%
2.5.3.8
(ii) Me2AICI 
OTBS CH2CI2, - 20°C 
77% OTBS
2.5.3.7
0 2f-Bu
2.5.3.10
n  H (i) PhS02CI, pyr 
2 0->10°C
------------------- 1 .5.1.1
OTBS (ii) 490/0 HF (acl)
THF, rt 
55%
Scheme 2.5.3
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the desired diol 2.5.3.4. This mixture was protected as the acetonide before the 
isomers were separated. However the minor diastereomer was not wasted: 
convenient re-equilibration under thermodynamic conditions (Q 1SO4 , acetone, 
TsOH) produced a mixture of three isomers enriched in the desired one (after 
re-silylation). In this way isomeric material could be salvaged.
Cleavage of the cyclohexene ring via ozonolysis with reductive work-up gave 
2.5.3.5, Selective pivaloyl protection of the primary alcohol and removal of the 
unwanted hydroxyl group (mesylation and treatment with super-hydride) gave 
alcohol 2.5.3.6 (the pivaloyl group is lost in the hydride reduction). Swern 
oxidation and homologation of the resultant aldehyde employing Gilbert's 
(diazomethyl)phosphonate conditions43,44 set up terminal acetylene 2.S.3.7, an 
appropriate substrate for a classical Negishi carboalumination with iodine 
quench. 45 The (E ) vinyl iodide 2.5.3.8 was then coupled with tert-butyl 
crotonate in the key Heck reaction catalysed by palladium acetate under newly 
developed conditions employing 1.1 equivalents of silver carbonate in 
dichloromethane. Only a few per cent of unwanted (Z, E) isomer was formed. 
Remarkably, with DMF or THF as solvents the reaction required 5-8 days to 
progress anywhere near completion! No explanation was offered for this 
solvent effect and no other studies were carried out with other non-complexing 
solvents.
Oxidation of the resultant diol with N-oxammonium chloride (2.5.3.9) gave an 
unstable hydroxy aldehyde which was immediately further oxidised to hydroxy 
acid 2.5.3.10 with sodium chlorite. Ring closure again with Adam's protocol 
and deprotection (aqueous HF, THF) afforded the natural product 1.5.1.1 in 2% 
overall yield.
Wovkulich's synthesis of 1233A is linear and not short at 24 steps but the 
overall yield of 2 % is reasonable when compared with previous approaches 
discussed above. However the first key step, [2,3]-Wittig rearrangement, only 
gave 40% of the desired product and the second key step produced mixtures of 
diastereoisomers. Although some of these isomers could be re-processed by 
equilibration, it is still somewhat inelegant and laborious to proceed with a 
reaction which is not selective synthetically (i.e. would require either very easy 
separation or no separation at all). Chiral pool materials are relied on heavily in 
the above approaches but Wovkulich has started with a catalytic asymmetric 
hydrogenation of diketone 2.5.2.1, a more efficient and forward-thinking
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strategy. Finally the palladium catalysed Heck cross-coupling, although 
requiring a large excess of tert-bvXy\ crotonate (35 equivalents), was very 
satisfying since installation of hindered multi-substituted olefin systems with 
most commonly used methodologies (e.g. Wittig, dehydration) are almost 
always accompanied by significant quantities of geometrical isomers.
2.6 The Guanti Formal Synthesis
Only three years ago, Guanti published a synthesis46 of advanced intermediate
2.5.3.6 from the Wovkulich synthesis therefore constituting a formal total 
synthesis.
The starting alcohol 2.6.1.1 was prepared from the corresponding diol by an 
enantioselective PPL catalysed monoacetylation (96% ee). Protection of the 
alcohol as it's pa ra-methoxybenzyloxymethyl (PMBOM), exchange of the 
acetate for TBS and ozonolysis with reductive work-up gave primary alcohol 
2.6.1.3, Swern oxidation allowed a diastereoselective Lewis acid catalysed 
allylation providing secondary alcohol 2.6.1.4 with a diastereomeric ratio of 
86:14. After removal of the PMBOM group with DDQ, acetonide formation 
and hydroboration of the terminal olefin, another Swern oxidation was 
performed to give an aldehyde which was the electrophilic partner in the key 
step: addition of the anion of sulfone 2.6.1.7 (derived from (/?)-methyl 3- 
hydroxy-2-methylpropanoate in 8 steps, 69% yield) to the aldehyde followed 
by in situ benzoylation of the intermediate /3-hydroxy sulfone and elimination 
to the olefin 2.6.1.8 with lithium in liquid ammonia. This route was found to 
produce an acceptable yield (34% from 2.6.1.5) compared to other standard 
work-up procedures e.g. elimination of the benzoyl derivative with sodium 
amalgam.
Platinum catalysed hydrogenation of the 9:1 E:Z mixture of alkenes produced 
the target intermediate 2.5.3.5 in 11% overall yield (c.f. Wovkulich's overall 
yield for the same intermediate of 3%).
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2.6.1.1
9H (i) PMBOMCI, /-Pr2NEt
(ii) KOH, MeOH 
-------------------------
(iii) TBSCI, imid 
OAc DMF, 87%
O(PMBOM)
2 .6.1.2 OTBS
(i) 0 3> MeOH-CH2CI2
(ii) NaBH4
92%
OH O(PMBOM) OH O(PMBOM)
= 2 .6 .1.3
d.r. = 86:14 ^OTBS 
2.6.1.4
(i) DDQ, pH 7 buffer 
CH2CI2, f-BuOH
(ii) MeO(Me)C=CH2 
PPTS, 67% 
 ►
(ii) allylSnBu3, MgBr2 
CH2CI2, -78 —»-20°C 
85%
O 9-BBN, then H20 2 
NaHC03, 90%
‘OTBS
2.6.1.5 OTBS 2.6.1.6 OTBS
.OH
2.5.3.6 OTBS
"'"r/ ^ S 0 2Ph
2.6.1.7
H2, Pt02 
C6H6, 90% .OH
OTBS2 .6.1.8
(i) (COCI)2, DMSO 
Et3N, CH2CI2 
-78 -4 -40°C
(ii) 2.6.1.7, BuLi 
THF, -78°C
(iii) Et3N, PhCOCI
(iv) Li, NH3, THF 
-78°C, 34%
Scheme 2.6.1
2.7 Conclusions
In this chapter, syntheses of the cholesterol biosynthesis inhibitor 1233A 
already published in the literature have been discussed. It is clear that, although 
these works possess some originality and reach their goals, there is still much to 
be improved. Particularly, the synthesis of the 2-oxetanone core has been 
approached in similar ways and there have been very few stereoselective 
methods towards the diene moiety.
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Chapter 3
Structural Features and Retrosynthetic 
Analysis of 1233A
i
I
3.1 Introduction
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This chapter will discuss the structural features of 1233A and the possible 
approaches to a total synthesis. These approaches will employ both novel and 
very recently published methodology. The goal is to make real contributions to 
the field of organic synthesis by designing a concise and stereocontrolled route 
to the target.
3.2 Structure Features of 1233A
1233A is an oxygenated natural product consisting of a strained trans 
disubstituted 2-oxetanone ring. On carbon 3', a  to the ring carbonyl, resides a 
hydroxymethyl group. On carbon 4' there is a straight chain of 11 carbons 
terminating in a carboxylic acid. In the centre of this chain resides an isolated 
chiral methyl group. A hexasubstituted diene unit is in conjugation with the 
terminal acid moiety, posing a considerable challenge to the synthetic chemist.
r Y ' Y ™
Figure 3.2.1 
3.3 Retrosynthetic Analysis
In the previous two chapters, biological data and previous total syntheses were 
discussed. Therefore it becomes clear that 1233A possesses usefulness through 
the inherent reactivity of the 2-oxetanone ring and that this structural feature 
may only be synthesised with difficulty using predominately ring closure 
strategies. Hence the oxetanone motif poses the most significant synthetic 
challenge since there is a real need for more efficient and generally applicable 
methodologies.
Past tactics have entirely relied upon the ring-closing methodology of Adams38 
(see Chapter 2). A new approach would be disconnection of both the indicated 
bonds in Scheme 3.3.1. An asymmetric [2+2] cycloaddition of a silylketene
Antibiotic 
1233A 
1.5.1.1
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with an aldehyde should accomplish this transformation. The history and 
development of this chemistry is fully detailed in chapters 6 and 7 and at this 
point it should be made clear that this methodology was developed before the 
synthesis of the natural product was undertaken. Before such a cycloaddition, 
retro synthetic removal of the hydroxymethyl group will be necessary. 
Quenching a /3-lactone-derived enolate with carbon dioxide in an aldol-type 
process could lead to an acid which could be reduced to the desired 
hydroxymethyl group. This chemistry had to be investigated before any work 
towards the natural product could be undertaken (see Chapter 8).
[2+2] cycloaddition
»2 aldol reaction
1.5.1.1 3.3.1.1
xKr^SiMe3
6.2.10.2
Scheme 3.3.1
Aldehyde 3.3.1.1 then becomes the next target for analysis. Shielding of the 
reactive aldehyde as a silyl protected alcohol (e.g. TBS) leads to consideration 
of possible disconnections towards the diene moiety. Wovkulich reported a 
stereoselective Heck reaction (see Chapter 2) which seems quite efficient 
(although a few per cent of an unwanted isomer was isolated), but it would be 
worthwhile to consider other interesting routes using new methodology.
A Julia olefination strategy47 (see Chapter 4) would be one possibility where 
either ketone 3.3.2.2 and sulfone 3.3.2.3 or sulfone 3.3.2.4 and aldehyde 3.3.2.5 
could be coupled together (Scheme 3.3.2).
3.3.1.1
OTBS &
\ ' 0
Julia olefination
3.3.2.2
OR
BTS02
3.3.2.3
%OTBS
Reformatsky
t4 3.3.2.4
,s o 2bt  +
OR
3.3.2.5
3.3.2.3
or
3.3.2.5
3.3.2.6
+  Br
o o
3.3.2.7 3.3.2.8
OR
Scheme 3.3.2
Sulfone 3.3.2.3 and aldehyde 3.3.2.5 should be available from common 
intermediate 3.3.2.6 which itself can be synthesised via a Reformatsky reaction 
of the appropriate a-bromo ester 3.3.2.8 with chloroacetone. 48 
Failing this, one alternative could be the Stille coupling49,50 of vinyl stannane
3.3.3.2 with vinyl iodide 3.3.3.1. This disconnection is shown in Scheme 3.3.3: 
vinyl iodide 3.3.3.1 would almost certainly be available through the Negishi 
carboalumination45 (see Wovkulich's total synthesis, Chapter 2) and vinyl 
stannane 3.3.3.2 could be accessed with a stannylcupration51 of the desired ester 
of tetrolic acid. Acetylene 3.3.3.3, the carboalumination substrate, could be 
formed with a Corey-Fuchs homologation52 of the corresponding aldehyde. An 
oxidation state change leads to the key intermediary chiral ester 3.3.3.4.
3.3.2.1 OTBS 3.3.3.1 OTBS
Stannylcupration 
RaSrv/ JDR
O
3.3.3.2
Stille Coupling
OTBS
,OEt
3.3.3.4
Carboalumination
OTBS
II
■c o 2r
3.3.3.5
3.3.3.3
Corey-Fuchs— 7
Scheme 3.3.3
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In order to install the isolated chiral methyl group in ester 3.3.3.4 it would be 
more efficient to employ a catalytic asymmetric reaction instead of using a 
chiral pool approach as in some past syntheses of 1233A. Cobalt semi-corrin 
catalysed reduction of a, j8-unsaturated esters to give /3-chiral saturated esters 
was developed by Pfaltz53 in the 1980's (see Chapter 4). This reaction, which 
has received little attention in the literature, is extremely efficient requiring only 
1 mol% of the catalyst which is commercially available. The disconnection to 
a, /3-unsaturated ester 3.3.4.1 is shown in Scheme 3.3.4.
>-i-TBSI
^desilylation 
.4.1
II
OH
O
3.3.4.2
3.3.4.3
Scheme 3.3.4
Retrosynthetic cleavage of the double bond in 3.3.4.1 with, perhaps, a Homer- 
Wadsworth-Emmons54 reaction leads to 7-hydroxyheptan-2-one (3.3.4.2). This 
seven carbon starting material is not commercially available but could be 
synthesised easily (via ozonolysis and selective reduction of the aldehyde 
group) after a reconnection reveals 1-methyl-cyclohexene (3.3.4.3).
The above analysis will, of course, change as laboratory work progresses.
3.4 Conclusions
In this chapter a retrosynthetic analysis of the cholesterol biosynthesis inhibitor 
1233A has been detailed employing a plethora of metal mediated reactions, 
including a novel [2+2] cycloaddition of an aldehyde with a silylketene and a 
catalytic enantioselective reduction.
Pfaltz
Reduction
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Chapter 4
The Use of a Cobalt Semicorrin 
Catalysed Enantloselective Reduction 
for the Synthesis of Chiral Ester 3.3.3.4
4.1 Introduction
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This chapter will discuss the approach towards the synthesis of the first chiral 
key intermediate: (5-chiral ester 3.3.3.4 (Figure 4.1.1).
OTBS
,OEt
3.3.3.4
Figure 4.1.1
4.2 The Cobalt Semicorrin Catalysed Enantioselective Reduction
Over the past two decades, asymmetric catalysis has evolved into a dynamic 
and rapidly growing area of research. As a result, powerful synthetic catalysts 
have become available which exhibit levels of enantioselectivity previously 
considered beyond reach for non-enzymatic processes.55 The impressive 
enantioselectivities that have been achieved are exemplified by combining a 
catalytically active metal with different types of chiral ligands, for example, 
ruthenium-BINAP hydrogenation,56 57 Sharpless epoxidation58*59 and now the 
Pfaltz conjugate reduction of an a,/3-unsaturated ester with cobalt semi-corrin 
catalyst 4.2.1.2 (Scheme 4.2.1).53’60
J
Scheme 4.2.1
Nx. >1
TBSOCH2 c h 2o t b s
4.2.1.2
(1.2 mol%)
.R
C0CI2 (1.0 mol%) EtOpC"
NaBH4 (2 eq)
4 .2 .1.1 EtOH, DMF, rt, 2 d 4.2.1.3
yields >90%, e e s  >90%
A new stereogenic centre is created if the olefin portion is tri- or tetra- 
substituted. The configuration of the product may be controlled at will by using 
either the natural or unnatural ligands derived from L- or D-pyroglutamic acid. 
Alternatively, the ligand is available commercially albeit at a premium. The
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product configuration may also be controlled by changing the geometry of the 
olefin substrate: the opposite product enantiomer is obtained by changing from 
(E) to (Z) if the same catalyst is used. Hence, this chemistry is very flexible and 
therefore the more accessible substrate isomer may be used with the appropriate 
catalyst to give the desired product.
The semi-corrin ligand which is complexed to cobalt is conformationally rigid 
with the chirality elements in close proximity to the co-ordinating metal centre. 
This is a central tenet of Pfaltz's approach to enantioselective catalysis and has 
borne much fruit.
The semi-corrin ligand may also be used for the copper catalysed 
enantioselective cyclopropanation of olefins with diazo compounds.53
4.3 Synthesis of Trisubstituted Olefin 3.3.4.1
In order to carry out the cobalt catalysed enantioselective reduction a 
stereocontrolled synthesis of trisubstituted a,/J-unsaturated ester 3.3.4.1 was 
required. From the discussion above it is clear that to obtain the desired (R) 
configuration of 3.3.3.4 an (£) olefin will be required using the ligand 4.2.1.2 
derived from natural L-glutamic acid. Two approaches were investigated: a 
Homer-Wads worth-Emmons reaction and a carbocupration reaction.
4.3.1 The Horner-W ads worth-Emmons Approach to a,/J-Unsaturated 
Ester 3.3.4.I.
4.3.1.1 Synthesis of Ketone 4.3.1.2 via Ozonolysis of 1-Methylcyclohexene
The now classical reaction between a carbonyl compound and a phosphorus 
ylid revolutionised organic synthesis after its original publication in 1949.61 
Alkenes became readily available and since they were invariably embedded in 
the stmcture of many natural products they were on the target list of many 
synthetic chemists. Inevitably this widespread use led to many improved 
versions of the original reaction. One of these improvements was the use of 
phosphonates instead of phosphoranes.54 Generally, phosphorane derived ylids 
give (Z) olefins and olefination with phosphonate carbanions gives (E )
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products. The phosphonate variation has come to be known as the Homer- 
Wadsworth-Emmons modification of the Wittig olefination.
In order to obtain (E) stereoselectivity in the synthesis of 3.3.4.1 the Homer- 
Wadsworth-Emmons (HWE) reaction could be applied . A reaction between a 
protected 7-hydroxyheptan-2-one (4.3.1.2) and the anion of 
triethylphosphonoacetate should yield 3.3.4.1, Therefore the first objective was 
to prepare 4.3.I.2. Although alcohol 3.3.4.2 is known in the literature, these 
published methods are not synthetically useful since yields were low and the 
product was often obtained as complex mixtures with other side-products.62’63 
An alternative approach could be the ozonolytic ring-opening of 1- 
methylcyclohexene (3.3.4.3) with reductive work up followed by selective 
reduction of the aldehyde. Scheme 4.3.1 shows the result of this chemistry.
3.3.4.3
(i) o 3, c h 2ci2
-78°C, 1 h 
----------------
(ii) DMS or 
PPh3, 18 h
60% 4.3.1.1
(i) NaBH(OAc)3 
THF, A, 0.5 h—» 
3.3.4.2 
 ►
(ii) TBSCI 
imid, DMAP 
CH2CI2, rt, 1 h
46%
OTBS
4.3.1.2
Scheme 4.3.1
Ozonolysis of 3.3.4.3 at -80°C in dichloromethane with reductive work-up 
(dimethylsulfide or triphenylphosphine) gave a 60% yield of aldehyde 4.3.1.1, 
Selective reduction of the aldehyde carbonyl with two equivalents of sodium 
triacetoxyborohydride in refluxing THF furnished alcohol 3.3.4.2 in 70% yield. 
Silylation of 3.3.4.2 proceeded uneventfully giving protected ketone 4.3.1.2, the 
HWE substrate, in a moderate 65% yield. However, preparation of 4.3.1.2 via 
this three step procedure was laborious and low yielding (27% overall) and the 
ozonide derived from 3.3.4.3 was found to only slowly decompose under the 
reductive conditions and in one case actually detonated on distillation (after 
probably inadequate reductive treatment) so a more practical route was sought.
4.3.1.2 Synthesis of Ketone 4.3.1.2 via Ring-Opening of £-Caprolactone
In 1993 Overman published procedure allowing transformation of an ester to 
the analogous methyl ketone via methyllithium addition.64 It is logical to
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extend this method to lactones thereby providing access to hydroxy methyl 
ketones. Hence, 3.3.4.2 could be accessed by a ring-opening reaction of the 
very cheap £-caprolactone with methyl lithium at -105°C (Scheme 4.3.2).
o (i) MeLi, THF 
-1 05°C  ►
(ii) MeaSiCI
4.3.2.1
TMS< OH
'iii) HCI
84% O 3.3.4.2
TBSCI, imid 
DMAP, CH2CI2 
97%
4.3.2.2
OTBS
O 4.3.1.2
Scheme 4.3.2
Temperature control is essential to prevent methyl ketone formation during the 
reaction and hence double addition of a methyl group. (In previous studies,
4.3.2.1 was ring-opened with methyl lithium and also methyl magnesium 
chloride; as expected, a statistical mixture of unreacted starting material, 
desired product and tertiary alcohol (from double addition) were isolated.) The 
second stage, after addition of the methyl group to the carbonyl, is the trapping 
of the anion intermediate with trimethylsilyl chloride. In this way, the mono­
addition product may be warmed to 0°C and hydrolysed with dilute 
hydrochloric acid resulting in a satisfying 84% isolated yield of 3.3.4.2. 
Protection with rm-butyldimethylsilyl chloride produced an almost quantitative 
yield (97%) of ketone 4.3.I.2. This improvement in yield was most likely due 
to better quality 3.3.4.2 stemming from a more efficient and cleaner 
preparation. The ring-opening reaction was performed on a 0.1 mole scale. 
Overall yields for this improved process are 81%, a three-fold improvement 
over the initial route.
4.3.1.3 The Horner-Wadsworth-Emmons Reaction
Having access to suitable quantities of ketone 4.3.1.2 provided the opportunity 
to explore the HWE reaction for the synthesis of 3 .3 .4 .1 . Using
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triethylphosphonoacetate with sodium hydride in refluxing THF gave 91% of 
the desired product (Scheme 4.3.3).
Scheme 4.3.3
Unfortunately, 3.3.4.1 was isolated as a 3.5:1 mixture of (E):(Z) geometrical 
isomers. Various conditions were explored to attempt to improve this isomeric
(i) Conducting the reaction at a lower temperature (rt, 18 h).
(ii) The influence of tertiary amine bases and added salts on enolate 
formation and stabilisation has been well documented. 65
(iii) Use of differently substituted phosphonates.
Attempt (i) resulted in no change in ratio or yield and (ii) gave no reaction, (iii) 
was tried with several phosphonates: ethyldizw-propylphosphonate was the best 
but only offered a marginal improvement in (E):(Z) ratio to 5:1. The greater 
cost and slim gain in isomer ratio was, on balance, judged to be unworthy of 
pursuit. Despite the above disappointments, the (E ) and (Z) isomers were 
separable with careful chromatography: various batches of different purities 
were obtained; repeatedly chromatographing these batches with the same 
column of silica gel in a recycling fashion eventually resulted in production of 
pure (E) isomer 3.3.4.I. Chromatographic separation in this manner is not 
entirely practical and somewhat laborious therefore a more efficient preparation 
of 3.3.4.1 was sought.
4.3.2 The Carbocupration Approach to a,/3-Unsaturated Ester 3.3.4.1.
o o
OTBS
(E):(Z) = 3.5:1
ratio:
Organocuprate methodology represents an important niche in organic synthesis. 
Organocuprates R2CuLi*LiI, prepared from two equivalents of lithium reagent 
and a copper (I) salt CuX (typically X = I, Br, CN) are indispensable reagents
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for selective carbon-carbon bond formation. 66,67 A fundamental problem with 
these reagents is that only one of the R groups is utilised in synthetic 
applications. Hence the ultimate goal in organocuprate chemistry would be a 
reactive cuprate with a cheap, non-toxic non-transferable ligand. Previous 
work towards this goal has comprised of two basic approaches using a non 
transferable ligand which is:
(i) bonded to Cu at an sp or sp2 carbon (e.g. alkynyl68 or 2-thienyl, 69,70 
respectively) or
(ii) attached to Cu via a heteroatom such as S ,71 N, 72,73 or P. 72'75
These approaches have all been less than ideal. The best solution to date 
appears to be RCu(Th)Li*LiI (Th = 2-thienyl) but this is often not reactive 
enough and the thienyl group is sometimes transferred.
However, recently, Bertz published a new approach76 based on his earlier work 
investigating the effect of TMS on the acceleration of organocuprate conjugate 
addition. 77 Incorporating a /3-silyl group into the cuprate structure was 
expected to give a highly reactive cuprate since, in this position, the silicon 
stabilises the transition state. Indeed when the trimethylsilylmethyl (TMSCH2) 
group is one of the cuprate ligands and the other is the alkyl group to be 
transferred, a cuprate of unparalleled reactivity is produced. To illustrate the 
stoichiometry, these new reagents may be written as R(TMSCH2)CuLi*LiX. 
They have been shown to be:
(i) highly reactive (even more reactive than the corresponding 
homocuprates);
(ii) thermally stable at room temperature;
(iii) economical with respect to the transferred group.
Two important reactions of cuprates were studied by Bertz: conjugate addition 
and ketone formation from acid chlorides.
Application of this new work to the synthesis of 3.3.4.1 was envisioned using a 
carbocupration of the commercially available acetylene compound ethyl 
tetrolate (also known as ethyl-2-butynoate (4.3.5.3)). Temperature control is 
essential to obtain entirely kinetic product. 78 Since kinetic addition will be syn
39
across the acetylene, the transferred ligand must be the more complex chain 
which may be derived from iodide 4.3.4.4 (Scheme 4.3.4).
4.3.4.1
TBSCT
(i) NaH, THF 
rt, 45 min 
 ►
(ii) TBSCI 
45 min
87%
Nal, Me20  
------------
TBSO"
4.3.4.2
TsCI, pyr 
0°C, 0.5 h
4.3.4.4
rt, 5 h 
70%
TBSO" 'OTs
4.3.4.3
Scheme 4.3.4
Hence mono-TBS protection of pentan-diol using sodium hydride in THF and 
TBSCI gives alcohol 4.3.4.2. 79 Mono-protection of diols is usually 
accompanied by the ^-protected product and some unreacted starting material 
but when sodium hydride is used, the mono-sodium anion precipitates from 
solution and slowly reacts with the TBSCI giving only protection of one 
alcohol. Subsequent tosylation and displacement with iodide gives the desired 
iodide 4.3.4.4. 80
The cuprate derived from commercially available trimethylsilylmethyl lithium 
was prepared from copper (I) iodide (the best results are obtained with freshly 
purified copper (I) iodide) in ether then added to lithium derivative 4.3.5.I. 
Lithiation of 4.3.4.4 with rerr-butyllithium in ether/pentane solvent was 
necessary since THF resulted in almost complete Wurtz coupling.
4.3.4.4
f-BuLi, Et20  
pentane
-80°C -> 0°C 
10 min
EtO.
3.3.4.1
Scheme 4.3.5
OTBS
4.3.5.1
E t02C—= = - 
4.3.5.3
-90°C, 5 min 
68%
TMSCH2Li 
Cul, Et20  
-80°C -4 0°C 
TMSCH2CiHJI 10 min then
Et20 , -80°C -80°C again
-20°C, 10 min
TBSO" ‘Cu(TMSCH2)Li*Lil 
4.3.5.2
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This mixed cuprate 4.3.5.2 is quite thermally stable and may be annealed at 
0°C. After cooling to -90°C (internal temperature) the ethyl tetrolate (4.3.5.3) 
may be added (Scheme 4.3.5). Maintaining the internal temperature at -90°C 
or below is essential for good stereocontrol. The reaction is complete before 
any TLC analysis can be performed and is quenched at the low temperature. 
Moderate yields of the product (68%) are obtained but importantly the (E) 
isomer is formed exclusively. Although chromatographic separation of the (E) 
and (Z) isomers is possible, as stated above, it is not practical so this cuprate 
methodology represents a significant improvement with both a reduction in the 
number of synthetic steps from known compounds and an improvement in 
overall efficiency.
4.4 Synthesis of Chiral Ester 3.3.3.4 via the Cobalt Semicorrin Catalysed 
Enantioselective reduction.
Due to its expense, commercially available ligand 4.2.1.2 had to be synthesised 
using the developed method of Pfaltz. 53 Scheme 4.4.1 shows this chemistry 
which starts with an esterification of either L- or D-pyroglutamic acid (4.4.1.1).
a.O (i) MeOH, acidic ion exchange resin NCCH2C02f-Bu
h o 2c
4.4.1.1
(ii) Et30 +BF4-  /
73% Me02C
4.4.1.2 Me02C TFA
rt
64%
4.4.1.2
CN
\  (ii) TBSCI
CH2OTBS imid, DMF Me02C 
40°C, 42%
(i) LiBH4 
THF, rt
TFA
(CH2CI)2
65°C
TBSOCH2 C 02Me C 02Me
4.2.1.2 4.4.1.5 4.4.1.4
Scheme 4.4.1
L-pyroglutamic acid is more cheaply available from L-glutamic acid by 
refluxing in water overnight. Iminoester formation with triethyloxonium 
tetrafluoroborate gives 4.4.I.2. Only part of 4.4.1.2 is taken forward for
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treatment with terr-butylcyanoacetate followed by trifluoroacetic acid. The 
resulting 1:1 mixture of vinyl cyanides 4.4.1.4 was then coupled with the other 
portion of iminoester 4.4.1.2, giving the first semi-corrin intermediate, bis- 
methyl ester 4.4.I.5. For the enantioselective conjugate reduction reactions, it 
is necessary to convert these methyl ester groups into TBS substituted 
hydroxy methyls. Hence, reduction of the methyl esters with lithium
borohydride in THF followed by TBSCI and imidazole in DMF at 40°C gave 
ligand 4.2.1.2 (42% yield for the last two steps; lit.53= 43%). For the reduction 
to succeed it is imperative that crystalline bis-tster 4.4.1.5 be obtained. Careful 
chromatography of 4.4.1.5 will result in material pure enough to be crystallised. 
However, in the reduction step, fresh or active but properly stored 
commercially available lithium borohydride solution in THF should be used to 
ensure successful conversion.
With large quantities of ligand 4.2.1.2 and olefin 3.3.4.1 in hand the reduction 
reaction could be attempted. At first, in order to generate material for 
evaluation of future steps, the reduction was carried out racemically with a 
standard palladium catalysed hydrogenation in ethyl acetate. A sample of the 
racemate is important in order to determine the eventual enantiomeric excess of 
the asymmetric process.
Initial attempts at the enantioselective reduction were successful but the 
reaction had not progressed to completion using 1.2 mol% of ligand 4.2.1.2 and 
1.0 mol% of cobalt chloride. In this example the starting olefin and product 
were inseparable using TLC and it was reasonable to assume that any unreacted 
starting material would be either impossible or very difficult to remove from 
subsequent products. Hence the quantities of ligand and metal were increased 
to 5.0 mol% and 4.4 mol% and the reaction time was increased from 2 to 5 days 
in an effort to push the reduction to completion.
CN
t b s o c h 2 c h 2o t b s
C0CI2 (4.4 mol%) 
NaBH4 (2 eq) 
EtOH, DMF, rt, 5 d
OTBS
O 3.3.4.1 O 3.3.3.4
Scheme 4.4.2
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To our delight, these measures furnished a 96% yield of chiral ester 3.3.3.4 
which was analytically pure after purification by chromatography (Scheme 
4.4.2).
Analysis of 3.3.3.4 with the chiral lanthanide shift reagent Eu(hfc)3, 81 after 
reduction and acetylation of 3.3.3.4 to 4.4.3.1 according to Pfaltz53 revealed that 
the product was of >90% ee or >20:1 ratio of enantiomers in favour of the 
desired (R) enantiomer (Scheme 4.4.3).
OTBS OTBS
(i) LiAIH4
,OEt
3.3.3.4
(ii) AC2O
£  
Scheme 4.4.3
v
4 .4 .3.1
o
Pfaltz has postulated a mechanism for the reduction involving initial formation 
of an in situ prepared Co(II)-semicorrin complex which is reduced by sodium 
borohydride to a Co(I)-semicorrin complex. This complex could then attack 
the electrophilic C=C ^-system of the a-j3-unsaturated ester substrate. This 
could lead to a cobalt /r-complex such as 4.4.4.1 (Figure 4.4.4) or, via addition 
to the
NC
Co--
complex 4.4.4.1
Figure 4.4.4
/3-position, to a cobalt (Ill)-alkyl compound. Experiments with deuterium- 
labelled reagents has shown that the /3-H atom of the product stems from the 
borohydride (NaBD4 in EtOH/DMF) and that the a-H atom stems from ethanol 
(NaBH4 in EtOD/DMF). An interpretation of these results could be that 
hydride transfer from NaBFU to a cobalt ^-complex or to a cobalt-alkyl
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intermediate is followed by intramolecular hydride shift to the /3-carbon of the 
substrate. This may lead to a cobalt enolate which is protonated by the solvent. 
This would predict that the /3-H atom is introduced on the same side of the C=C 
double bond which initially interacts with the cobalt. The observed 
enantioselectivities may be rationalised by referring to the hypothetical n- 
complexes in figure 4.4.5.
COoEt
4.4.5.1 4.4.5.2
Figure 4.4.5
In 4.4.5.1 the ester group occupies a sterically non-congested area of space 
around the co-ordination sphere with the small H-atom placed in a sterically 
more crowded environment. In 4.4.5.2 the transition state is likely to be less 
stable since there is a strong steric interaction between the ester group and 
substituent of the semi-corrin ligand. Although experimental facts concerning 
the mechanism of this reaction are scarce, this model does explain the observed 
enantioselection in the reduction of 3.3.4.1 to 3.3.3.4.
4.5 Conclusions
In this chapter, a practical, catalytic, enantioselective synthesis of the first key 
intermediate in our synthesis of 1233A has been discussed. Several routes to 
ketone 4.3.1.2 were explored but rejected in favour of a new cuprate protocol 
which only requires one equivalent of the transferred ligand. The resulting a,fi- 
unsaturated ester 3.3.4.1 underwent the Pfaltz asymmetric cobalt semi-corrin 
catalysed reduction to give 3.3.3.4 in almost quantitative yield and high 
enantiomeric excess.
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Chapter 5
The Use of a Copper (I) Thiophenecarboxylate 
Mediated Coupling for the Synthesis of Diene 3.3.2.1
5.1 Introduction
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This chapter will discuss approaches towards the synthesis of the diene moiety
3.3.2.1 in the target 1233A (Figure 5.1.1 and see Chapter 3).
Figure 5.1.1
5.2 The Julia Olefination Approach for the Synthesis of Diene 3.3.2.1
Reaction of an a-metallated benzothiazolylsulfone (5.2.1.1) with an aldehyde 
or ketone (5.2.1.2) produces a ft-lithioxy sulfone (5.2.1.3) which may undergo 
elimination to alkene 5.2.1.7 via 5.2.1.4 and 5.2.1.5 (Scheme 5.2.1).
Scheme 5.2.1
This one-pot reaction was reported in 1991 by Julia47’82 83 and is known as the 
one-pot-Julia olefination. This reaction was used to synthesise diene 3.3.2.1 
according to the previously described retrosynthetic analysis (Chapter 3). 
There are two permutations of reagents that may be combined in order to give
OTBS
3.3.2.1
Li 
5.2.1.45.2.1.1 5.2.1.3
5.2.1.7 5.2.1.6 5.2.1.5
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the same product: either ketone 3.3.2.2 and sulfone 3.3.2.3 OR aldehyde 3.3.2.5 
and sulfone 3.3.2.4 (see Scheme 3.3.2).
This chemistry was investigated using racemic compounds. Ketone 3.3.2.2 was 
synthesised from racemic ester 3.3.3.4 (from a Palladium catalysed 
hydrogenation of a ,ft-unsaturated ester 3.3.4.1, see Chapter 4). Hence 
saponification of 3.3.3.4 with potassium trimethylsilanolate furnished a 
quantitative yield of acid 5.2.2.1 (Scheme 5.2.2).
OTBS
KOTMS 
(10 eq)
O HO E t THF, rt 
18 h 
quant3.3.3.4O 5.2.2.1
Scheme 5.2.2
OTBS
MeLi 
(3 eq)
-80°C —» 
rt, 20 h 
32%
OTBS
3.3.2.2
This reagent was used by Barrett to saponify an ester in the presence of 
sensitive silyl-protecting groups. 84 Treatment of acid 5.2.2.1 with three 
equivalents of methyl lithium led to the desired ketone 3.3.2.2. Although the 
overall yield was low, sufficient quantities of 3.3.2.2 could be prepared in order 
to investigate the Julia olefination.
Sulfone 3.3.2.4 was also prepared from racemic ester 3.3.3.4 (Scheme 5.2.3). 
Initial functional group transformation of the ester to aldehyde 5.2.3.1 with 
DIBALH (see later discussion, Section 5.3.1.1) was followed by a methyl 
magnesium bromide Grignard addition to furnish alcohol 5.2.3.2 as a mixture 
of diastereoisomers. The benzothiazolyl group was installed in a 2 step 
procedure: Mitsunobu substitution of alcohol 5 .2 .3 .2  with
mercaptobenzothiazole led to sulfide 5.2.3.3 which was oxidised in moderate 
yield with m-CPB A to the desired sulfone 3.3.2.4,
OTBS OTBS
DIBALH MeMgBr
V B
O 3.3.3.4
PhMe, -80°C 
93% 5.2.3.1
ether, 0°C 
70%
HSBT, Ph3P 
DIAD, THF m-CPBA
CH2CI2
54%
Scheme 5.2.3
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Compounds 5.2.5.2 and 5.2.4.5 were prepared from common intermediate 
5.2.4.4. This compound was prepared by the method of Epstein48 as one double 
bond isomer in 2 steps via Reformatsky reaction between methyl-bromoacetate
(5.2.4.1) and chloroacetone (3.3.2.7) to give 5.2.4.2 in 80% yield (Scheme 
5.2.4). Base induced stereospecific elimination proceeds via epoxide 5.2.4.3 to 
give 5.2.4.4 in the rather low yield of 26%. Although low yielding, this 
procedure was suitable for scale-up so that enough material could be generated 
for subsequent reactions. Swem oxidation of 5.2.4.4 gives 5.2.4.5 in 83% 
yield. Mitsunobu reaction of 5.2.4.4 with mercaptobenzothiazole, as above, 
followed by ammonium molybdate oxidation gave 5.2.S.2 in excellent yield 
(Scheme 5.2.5).
MeCL ftT^Br+ Aci Zn, TMSCI H--------------ether/benzene
5.2.4.1 3.3.2.7 80%
reflux, 12 h Me02c  H 0 ^ H
5.2.4.2 B:
B r>
MeQ2C h
5.2.4.3
MeO. Swern MeO
KOH,
MeOH
26%
OH
5.2.4.5
83%
OH
Me02C
5.2.4.4
Scheme 5.2.4
MeO.
OH
O 
3.3.2.6
HSBT, Ph3P
DIAD, THF 
-------------
rt. 18 h 
94%
MeO
SBT
5.2.5.1
(N H 4 )6 M 0 7 0 24 .4H 20  
H20 2, EtOH 
92%
MeO
s o 2bt
O
5.2.5.2
Scheme 5.2.5
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With the four required starting materials in hand, the investigation into the 
applicability of the Julia olefination for the synthesis of the diene portion of 
1233A could commence. Table 5.2.6 shows the coupling of reagents to 
produce diene 5.2.6.1 (equivalent to 3.3.2.1, R = Me). Unfortunately, both a 
low yield and poor selectivity were observed in entries 1 and 2 , employing 
aldehyde 5.2.4.5. No reaction was detected with the third entry, using ketone
3.3.2.2. This could be due to the lower reactivity of the ketone present in
3.3.2.2, Interestingly, the ratio of isomers produced in the successful case could 
be significantly influenced in favour of the desired (E , E) diene with the 
alternative base potassium hexamethyldisilazide.
However, since there are no documented examples of high control in the 
synthesis of trisubstituted alkenes with the Julia olefination, it was unlikely that 
any further perseverance with this approach would have resulted in complete 
stereocontrol. Therefore another method will be required in order to achieve an 
efficient diene installation.
MeO.
5.2.4.5
+
3.3.2.4
MeO.
s o 2bt +
5.2.5.2
OTBS
base
OTBS THF
3.3.2.2
OTBS
OMe
5.2.6.1
Entry Reactants Base Yield Ratio (E, E):(E,Z)
1 5.2.4.5 + 3.3.2.4 LDA 40 1:1
2 5.2.4.5 + 3.3.2.4 KHMDS 35 2:1
3 5.2.5.2 + 3.3.2.2 LDA 0 -
Table 5.2.6
5.3 Palladium Catalysed Coupling protocols for Diene Synthesis
Palladium catalysed organic reactions have revolutionised contemporary 
organic synthesis. With the ability to form strategic bonds under extremely 
mild conditions, organic chemists have indeed found themselves a powerful
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weapon. Two coupling protocols which may be carried out with some of the 
many available palladium catalysts are the Heck and Stille couplings.
5.3.1 The Heck Reaction
One highlight from the Wovkulich total synthesis of 1233A was an efficient 
synthesis of the diene moiety employing a palladium catalysed Heck reaction 
(see Chapter 2). This powerful carbon-carbon bond forming process is one of a 
plethora of palladium catalysed organic reactions which are believed to proceed 
via an oxidative addition of a coordinatively unsaturated 14-electron Pd° 
species A with an alkenyl or aryl halide (typically iodine) bond to give 16- 
electron complex B (Scheme 5.3.1).
p d (°)
R1—X +  < ^ R 2  +  base*HX
base
R1 = aryl or vinyl 
X = I or Br
Pd(PPh3)4
syn ^-hydride 
elimination
-PPh3
base«HX
base
Pd(PPh3)3
-PPh3
Pd(PPh3)2
A
R1—X 
oxidative addition
H-Pd(PPh3)2-X 
F
R1-Pd(PPh3)2-X 
B
< ^ R 2
alkene insertion
H Pd(PPh3)2X R1 Pd(PPh3)2X
— ^»H H -)— ("H
H R2 H R2
D ^  C
C-C bond 
rotation
Scheme 5.3.1
This is followed by insertion of the alkene or arene into the Pd-C bond 
generating intermediate C via a 4-centre transition state. This insertion occurs 
as a syn addition and it should be noted that the organic ligand from the 
palladium becomes bonded to the less hindered carbon of the olefin. In order to
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create the necessary syn relationship between the Pd and /3-hydride, a bond 
rotation of C occurs to give D, which may then eliminate to give F and the 
coupled product E. Finally a base-assisted reductive elimination of HX from F 
occurs to regenerate the Pd° catalyst.
Wovkulich used a vinyl iodide and tert-butyl crotonate (see Scheme 2.5.3) to 
achieve his transformation. Incorporation of this chemistry into our 1233A 
synthesis would constitute a useful exercise if only to generate material for 
investigation of future steps. Later, if successful, an alternative approach to the 
diene moiety could be developed if resources permit.
5.3.1.1 Synthesis of Iodide 3.3.3.1
Iodide 3.3.3.1 (see Scheme 3.3.3) would be required for coupling to tert-butyl 
crotonate. Synthesis of 3.3.3.1 could be approached as outlined in Chapter 3.. 
Hence DIBALH reduction of ester 3.3.3.4 produced aldehyde 5.2.3.1 smoothly 
in 93% yield (Scheme 5.3.2).
(i) DIBALH, PhMe 
-80°C, 0.5 h, 93% 
 ►
TBS
3.3.3.4
(ii) MeOH 
-80°C -» rt
TBS
5.2.3.1
Scheme 5.3.2
A problem often associated with DIBALH reductions of esters is over-reduction 
to the undesired alcohol. Although some structures are predisposed towards 
over-reduction, e.g. /3-oxygenated esters, this problem could also be due to 
unreliable TLC analysis. These reactions are typically closely analysed at low 
temperature for any alcohol formation. If this happens, the experimentalist 
often adds another equivalent of DIBALH thereby completely reducing the 
substrate to the alcohol which would be subsequently oxidised back to the 
required aldehyde (e.g. Swem). However, when the synthesis of aldehyde
5.2.3.1 was carried out, some alcohol was detected in the initial TLC analysis of 
the reaction mixture which was at -80°C. No more DIBALH was added, 
instead the reaction was quenched and worked-up in a standard fashion (see 
Experimental section for complete details) to reveal alcohol-free crude product. 
It is unlikely that any alcohol present would be washed into the aqueous layer
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since the molecule is quite lipophilic, and considering the very high yield of 
purified product, it must be concluded that the TLC analysis of the reaction 
mixture indicated what was in the considerably warmer capillary and not what 
was actually in the reaction mixture itself.
Aldehyde 5.2.3.1 then had to be converted into a one-carbon homologated 
terminal acetylene which would be the substrate for a Negishi carboalumination 
(see similar steps in the Wovkulich synthesis of 1233A, see Chapter 2). Two 
methods were considered for achieving this goal: the Corey-Fuchs procedure52 
and Ohira's diazophosphonate reagent85 (Scheme 5.3.3).
o
J R-
Corey-Fuchs
(i) CBr4, PPh3
(ii) BuLi, THF
Ohira diazophosphonate
On
(MeO)2' ' BY 'R
N2
R = H 5.3.3.1
R = Ac 5.3.3.2
Scheme 5.3.3
The former approach was used initially: treatment of aldehyde 5.2.3.1 with a 
previously prepared mixture of carbon tetrabromide and triphenylphosphine in 
dichloromethane solvent at 0°C for only a few minutes yielded the one-carbon 
homologated geminal dibromide 5.3.4.1 in almost quantitative yield. This 
compound then underwent elimination of HBr using n-butyl lithium in THF at 
low temperature. Protonolysis of the resulting lithium acetylide salt furnished 
terminal alkyne 3.3.3.3 in a satisfying overall yield of 89% (Scheme 5.3.4).
OTBS
5.2.3.1
CBr4, PPh3 
 ►
0°C, 10 min 
95%
BuLi, THF
5.3.4.1
OTBS
3.3.3.3-75 -> -40°C 
1 h then 
NH4CI (aq)
-40 -> 0°C 
94%
Scheme 5.3.4
One of the disadvantages associated with this series of reactions is that there are 
2 steps to be performed in order to install only one extra carbon. If this were 
true of the whole target molecule the synthesis would run up to 36 steps, a 
clearly undesirable scenario! Another problem is that the first step requires 2 
equivalents of the reagent derived from CBr4 and PPI13 which has 1:2
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stoichiometry, respectively. Therefore product isolation becomes arduous since 
there are 4 equivalents of phosphorus related compounds to be removed. 
Although the second step is not problematic (BuLi, THF, 80°C) it is always 
preferable to avoid low temperatures and expensive organolithium reagents. 
Having considered the above points, the diazophosphonate method could serve 
as an improvement. Two reagents may be used to accomplish the same 
transformation: either 5.3.3.1 or 5.3.3.2. The latter has been shown to give 
higher yields, although 5.3.3.1 is formed in solution as the active reactant 
probably through loss of methyl acetate (see Scheme 5.3.5).
o o o o
5.3.3.2
r  tr k2c°3 it
N“ N NX XO- y  MeO ^
n h ^ r S 9 )R ^ H  p / \u p H I
- * -----  Y )  - * ------  (M e O ^  Y - ^ -------- (MeO)-?'
u X m+ n+ n+
H «\ 5.3.3.1 !!!
Scheme 5.3.5
In situ formation of 5.3.3.1 in this manner probably enhances the yield by 
supplying a more reactive form of 5.3.3.1 directly where it can be consumed. 
Following previously published work, the phosphonate 5.3.3.2 could be easily 
prepared (Scheme 5.3.6).
O  P(OMe)3, Kl o O NaH, TsN3 ji j?
Me2CO, MeCN ( M e O ) ;^  ^  C6H6> THF (Me0)2
rt, 6 h then 0oC ^  rt N2
5.3.6.1 50°C, 4 h 5.3.6.2 710/ 5.3.3.2
47%
Scheme 5.3.6
An Arbuzov reaction with trimethylphosphite, chloroacetone (5.3.6.1) and 
potassium iodide in hot acetone/acetonitrile produced phosphonate 5.3.6.2 in 
47% yield according to Noyori.86 Formation of diazo compounds requires a 
suitable source of electrophilic nitrogen, usually tosyl azide. This compound
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has an explosive character under extremes of pressure or temperature so caution 
was exercised. Its synthesis is very simple: tosyl chloride is mixed with sodium 
azide in aqueous ethanol and the product forms as a colourless oil which may 
be collected neat with a separating funnel. 87 After drying the product, no 
further purification is necessary and the reagent may be stored indefinitely in 
the refrigerator, at which temperature it forms colourless crystals.
Treatment of 5.3.6.2 with sodium hydride in benzene/THF then with tosyl azide 
gave diazophosphonate 5.3.3.2. If this reaction is carried out in THF alone, the 
de-acetylated product 5.3.3.1 is formed instead. This was not a great problem 
since 5.3.3.1 also homologates aldehydes to acetylenes but with a lower yield 
(56% versus 92%).
Reaction of aldehyde 5.2.3.1 with 5.3.3.2 in the presence of anhydrous 
potassium carbonate in dry methanol gave acetylene 3.3.3.3 in 92% yield 
(Scheme 5.3.7). Circumvention of an unnecessary Corey-Fuchs process has 
therefore been successfully achieved.
Scheme 5.3.7
Negishi's now classical carboalumination of acetylenes occupies a special niche 
in organic synthesis. The stereocontrolled functionalisation of an acetylene is 
itself of high utility but with many electrophiles to choose from the array of 
accessible functional groups is vast. Scheme 5.3.8 shows a few of the 
possibilities for one-carbon functionalisation. After carboalumination of alkyne
3.3.3.3 with zirconocene dichloride and trimethylaluminium, the intermediate 
vinyl alane 5.3.8.1 may be quenched with iodine giving vinyl iodide 5.3.8.2 or 
with a chloroformate to install an extra carbon atom as in compound 5.3.8.3.
5.3.8.1 may be made more reactive by forming the ate complex 5.3.8.4 with n- 
butyl lithium. This complex may then be elaborated with a number of carbon 
electrophiles: paraformaldehyde gives allylic alcohol 5.3.8.5; a carbon dioxide 
quench gives acid 5.3.8.6 and methoxymethylchloride (MOMC1) results in 
allylic ether 5.3.8.7.
o o
OTBS (MeO)2
K2C 03> MeOH 
92%
Cp2ZrCl2, 
MesAI 
 ►
R H
)=K
Me AIMe2
5.3.8.1
CIC02Et 
 ►
n-BuLi (CH20 )n  ►
R H)=(Me C 0 2Et
5.3.8.3
R H
)=K
Me CH2OH 
5.3.8.5
Scheme 5.3.8
R  H Lj+ C 02
Me AIMe2Bu
5.3.8.4
R H)=^Me C 0 2H
5.3.8.6
\  CICH2OMe R H 
 ► Me CH2OMe 
5.3.8.7
For the synthesis of iodide 3.3.3.1 the intermediary vinyl alane 5.3.9.1 will need 
to be quenched with iodine, a rapid and most efficient protocol. Indeed the syn 
addition of the trimethylaluminium to alkyne 3.3.3.3 proceeded smoothly at 
room temperature (Scheme 5.3.9).
OTBS Cp2ZrCI2 
Me3AI 
 »
(CH2CI)2 
rt, 12 h
3.3.3.3
Scheme 5.3.9
5.3.9.1
OTBS
l2. THF
88%
3.3.3.1
OTBS
Iodine quench was straightforward at -20°C giving a yield of 88% after 
chromatography. Many vinyl iodides are unstable in storage but 3.3.3.1, if 
pure, did not appreciably decompose even over several months.
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5.3.1.2 The Use of a Heck Coupling for Diene 3.3.2.1
Having developed a high yielding and practical route to the required vinyl 
iodide 3.3.3.1, all that remained was to prepare sufficient quantities of tert-butyl 
crotonate88 (5.3.10.2) before the palladium catalysed Heck coupling could be 
attempted.
According to the method of McCloskey for te/t-butyl ester synthesis, 5.3.10.2 
was synthesised from crotyl chloride (5.3.10.1) in 66% yield (Scheme 5.3.10).
CIY ^ ^  f-BuOH, PhNMe2
o  CHCI3i A, 3 h O
66%5.3.10.1 5.3.10.2
Scheme 5.3.10
OTBSOTBS
f-BuO. see table
+
.Of- Bu(Ph3P)2PdCI2 (10 mol%) 
CH2CI2
3.3.3.1 5.3.10.2 5.3.11.1
Entry Equiv of 
5.3.10.2
Silver
Additive
(Equiv)
Equiv of 
EtOH
Yield (%) (E, E) i (Z, E)
1 7 Ag2C0 3
(1.05)
65 89 1.2:1
2 21 AgN0 3
(1.1)
20 >95* 2.4; 1
3 20 Ag2C0 3
(1.16)
11 >95* 1.9:1
4 40 Ag2C0 3
(1.13)
23 >95* 2:1
= crude yield
Table 5.3.11
The Heck reaction was investigated with racemic iodide 3.3.3.1 and 5.3.10.2, 
Initially, a modified reaction of Wovkulich42 was used, instead of "re-inventing 
the wheel" due to the similarity between the vinyl iodides 2.5.3.8 and 3.3.3.1. 
Entry 1 shows the conditions and results of this attempt using silver carbonate 
as the additive (see Table 5.3.11).
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Although the yield was high (89%), crucially, the ratio of geometrical isomers 
was only 1.2:1 in favour of the desired (E , E) diene. The undesired (Z, E) 
isomer was inseparable by chromatography even after desilylation to the 
primary alcohol (TBAF, THF, rt). In an effort to increase the ratio of isomers, a 
different added silver salt was examined: silver nitrate influenced the reaction 
in a favourable manner but only up to 2.4:1 (Entry 2). Also in this case a larger 
excess of 5.3.10.2 was used (21 equivalents) since the literature example of 
Wovkulich used such a quantity. A closer look at the importance of the 
crotonate and added silver salt revealed that there are probably contributing 
factors from both variables since the ratio of 1.9:1 in entry 3 lies between that 
of entries 1 and 2. Finally, a reaction very similar to the literature example was 
conducted (Entry 4) but to no avail: a 2:1 ratio resulted. Clearly the goal of a 
highly stereoselective Heck approach towards the diene moiety may not be 
easily realised. The stability of the product was tested by resubmitting it to the 
reaction conditions and heating it in the presence of palladium catalyst and 
silver salts. No change in the initial ratio of diene isomers was observed. This 
suggests that the difference in product isomer ratios between 5.3.11.1 and 
2.53.7 could be due to substrate structure. Therefore an alternative method 
will be required to synthesise diene 5.3.11.1 with complete stereocontrol.
5.3.2 The Sonogashira-Negishi Approach to Diene 3.3.2.1
In 1975 Sonogashira et al demonstrated that terminal alkynes react smoothly 
with bromoalkenes, iodoarenes and bromopyridines in the presence of catalytic 
amounts of bis(triphenylphosphine)palladium dichloride and copper (I) iodide 
in diethylamine at room temperature. 89,90 This very mild Pd0/CuLcatalysed 
linking of sp and sp2 centres has proved most useful in complex natural product 
syntheses and in recognition of the valuable contribution of Sonogashira et al it 
is often referred to as the Sonogashira coupling reaction. Scheme 5.3.12 shows 
the presum ed cataly tic cycle: the active catalyst, bis
(triphenylphosphine)palladium (0) could be formed in situ through sequential 
copper (I) iodide-catalysed fe-alkynylation and reductive elimination reactions 
(A —> B —» C). Coordinatively unsaturated 14-electron complex C participates 
in an oxidative addition reaction with the aryl or vinyl halide to give the 16- 
electron complex D. A copper (I)-catalysed alkynylation of D then furnishes 
aryl- or vinylalkynyl palladium (II) complex E. Finally, a terminating reductive
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elimination step reveals the coupled product F and regenerates the active 
palladium (0) catalyst. These reactions are also successful starting with a 
palladium (0) catalyst, e.g. Pd(PPh3)4 , as may be expected from the postulated
mechanism.
(Ph3P)2PdCI2 (cat)
R1—X +  = — R2  ►  R1 =  - R2
Cul (cat), Et2NH, rt
R1 = aryl, vinyl or pyridyl 
X = I or Br
(Ph3P)2PdCI2
A
■R‘
Cul (cat), Et2NH
Et2NH«HCI
(Ph3P)2P d { = :  R2), 
B
reductive
elimination R‘
-R‘R1
reductive elimination
(Ph3P)2Pd°
C
R
(Ph3P)2Pc( 
R2 «  X
R1—X
oxidative addition 
1
(Ph3P)2Pd
E D
Et2NH*HCI Et2NH = ■R2
Scheme 5.3.12
Notably, the Sonogashira coupling of a haloalkene of defined stereochemistry 
with an alkyne proceeds with retention of alkene geometry. For an application 
to the synthesis of 1233A, this would be ideal for extending the structure of 
iodide 3.3.3.1. A further Negishi carboalumination of the resulting alkyne, 
quenching with a chloroformate (see Scheme 5.3.8), should result in the desired 
diene with complete stereocontrol.
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Scheme 5.3.13 highlights the foray into this chemistry. The standard 
Sonogashira coupling with 3.3.3.1 and trimethylsilylacetylene was very 
successful yielding 96% of the coupled product 5.3.13.1 (Scheme 5.3.13).
OTBS
3.3.3.1
OTBS
tyt
5.2.6.1
Scheme 5.3.13
= — TMS (2 eq) 
(Ph3P)2PdCl2 (cat)
Cul (cat), Et2NH 
Et20 , rt
96%
(i) evaporation
(ii) extraction
(iii) methyl 
chloroformate 
21%
OTBS
TMS
5.3.13.1
OTBS
AIMe2
Cp2ZrCI2
Me3AI
(CH2CI)2 
rt, 12 h
5.3.13.3
TBAF 
(1.1 eq) 
THF, 0°C 
10 min 
quant
OTBS
5.3.13.2
Only 7.6 mol% of Cul and 3.4 mol% of (Ph3P)2PdCl2 were required in 
ether/diethylamine for 12 h. 5.3.13.1 was selectively desilylated with a 
controlled amount of TBAF in quantitative yield to give terminal alkyne
5.3.13.2 which underwent carboalumination under Negishi’s conditions to give 
vinyl alane 5.3.13.3, as in the synthesis of 3.3.3.I. The experimental procedure 
for quenching a vinyl alane such as 5.3.13.3 with a chloroformate is more 
complex than for the iodine quench: the solvent from the carboalumination 
(1,2-dichloroethylene) must be evaporated in vacuo under inert gas conditions 
then an extraction with multiple aliquots of petrol must be performed before the 
vinyl alane may be quenched with chloroformate. Happily, this sequence of 
reactions proved successful but unfortunately only a 21% yield of diene 5.2.6.1 
was obtained.
Although a low yield, stereochemical analysis with lH NMR of 5.2.6.1 
indicated complete stereocontrol had been achieved. Attempts at repetition, or 
formation of the ate complex (c./. Scheme 5.3.8), in order to increase the 
chemical yield were fruitless. An alternative use of vinyl alane 5.3.13.3 could 
be iodine quench followed by lithiation and then chloroformate quench. This 
idea was tested on vinyl iodide 3.3.3.1 (Scheme 5.3.14).
o t b s  5:Bi*L i .
I (1.4 eq)
THF
-80°c
I 30 min
3.3.3.1
Scheme 5.3.14
Lithiation at low temperature with tert-butyllithium was followed by reaction of 
vinyl lithium 5.3.14.1 with methyl chloroformate. The configurational stability 
of the sp2 anion in 5.3.14.1 was thought to be questionable due to the ^-system 
being trisubstituted and, disappointingly, this proved to be the stumbling block: 
a good chemical yield of a,/J-unsaturated ester 5.3.14.2 was achieved but the 
stereochemical integrity of the double bond was destroyed.
A criticism of this Sonogashira-Negishi strategy is that it is somewhat linear 
Importantly, this approach could not be considered an improvement on 
Wovkulich's synthesis of 1233A (see Chapter 2) which uses the more 
convergent Heck reaction strategy. Therefore another tactic was required.
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OTBS
5.3.14.1
OTBS
methyl 
chloroformate
THF, -80°C
OMe
5.3.14.2
70%, E:Z= 2:1
5.3.3 The Stille Coupling Approach to Diene 3.3.2.1
The final palladium catalysed reaction to be used in this study is the ubiquitous 
Stille coupling of an alkenyl stannane and vinyl iodide. This reaction has been 
used extensively in organic synthesis for more than a decade and adequate 
reviews are available.49*50 Mechanistically, there are broad similarities with the 
other Pd-catalysed reactions discussed above, particularly the Heck coupling 
(Scheme 5.3.1) where the alkene may be replaced by an organotin reagent.
For the synthesis of diene 3.3.2.1, the vinyl iodide would need to be coupled 
with an appropriate vinyl tin reagent. Scheme 5.3.15 shows the synthesis of 
such a suitable compound. A stannylcupration reaction of methyl tetrolate
5.3.15.1 (methyl 2-butynoate) according to Piers91 or Lipshutz51 produced a 
71% yield of trimethylstannyl ester 5.3.15.2 (Scheme 5.3.15).
CuCN, MeLi
Me3SnSnMe3 M e ( X ^ . S n M e 3
M e02C— = —  ------------------
THF, -80°C  O 1
71%
5.3.15.1 5.3.15.2
Scheme 5.3.15
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With both partners now in hand, the coupling reaction could be attempted. 
Employing bzs-(triphenylphosphine) palladium dichloride in DMF solvent the 
reaction was only narrowly successful, progressing slowly even at higher 
temperatures (Scheme 5.3.16).
Scheme 5.3.16
The product was isolated in only 12% yield from a mixture of many other 
products. However, retention of geometry at both sp2 centres occurred so the 
reaction still had some promise. At this stage, however, the chemistry in the 
following section was also being explored with considerable success, resulting 
in efforts towards the Stille approach ceasing.
5.4 A Novel Copper (I) Thiophenecarboxylate Coupling for Diene 3.3.2.1
Recently Liebeskind reported that copper (I) thiophenecarboxylate (5.4.1.2) 
cleanly and rapidly couples vinyl or aryl stannanes with vinyl iodides in high 
yield with no palladium catalyst present.92 This landmark publication has 
opened a multitude of possibilities with cheap copper in place of expensive and 
often capricious palladium catalysts. Liebeskind reports that the reagent is 
easily and rapidly prepared on large scale from cheap thiophene carboxylic acid
(5.4.1.1) and copper (I) oxide.
O T R .Q OTBS
(Ph3P)2PdCl2 
.SnMe3 (20 mol%)
3.3.3.1 5 .3 .15 .2 5.2.6.1
(i) Cu20 ,  PhMe
C 0 2Cu
5.4.1.1 5 .4 .1 .2
Scheme 5.4.1
In our hands the preparation of 5.4.1.2 was indeed facile. It was found that only 
6 hours reflux time was required and after filtration and washing with ether (a 
large quantity of ether was required so soxhlet extraction was sometimes used),
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which removes copper (II) salts. The resulting tan powder could be ground into 
a finer powder with higher activity. In this form 5.4.1.2 was an extremely 
effective mediator (1.5 equivalents) for the coupling of vinyl stannane 5.3.15.2 
with iodide 3.3.3.1 in Af-methylpyrrolidinone solvent in a matter of minutes at 
room temperature! Complete retention of double bond geometry was achieved 
therefore providing diene 5.2.6.1 as one isomer (Scheme 5.4.2).
Scheme 5.4.2
In initial studies, shown in scheme 5.4.2, a severe drawback was encountered: 
the vinyl stannane self-coupled to a such an extent that it was the major product 
(65% of 5.4.2.1 versus only 25% of diene 5.2.6.1)
In order to prevent self coupling of 5.3.15.2 and promote cross-coupling'to the 
desired diene, more equivalents of iodide 3.3.3.1 were employed. Additionally, 
changing the tin substitution from trimethyl to tributyl was thought to be 
worthwhile since the bulkier tributyltin group should react slower. Hence, the 
synthesis of the tribuylstannane 5.4.3.3 is depicted in Scheme 5.4.3 (c.f Scheme
OTBS
5.4.1.2
(1.5 equiv)
C 02Cu.SnMe3
O
65%, 5.4.2.1
5.3.15).
h o 2c -
f-BuO CCI3
Bu
Bu3Sn-Cu(CN)Li2* fBuQk ^ ^ / SnBu3
^  f-Bu02C
5.4.3.1
CH2CI2> c-hexane 
rt, 10 min 
88% 5.4.3.2
THF, -80°C 
91%
5.4.3.3
Scheme 5.4.3
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A tert-butyl ester was employed to facilitate deprotection later in the synthesis. 
rm-butyltrichloroacetimidate93 was the ideal reagent for esterification of 
tetrolic acid (5.4.3.1). In this extremely efficient and rapid reaction, 5.4.3.1 
appeared to act as its own catalyst since no Lewis acid was required to induce 
reaction. The stannylcupration of 5.4.3.2 proceeded most efficiently to give an 
excellent yield of the desired (E)- vinyl stannane. From a practical perspective, 
the (E)-isomer of 5.4.3.3 was much more polar than the (Z)-isomer, which 
eluted near the solvent front with unreacted tributyltin hydride in 2% 
etheripetrol. This always ensured remarkably facile purification of (E)- 
stannane even if, in some cases, the stannylcupration reaction was not 
stereoselective.
Implementing the measures above proved quite successful: up to 7.5
equivalents of 3.3.3.1 were used to couple to stannane 5.4.3.3 with yields up to 
75%. Although unreacted 3.3.3.1 could be recovered in good yield, this 
strategy was still unsatisfactorily atom efficient particularly since the excess 
component was the more valuable and took longer to prepare in large 
quantities. However, further experimentation reduced the required amount of 
iodide to only 2 equivalents with an 85% yield of 5.3.11.1 (Scheme 5.4.4).
OTBS
f-BuO
3.3.3.1 (2 eq)
Scheme 5.4.4
yyO 1
5.4.3.3
SnBu3
5.4.1.2
n—*  (1.5 equiv)
\ s /^ C 0 2Cu
----------------------
NMP, rt, 10 min
OTBS
YYY
85%, 5.3.11.1
Of-Bu
With 1 equivalent of 3.3.3.1 the yield is a reasonable 56% but since any 
unreacted iodide may be fully recovered, the best compromise is using 2 
equivalents and obtaining the higher yield.
Mechanistically, the first step could be either transmetallation of Sn to Cu or 
oxidative insertion of Cu into the C-I bond (Scheme 5.4.5).
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RSnBu3 XSnBu3
R'RCuX
R'— X
CuX
R'RCuX RCu
R'— X
Scheme 5.4.5
Since considerable self-coupling of stannane 5.4.3.3 is observed, the lower 
cycle in scheme 5.4.5 illustrates the likely mechanism involved in the synthesis 
of 5.3.11.1 i.e. initial transmetallation of copper for tin giving a vinyl copper 
species which may oxidatively insert into the CX bond of the vinyl halide to 
give a R'RCuX intermediate. Product expulsion could then occur with 
generation of CuX.
Liebeskind investigated the effect of tin halide accumulation by monitoring a 
test system using GLC.92 An initial rapid rate was followed by a considerable 
rate retardation as the reaction approached 50% completion. Significantly, the 
addition of 1 equivalent of Bu3SnCl into an identical test system only produced 
a trace of product. These observations are consistent with a reversible 
transmetallation of tin to copper that is retarded by the formation of increasing 
concentrations of BU3S11X.
If a reaction catalytic in copper were to be considered, control over all halide 
species introduced into the reaction would be necessary in order to ensure 
production of impotent tin halides. Therefore both the copper (I) salt (CuX) 
and the organic halide (R'X) must possess a moiety, X, that produces the same 
form of Bu3SnX. Effective copper catalysis may eventually be feasible if a 
viable reaction partner, R'X, can be found that both participates in efficient
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coupling with RSnBu3 and possesses a group, X, that leads to an unreactive 
form of Bu3SnX.
Nevertheless, the stoichiometric quantities of 5.4.1.2 required to mediate the 
reaction which produces diene 5.3.11.1 does not present a problem. On the 
contrary, this chemistry has circumvented what was appearing to be an 
insurmountable obstacle: the stereocontrolled, high yielding and practical 
synthesis of the diene portion of the natural product 1233A.
5.5 Conclusions
Five separate assaults were made on the challenge of preparing the diene 
moiety of 1233A: the Julia olefination, the Heck reaction, the Sonogashira- 
Negishi approach, the Stille coupling and finally a copper (I) mediated coupling 
first reported by Liebeskind. The first two methods resulted in good yields but 
poor stereocontrol. Complete command of double-bond geometry was 
achieved in methods 3 and 4 but yields were diabolical. Only the copper (I) 
mediated coupling of vinyl stannane 5.4.3.3 with iodide 3.3.3.1 resulted in 
complete control of stereochemistry and a high yield.
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Chapter 6
Overview of /3-Lactone, Silylketene and 
Chiral Lewis Acid Chemistry
6.1 Introduction
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This chapter will discuss relevant key developments in the literature in the 
fields of interest: synthesis of /3-lactones, chemistry of silylketenes and chiral 
Lewis acid catalysed reactions.
6.2 Overview of /3-Lactone Chemistry
The past decade has seen considerable developments in the field of /3-lactone 
chemistry. This interest is, in part, due to the presence of the /3-lactone moiety 
in many natural products such as 1233A, the immunostimulants ebelactone A
(6.2.1.1) and B (6.2.1.2)94*96 and tetrahydrolipstatin (6.2.1.3), the non-natural 
saturated analogue of lipstatin97 98 (Scheme 6.2.1).
Scheme 6.2.1
The latter is a pancreatic lypase inhibitor and is being developed as a treatment 
for obesity. Such potentially attractive possibilities have also led to exploitation 
of the inherent strain in the 4-membered ring. Thus useful synthetic reactions, 
not seen with esters or larger ring lactones, may be performed with /3-lactones. 
There are three principal methods for formation of a /3-lactone ring (Scheme
NHCHO
R = Me Ebelactone A (6.2.1.1)
R = Et Ebelactone B (6.2.1.2) Tetrahydrolipstatin (6.2.1.3)
6.2.2):
(i) lactonisation via oxygen-alkyl bond formation
(ii) lactonisation via oxygen-acyl bond formation
(iii) [2+2] cycloaddition
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O-alkyl bond 
formation via 
OH-activation
[2+2] cycloadditionO-acyl bond 
formation via 
C02 H-activation 
 ►-
FT
Scheme 6.2.2
A short overview of /3-lactone synthesis now follows but a more comprehensive 
discussion may be found in recent reviews by Pommier and Pons.97,99
6.2.1 Lactonisation via Oxygen-Alkyl Bond Formation
An intramolecular displacement reaction by the carboxyl group of a /3- 
substituted carboxylic acid results in the formation of a /3-lactone ring with 
inversion of configuration at the carbon which bore the leaving group (Scheme 
6.2.2). Three of the more popular ring-closing methods for achieving this goal 
are from:
(i) /3-halocarboxylic acid salts
(ii) /3-y-unsaturated carboxylic acids
(iii) /3-hydroxy carboxylic acids
The first of these is the oldest known method for preparing /3-lactones. The 
acid salt is prepared in situ from the acid in a mild base and then cyclisation 
proceeds at room temperature. Scheme 6.2.3 shows the example of bromo-acid
6.2.3.1 being lactonised into 6.2.3.2 in 65% yield. 100
ro  h NaOH (aq) jPp o 2H rt> 30 min O—r
nr r P h  -------- ^
Br ph 65% Ph
Ph
6.2.3.1 6.2.3.2
Scheme 6.2.3
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Due to frequent problems with loss of CO2 to form the olefin (see later), the use 
of /5-haloacid salts has been superseded by better methods.
Treatment of /5-y-unsaturated carboxylic acids with halogens induces a 
halolactonisation reaction. The kinetic products of these reactions may be 
formed under specific conditions. An intermediary halonium ion is attacked 
either via a 4-exo-tet or 5-endo-tet cyclisation forming either a /5-lactone or the 
thermodynamically preferable 7 -lactone. The formation of lactone 6.2.4.2 from 
acid 6.2.4.1 adequately illustrates this method.101
Scheme 6.2.4
/5-Hydroxy acids may also ring-close under Mitsunobu conditions: 
PPI13/DEAD. Regioselective attack of the triphenylphosphine is the problem 
with this technique: generally, mixtures of isomers and decarboxylation 
products will be formed, such as in the reaction of acid 6.2.5.1 (Scheme 6.2.5).
Scheme 6.2.5
6.2.2 Lactonisation via Oxygen-Acyl Bond Formation
This method involves activation of the carboxyl group which then undergoes 
attack by an oxygen atom in the /5-position. The principle reaction substrates 
are:
Br2/CH2CI2
O
NaHC03 (aq) II
6.2.4.1 6.2.4.2
PPhyDEAD
THF.rt
90% overall
6.2.5.1 44%, 6.2.5.2 44%, 6.2.5.3 12%, 6.2.5.4
(i) /5-hydroxy carboxylic acids
(ii) /5-hydroxy acid derivatives
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(iii) /3-hydroxy lithiated ketenes
The first of these includes the most popular method for preparing the /3-lactone 
moiety in natural product syntheses, introduced by Adam in 1972.38 Activation 
of the carboxyl group, by formation of a mixed anhydride with benzenesulfonyl 
chloride, is followed by attack of the hydroxy group to give the 4-membered 
ring. Thus, /3-lactone 6.2.6.3 is prepared in excellent yield from 6.2.6.1 via 
mixed anhydride 6.2.6.2 (Scheme 6.2.6).38
h o 2Q o h  
H-W **phI RnBn
6 .2 .6.1 
Scheme 6.2.6
PhS02CI 
pyridine 
 ►
0 —»5°C, 12 h 
93%
PhS02 O
O - ^ ' O H
H -W '''Ph
1 Bn
6 .2 .6.2
x t
1 Bn 
6.2.6.3
Other sulfonyl chlorides have been successfully applied: tosyl chloride, p- 
bromobenzenesulfonyl chloride and methanesulfonyl chloride.
One example of a /3-hydroxy acid derivative is thiol ester 6.2.7.1 which was 
ring-closed to 6.2.7.2 with mercury (II) methanesulfonate/disodium hydrogen 
phosphate in acetonitrile (Scheme 6.2.7).102
Hg(MeS03)2 (2 eq) r>
OH O Na2HP04 (8 eq) O —r
B ^ ^ ^ S P h  MeCN, 25°C, 10 min ~
90% S'* 18
6.2.7.1 6.2.7.2
Scheme 6.2.7
Lithium alkynolates (lithioketenes) react with carbonyl compounds and yield /3- 
lactones via /3-hydroxy lithiated intermediates such as 6.2.8.4 in the preparation 
of 6.2.8.6.103’104
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BuLi, THF, 
HMPA, -60°C
6.2.8.26 .2.8.1
[Ph—= — OLi] +  PhCN
6.2.8.S
PhCHO
BnBr, THF 
-60°C, 20 min
Ph 
6 .2 .8.6
68%
ou'
J X
-------
pn Ph Ph Ph
6.2.8.5 6.2.8.4
Scheme 6.2.8
6.2.3 Lactonisation via [2+2] Cycloaddition
As demonstrated in scheme 6.2.2, the [2+2] cycloaddition of an aldehyde or 
ketone may lead to a /3-lactone. This reaction was first introduced in 1911 by 
Staudinger105 who observed a reaction between benzoquinone (6.2.9.1) and 
diphenylketene (6.2.9.2) which led to the olefin 6.2.9.4 via /3-lactone 6.2.9.3.
o
+  /Pn Ph
Et20 , rt
72%
O
6.2.9.1 6.2.9.2
Scheme 6.2.9
6.2.9.3
-co2
6.2.9.4
Decarboxylation is a synthetically useful reaction of /3-lactones and will be 
discussed later in this chapter. Staudinger did not require a catalyst but similar 
reactions with ketene itself do require catalysts. However the instability of 
many ketenes and the problems of preparation meant that this method has been 
seldom used in synthesis.
Ketenes may be generated in situ by several methods including the elimination 
of HC1 from acyl chlorides using tertiary amines106*107 and the reductive 
elimination of a-halo acyl chlorides with zinc.108109
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However, these methods are not practical particularly on large scale. In 1975, 
Russian chemist Zaitseva published the first preparation of the /Llactone moiety 
via a Lewis acid catalysed [2+2] cycloaddition between an aldehyde and the 
remarkably stable but reactive (trimethylsilyl)ketene 6.2.10.2 (Scheme 
6 .2 . 10).110
*.JL
BF3#OEt2
H SiMe3  
6.2.10.1 6.2.10.2
PIT %SiMe3  
(±)-6.2.10.3
— CO2 iMe3
trans
minor
6.2.10.5
150-160°C / =
►  P i /  \ \ M e 3
Ph'''' SSiMe3  ~ ° ° 2 
(±)-6.2.10.4
C IS
major
6.2.10.6
Scheme 6.2.10
First discovered in 1965 by Shchukovskaya, 111 6.2.10.2 may be prepared on a 
large scale by pyrolysis of ethoxy(trimethylsilyl)acetylene (6.2.11.1) in 65% 
yield (Scheme 6.2.11). 6.2.10.2 may be handled in air and stored for protracted 
periods of time with no loss of effectiveness.
A (120°C bath)
EtO— = — SiMe3  -----------------
50%
O
Jl
H SiMe3
6.2.11.1 6.2.10.2
Scheme 6 .2 .11
The practical advantages are self-evident when a comparison is made with 
ketene itself: ketene is a reactive gas which is prepared with specialised 
equipment and must be used immediately whereas (trimethylsilyl)ketene is a 
stable mobile oil which is easily handled, purified and stored with no special 
precautions.
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Since Zaitseva’s initial publication, the [2+2] cycloaddition of aldehydes and 
silylketenes received very little attention until the late 1980's when Kocienski 
and Pons reported a concise synthesis of tetrahydrolipstatin (6.2.1.3), a 
pancreatic lipase inhibitor (see Scheme 6.2.1) . 112 The key step was a 
diastereoselective [2 +2 ] cycloaddition of aldehyde 6 . 2 . 1 2 .1  with n- 
hexyl(trimethylsilyl)ketene (6.2.12.2) giving silyl-/3-lactone 6.2.12.3 (Scheme 
6 .2 .12).
o / °
BnO O 'I EtAICI2 Bn9
H23C „ ' ^ ) Me3s A c 6H13 92% *  H23Cl1" ^ H ~ f c l e 3H13
6.2.12.1 6.2.12.2 90% (S) 6.2.12.3
Scheme 6.2.12
Consideration of all the points from the above discussion indicates clearly that 
efforts towards the /3-lactone moiety of 1233A should be channelled in the 
direction of an asymmetric [2 +2 ] cycloaddition between an aldehyde and a 
silylketene.
Finally, a short word on the utility of /3-lactones themselves as motifs for 
further elaboration to useful organic fragments. The /3-lactone moiety may be 
considered as an internally protected aldol adduct and hence is useful since the 
acyl-oxygen bond may be selectively cleaved by nucleophilic attack at the 
carbonyl113(Scheme 6.2.13). Additionally, these strained 4-membered rings 
may be cleaved at the alkyl-oxygen bond with cuprates114’115 giving rise to 
useful chiral acids.
r3 o
Nuc or R1x *Vsr ^ O H  
H SiM e3 (R3)2CuLi R2 R2
Scheme 6.2.13
Q—f
O
Nuc"
OH O
R1 /* R2 Ror
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6.3 Silylketenes: Synthesis and Reactivity
The following is a short introduction of some relevant works from the literature 
describing silylketene chemistry. A comprehensive overview concerning all 
aspects of ketene chemistry is available.116
6.3.1 (Trialkylsilyl)ketenes
As detailed above, the first synthesis of trimethylsilylketene (6.2.10.2) was in 
1965 by Shchukovskaya (see Scheme 6.2.11). Throughout the past 2 decades, 
Zaitseva has explored the chemistry of various silyl and germyl ketenes. 117127 
As yet stannyl ketenes have not been prepared with the exception of 
b is  ( tr ia lk y ls ta n n y l)k e te n e s  p rep ared  by trea tm en t of 
alkoxy(trialkylstannyl)acetylenes with a trialkylmetal bromide in the presence 
of MgBr2.128,129 However, there has been very little activity in this area.
The trichloro and triethylsilyl, £nXdeuteromethyl)silyl,130,131 trimethylgermyl 
and triethylgermyl ketenes132 and the (-)-(methyl-l-naphthylphenylsilyl) 
ketene,133 the first optically active silylketene, have also been made. 
Trialkylsilyloxyalkynes were also seen as intermediates in the formation of 
trialkylsilylketenes by the retro-Diels-Alder reaction of silyl enol ethers of 
ethenoanthracenes134 by thermolysis of 2-trimethylsilyl-4,5-dihydrofurane.135 
Acetylenic tert-butyl ethers provide a substrate which may be thermolysed 
under conditions notably milder than those used for the corresponding ethyl 
ethers, above. Hence, the pyrolysis of 1 -tert-butoxy(tert- 
butyldiphenylsilyl)acetylene (6.3.1.1) permits the preparation of (tert- 
butyldiphenylsilyl)ketene (6.3.1.2) 136 (Scheme 6.3.1).
Af-BuPt^Si— = —Of-Bu---------
6.3.1.1
6.3.1.2
Scheme 6.3.1
(Trialkylsilyl)acetic acids 6.3.2.1 may be used for the preparation of 
(trialkylsilyl)ketenes by either formation of acid chloride 6 .3 .2 .2  and 
dehydrochlorination with triethylamine or formation of anhydride 6.3.2.3 and 
thermolysis via anhydride 6.3.2.4137139 (Scheme 6.2.14).
H
H-
f-BuPt^Si
O
u
H Sif-BuPh2
t\  TA6-3-2-1 - ^ ,o o A / o'
R3Si\^ jQ
6.3.2.3 X 2
6.3.2.4
Scheme 6.3.2
6.3.2 Aryl-, Alkyl- and Alkoxy-(Trialkylsilyl)ketenes
One practical method for preparing these more complex ketenes is the thermal 
rearrangement of (trialkylsilyloxy)alkynes which may be obtained from 
alkoxyalkynes in the presence of trimethylsilyl iodide140 142. Following this 
approach, butyl(trimethylsilyl) ketene 6.3.3.3 was obtained in 57% yield by 
treatment of ethoxyhexyne 6.3.3.1 with trimethylsilyl iodide (TMSI) and 
rearrangement of the intermediary (trimethylsilyl)oxyhexyne 6.3.3.2 (Scheme 
6.3.3) .143
EtO—= — n-Bu
OMe3Sil
1 Me3SiO—= — n-Bu i
Me3SK^ /^7-Bu6.3.3.1 6.3.3.2
6.3.3.3
Scheme 6.3.3
Other alkyl(trialkylmetal)ketenes may be prepared with this general method.144 
Others may be obtained by the action of Et3N on acid chlorides, e.g. preparation 
of vinylketene 6.3.4.2 from acid chloride 6.3.4.1 (Scheme 6.3.4) .145
Scheme 6.3.4
6.3.4.1 6.3.4.2
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This method has been used to synthesise bromo(trimethylsilyl)ketene. 146 
Thermal147 or photochemical148 decomposition of (trialkylsilyl)diazoacetates 
and trialkylsilyldiazoketones is also a source of alkyl(trialkylsilyl)ketenes and 
alkoxy(trialkylsilyl)ketenes, via the Wolff rearrangement (Scheme 6.3.5).
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6.3.3 Structure and Stability of Silylketenes
Initially the structure of silylketenes were thought to have major contributions 
from the tautomers 6.2.10.2 and 6.3.6.1 (Scheme 6.3.6) . 111
Me3^ > = « = 0  H—= - O S iM e 3
6.2.10.2 6.3.6.1
Scheme 6.3.6
On the basis of NMR and IR studies this hypothesis was abandoned in favour 
of the ketene structure 6 .2 .1 0 .2 : 130,131 the chemical shift for the ketene proton in
6.3.6.2 (8 = 1.65 ppm, doublet) was in the region for an acetylene (S = 1.53 
ppm for ethoxyacetylene) but a doublet could only be formed by the ketene 
structure of type 6 .2 .1 0 .2 .
Et2HSk
H‘
•=o
6.3.6.2
Silylketenes are quite stable, regarding dimerisation122,149-151 and can be stored 
for prolonged periods. It is therefore necessary to heat (trimethylsilyl)ketene 
(6.2.10.2) at 150-200°C for 35 h before formation of 30-40% of allene 6.3.7.3,
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formed by decarboxylation of cyclodimerisation product 6.3.7.2, is observed122 
(Scheme 6.3.7).
oII 150-200 c
35 h
6.3.7.1 6.3.7.2
-C 0 2
30-40%
EtsS'— <—  m==—SiEt3
6.3.7.3
Scheme 6.3.7
This stability, confirmed by calculation, is due to the electropositive silicon and 
its ability to stabilise an adjacent negative charge. However 
ethoxy(triphenylsilyl)ketene is very reactive: the destabilising effect of the 
ethoxy group opposes the stabilisation due to silicon. Two hypotheses were 
initially offered in explanation: Brady and Cheng152 proposed s-p donation via 
the C-Si bond (Scheme 6.3.8).
Me3Si Me3Si+
)= < = o  —— -  <c=-o-
H H
6.2.10.2 6.3.8.1
Scheme 6.3.8
Alternatively, Runge153 used CNDO/S calculations to propose a retrodonation 
of the ^-system of the ketene to the d-orbitals of silicon as in the proposed 
resonance structures 6.3.9.1 and 6.3.9.2 where a negative charge on silicon and 
a C=Si double bond (silene) are present (Scheme 6.3.9).
Me3S l ^ _  ,  .  MeaSiT
*=«=o 7— «==o+
^ H
6.3.9.1 6.3.9.2
Scheme 6.3.9
In 1991, Tidwell carried out a theoretical ab initio study/calculation on the 
influence of the nature of the substituents on the stability of ketenes. 154155 
These calculations showed that stability was imparted by electropositive 
substituents (cr-donation). This hypothesis proposes an important contribution
77
from structure 6 .3 .8 .1  which would affect the geometry of the silyl ketene 
(Scheme 6.3.8, above).
This is in discord with the C=C and C=0 bond lengths calculated by Tidwell154 
for (trimethylsilyl)ketene and methyl ketene. In addition, d-k conjugation 
(Scheme 6.3.9) is not considered important in the effects of silyl substituents.156 
In conclusion, the electropositive character of silicon is the apparent principle 
cause of the stabilisation of silylketenes.
6.3.4 Reactivity of Silylketenes
Silylketenes react, in good yields, with a large variety of heteroatomic or carbon 
nucleophiles. They also undergo a number of useful cycloaddition reactions. 
There now follows some key studies from the literature which are of interest in 
the present context.
6.3.4.1 Reaction of Silylketenes with Heteroatom ic and Carbon 
Nucleophiles and Others
Under neutral conditions, nucleophilic addition to (trimethylsilyl)ketene is 
slow155 due to the stability of these compounds. However, with a little acid or 
base, the reactivity of the ketene is considerably augmented. This is due to the 
ability of the silicon atom to stabilise a negative charge at the a-position (with 
base) or a positive charge, j3,with acid. (Trialklsilyl)ketenes react well with 
alcohols130’131*133’147’157’158, amines130*131’159’160 and hydroxylamines. 161 The use of 
Lewis acids, such as BF3*OEt2 ,151 ZnCl2 or Znl2162 in the condensation of 
alcohols with silylketenes, increases the rate of reaction.
Other a-silyl acetates, such as 6.3.10.2, have been prepared in excellent yield 
by Kita et a /162(Scheme 6.3.10).
o n O
6.3.10.1 6.2.10.2 6 .3 .10.2
Scheme 6.3.10
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In the presence of stabilised phosphorus ylids, (trimethylsilyl)ketenes undergo a 
Wittig-type reaction. With this method, the ester allene 6.3.11.1 has been 
prepared in 85% yield151 (Scheme 6.3.11).
MesSL Ph3R=CHC02Et, CH2 CI2  MesSl H
> = - = 0   ► )=«=<
H 85% H C 02Et
6.2.10.2 6.3.11.1
Scheme 6.3.11
Condensation of n-butyl lithium with ketene 6.3.12.1 followed by addition of 
chlorotrimethylsilane, gives silyl vinyl ether 6.3.12.2 as the (Z)-isomer163 
(Scheme 6.3.12).
(i) n-BuLi
Me3SL (ii) TMSCI Me3SL   OSiMe3
Et 78% Et n-Bu
6.3.12.1 6.3.12.2
Scheme 6.3.12
Addition of reactive organocerium compounds to silylketenes gives, via the 
intermediate enolate, compounds 6.3.13.3 and 6.3.13.4,164
o
f-BuMe2 Si n-BuCeC^
y = < = o  — ►
H
CT
t- BuMe2Si-V(^ 4v
Bu
NH4 CI 
91%
f-BuMe2Siv>^ iL Bu
6.3.13.3
6.3.13.1 6.3.13.2
Mel
HMPA f-BuMe2 Si.
76%  ^ Bu
Me
O
6.3.13.4
Scheme 6.3.13
The reactivity of trialkylsilylketenes with diazomethane has been largely 
studied by Zaitseva et all 2°> 126,165 jn ^  presence of diazomethane, 
(trimethylsilyl)ketene gives cyclobutanones 6.3.14.2 and 6.3.14.3 v ia  
cyclopropanone 6.3.14.1118 (Scheme 6.3.14).
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MeaSi Me3Si
---------
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Scheme 6.3.14
In 1980, Danheiser et al published results concerning the use of 
vinyl(trimethylsilyl)ketene (6.3.4.2) as a diene in the Diels-Alder reaction. In 
the presence of maleic anhydride this ketene gives, with good yield, 
cycloadduct 6.3.15.2145(Scheme 6.3.15).
Scheme 6.3.15
Silylketenes also react as dieneophiles in [4+2] cycloaddition reactions. 
Recently, the [4+2] cycloaddition of trialkylsilylketenes and electron rich 1,3- 
dienes was studied. Experiments showed that the reaction was a stepwise 
process: initially, nucleophilic attack of 6.3.16.1 on the sp carbon of 6.3.13.1 
gave betaine intermediate 6.3.16.2, Stopping the reaction at this stage gave 
acyclic ether 6.3.16.3, If the reaction is allowed to continue at higher 
temperature, 6.3.16.2 cyclizes to dihydropyranone 6.3.16.4 which isomerises to 
give pyranone 6.3.16.5166 (Scheme 6.3.16).
6.3.4.2 6.3.15.1 6.3.15.2
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Ozonolysis of (trialkylsilyl)ketenes gives the corresponding 
trialkylsilylformates167 (e.g. Scheme 6.3.17).
Et3Si. 0 3 EtsSiO
)=«= O ----------------- }=0
H H
6.3.7.1 6.3.17.1
Scheme 6.3.17
6.3.4.2 [2+2] Cycloadditions of Silylketenes
The [2+2] cycloaddition of ketenes with olefins, imines or carbonyl compounds 
is a frequently used reaction for the preparation of cyclobutanones, 168*169 /?- 
lactams,170 or p-lactones," respectively.
The first [2+2] cycloaddition between a silylketene and a carbonyl compound 
was described by Zaitseva et al in 1975.110 Hence, in the presence of a 
catalytic amount of BF3 *OEt2 , trimethylsilylketene (6 .2 .1 0 .2 ) and 
benzaldehyde (6.2.10.1), at -50°C, gave a 1:2 mixture of trans and cis 4- 
phenyl-3-trimethylsilyl-2-oxetanones (6.2.10.3 and 6.2.10.4, respectively) (see 
Scheme 6.2.10, above). When the reaction mixture is heated at 50°C for 6 h, a 
decrease in the proportion of the trans isomer is observed. Distillation of the 
crude reaction product gives 13% of frans-(trimethylsilyl)styrene 6.2.10.5 and 
65% of c i s  4-phenyl-3-trimethylsilyl-2-oxetanone 6.2.10.4. c i s-
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(Trimethylsilyl)styrene 6.2.10.6 is only obtainable on heating 6.2.10.4 to 150- 
160°C.
In an investigation to determine the influence of the structure of the reactants on 
the ease of formation of 2 -oxetanones and on the relative proportions of the cis 
and trans isomers, Zaitseva enlarged her study of the number of ketenes and 
carbonyl compounds. 119 Studied substrates include formaldehyde and 
analogues (acetaldehyde, propionaldehyde, butyraldehyde, isobutyraldehyde, 
isovaleraldehyde), chloral and bromal and some ketones. In the absence of a 
catalyst, (trimethylsilyl)ketene doesn't react with chloral. In summary, the use 
of BF3*OEt2 complex allows isolation of both cis and trans isomers of the 2 - 
oxetanone in various proportions, dependant on the reaction conditions 
(Scheme 6.3.18).
Me3Si
> = « = 0
H
O <06.2.10.2 q / s
BF3 O E t2
+  CI3C ^SiMe3  CI3 C'"' SiMe3
O 6.3.18.2 6.3.18.3x
CI3 C H Conditions: 90-100°C ,4h  (20:80)
6.3.18.1 -78°C , 15 h (40:60)
Scheme 6.3.18
The use of the more reactive [(chloromethyl)dimethylsilyl]ketene (6.3.19.1) in 
the cycloaddition reaction with chloral and bromal allows the exclusive 
isolation of the corresponding trans 2-oxetanone119 (Scheme 6.3.19).
(CIH2 C)Me2Si
) = - 0
H
6.3.19.1 D
BF3 ..OEt2  Q_ J
o - 1 0 °fiio / 0  min Br3 c '  '''SiMe2 (CH2 CI)11 04 /o
Br3 C ^ H  6.3.19.3
6.3.19.2
Scheme 6.3.19
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The cycloaddition of (trimethylsilyl)ketene with isobutyraldehyde gives the 
corresponding cis and trans 4-alkyl-2-oxetanones in the ratio 60:40 and with 
90% yield (Scheme 6.3.20).
Me3Si,
H
6.2.10.2 BF3*OEt2 . pY
+  20°C’ 2o° m'n i-p S  NSiMe3 /-P r' SiMe30  90%
6.3.20.2 6.3.20.3
, - P r A  60 40
6.3.20.1
Scheme 6.3.20
Reaction of a, /3-unsaturated aldehydes and (trimethylsilyl)ketene also gives 2- 
oxetanones. One example is shown in Scheme 6.3.21: on distillation of the 
crude /3-lactone products, the TMS group migrates from carbon to oxygen 
giving the corresponding oc,p-unsaturated silyl esters.
Me3Si
) = . = o
^  BF3*OEt2
H
H Ph
H
O
6.3.21.1
PI
6.3.21.2
.2.10.2 _______ ^  \__I +
0°C to rt / = *  SiMe3
+  62% p n ______
,K./ — v SiMe3
Ph
6.3.21.3
0 2SiMe3
H H
( E, Z)
6.3.21.4
H
H C 02SiMe3
( E , E)
6.3.21.5
Scheme 6.3.21
Zaitseva et al has used other ketones (acetone, butanone, cyclohexanone, 
pinacolone, acetophenone) which are less reactive than aldehydes in the 
cycloaddition with ketenes. 119 With acetone, reactions were monitored by IR. 
After 10 h at 50°C, formation of a 2-oxetanone (1830cm" 1) and an a,j5- 
unsaturated ester (1700 and 1650 cm'l) were observed. Distillation of the
83
crude reaction mixture allowed isolation of trimethylsilyl-2-butenoate 6.3.22.3 
in 28% yield (Scheme 6.3.22).
Me3S
H
6 .2.10.2
+
O
X
6.3.22.1
Scheme 6.3.22
BF3*OEt2
50 C, 1 0 h
o S
o
SiMe3 
6.3.22.2
28%
H
CC>2SiMe3 
6.3.22.3
In synthesis, the use of the [2+2] cycloaddition between silylketenes and 
carbonyl compounds has not been fully exploited. However, in 1988 Mead et 
al reported the preparation of silyl-p -lactones as precursors to 
tetrahydrofurans171’172 (Scheme 6.3.23).
MesSi,
y=«=o
H
6 .2 .10.2
+
PhCH2Q
O
BF3*OEt2 
---------n
CH2CI2
81%
o—&0
p hCH20>s^ J v"SiMe3
'3
6.3.23.1
Scheme 6.3.23
/3 H 
6.3.23.2
O
c x xT > ^ ^ t 3 C H 2Ph
6.3.23.3
Another elegant synthetic use of these [2+2] cycloaddtions has been provided 
by Kocienski et al in a synthesis of tetrahydrolipstatin, the pancreatic lipase 
inhibitor (see Scheme 6.2.1, above). Here, the cycloaddition was performed 
with n-hexyl(trimethylsilyl)ketene (6 .2 .1 2 .2 ) and aldehyde 6 .2 .1 2 .1  (see 
Scheme 6.2.12, above).
Recently, Yamamoto et alm  observed, in the presence of methylaluminium bis 
(4-bromo-2,6-di-tert -butylphenoxide) (MABR), cis stereoselectivity for the 
cycloaddition between (trimethylsilyl)ketene and aldehydes (Scheme 6.3.24).
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OX +R H M63SH
6 .2 .10.2
MABR
CH2CI2 R
tf
SiMe3
u
R'' SiMe3
Aldehyde (R) Lewis Acid 
(equiv)
Conditions 
(°C, h)
% yield 
(cis /trans)
CH2CH3
0 C6H11
BF3»OEt2 -20°C, 3.5 h; 0°C 42 (70:30)
MABR (1.0) o.5 h; -78°C, 2 h 82 0 00:0)
BF3»OEt2 -20°C, 1 h; 0°C, 0.5 h 52 (41:59)
MABR (1.0) -78°C, 1 h; -40oC, 1.5 h 88 (90:10)
Me _
Br
MABR
6.3.24.1
Scheme 6.3.24
One possible synthesis of the /3-lactam moiety is the cycloaddition between a 
ketene and an imine. This reaction can be done with certain ketenes and 
silylketenes. The first cycloaddition between silylketenes and imines was 
described by Brady in 1976.146 Prepared in situ by the action of triethylamine 
on acid bromide 6.3.25.1, bromo(trimethylsilyl)ketene (6.3.25.3) and N-tert 
-butylbenzylimine (6 .3 .25.2) give N-tert -butyl(trimethylsilyl)-/3-lactam
6.3.25.4 (Scheme 6.3.25).
—  ’ B\ f -56% P f r /  \ SiMe3 
H Br
6.3.25.4
O
Me3Si
Br
6.3.25.1
+
■-Bu
Br
XB>lr^H
Et3N 
 >
heptane
Me3Si,
Br 
6.3.25.3 
+
-Bu
Pt l ' B>tr"H
6 .3.25.2 6 .3.25.2
Scheme 6.3.25
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It should be stressed, however, that the [2+2] cycloaddition of an imine with a 
silylketene is not a general process as for aldehydes; usually electron 
withdrawing groups are required on both the ketene and the imine hence 
severely reducing the scope of this potentially useful reaction.
The situation is somewhat similar with the preparation of the cyclobutanone 
moiety via [2+2] cycloaddition of an alkene with a silylketene. There are very 
few examples in the literature and no further discussion is pertinent in the 
present context.
In conclusion, silylketenes are compounds of remarkable stability and utility. 
Many methods of preparation allow synthesis of a wide range of these ketenes. 
They react with electrophiles (Lewis acid catalysed), alcohols, water and 
nucleophilic carbon giving a diverse choice of organic fragments. [2 +2 ] 
Cycloaddition is an important reaction of silylketenes. Of particular importance 
are the results of Zaitseva which show carbonyl compounds possessing 
electrophilic character react rapidly, hinting at the nucleophilic character of the 
ketene moiety.
6.4 Chiral Lewis Acids In Synthesis
6.4.1 Introduction
A Lewis acid is defined as a molecule capable of receiving an electron pair into 
the shell o f one of its atoms. Such acids may form stable complexes with Lewis 
bases which are defined as molecules with an electron pair capable of entering 
such a shell to create an electron pair bond. Some examples of Lewis acids are 
BF3, A1C13, ZnBr2, TiCl4,and SnCl4 .174
Among the Lewis acid-catalysed reactions, those involving the formation of 
complexes between carbonyl compounds and Lewis acids are particularly 
important since these complexes play a fundamental role in organic and 
bioorganic chemistry. In asymmetric synthesis, the key carbon-carbon bond 
forming reactions which are catalysed by Lewis acids are: the carbonyl-ene 
reaction , the Mukaiyama aldol reaction (silyl enol ether additions to aldehydes 
or ketones), the Sakurai reaction (allylsilanes or allylstannanes additions to 
aldehydes and to conjugated enones) and the Diels-Alder reaction. These
reactions may be enantioselective and catalysed by chirally modified Lewis 
acids. Some examples of recent enantioselective chiral Lewis acid catalysed 
processes now follow.
6.4.2 The Carbonyl-Ene Reaction
A review is available detailing the carbonyl-ene reaction up until 1992.175 An 
asymmetric example of this reaction is Mikami's titanium binolate (6.4.1.3) 
catalysed addition of 2-butene (6.4.1.1) to methyl glyoxalate (6.4.1.2) forming 
homoallylic alcohol 6.4.1.4 in 72% yield and 95% ee176*177 (Scheme 6.4.1).
H
6.4.1.1
Scheme 6.4.1
o
H C 02Me 
6.4.1.2
.Cl
.•o Cl
6.4.1.3 (10 mol%) 
 »
molecular sieves (4A)
CH2CI2, 72%
X X
6.4.1.4
This popular BINOL ligand was further modified in 1994 leading to titanium 
based chiral Lewis acids such as bromine substituted 6.4.2.1, fe-triflamide
Bfv
X = Cl, Br
6.4.2.1 6.4.2.2
Al—Me
6 .4.2.3 6 .4 .2.4
Figure 6.4.2
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6.4.2.2178 and earlier in 1990, the unusual oxotitanium species 6.4.2.4, used by 
Mukaiyama himself but only reaching 85% ee.Very bulky ortho-triphenylsilyl- 
substituted aluminium Lewis acid 6.4.2.3 was used as the catalyst (20 mol%) 
for the addition of but-2-ene to pentafluorobenzaldehyde179 (Figure 6.4.2). 
Catalysts 6.4.2.1 and 6.4.2.2 as well as 6.4.1.3 were shown to be effective for 
the addition of tri-substituted olefins to methyl glyoxylate in up to 89% ee and 
94:6 d.e. 178 (Scheme 6.4.3).
Scheme 6.4.3
Catalytic quantities of as little as 0.5 mol% have been used in a highly practical 
ene reaction between a-methylstyrene (6.4.4.1) and methyl glyoxalate (6.4.1.2), 
carried out on a 70 mmol scale and detailed in Organic Syntheses180 (Scheme 
6.4.4).
CC^ Me
6.4.2.1 (10 mol%) syn-6.4.3.2 . . .7 84% yield
C0 2 Me molecular sieves (4A) 
PhMe, 0°C, 2 h
6.4.1.2 (XX,
+  symanti = 94:6
89% ee (syn)
6.4.3.1 CC^ Me
anti-6A.3.3
H C02Me molecular sieves (4A) CC^ Me
6.4.4.1 6.4.1.2 CH2CI2> -30°C, 6 h 6.4.4.3
84% yield 
93-95% ee70 mmol scale
Scheme 6.4.4
This catalyst possesses, significantly, bromine substitution on the titanium atom 
(c.fi dichloro catalyst 6.4.1.3), Judicious choice of either dichloro or dibromo 
chiral catalysts may provide ene products in high enantiomeric purity.
A review on the many applications of the chiral binaphthyl unit in asymmetric 
synthesis is available.181 Chiral titanium complexes and their additions to 
carbonyl groups has also been reviewed.182
6.4.3 The Mukaiyama Aldol Reaction
Lewis acid induced reaction of a silyl enol ether with aldehydes and ketones, an 
aldol cross-coupling reaction, is commonly referred to as the Mukaiyama aldol 
reaction after the name of its discoverer. 183 187 This extremely mild method of 
effecting carbon-carbon bond formation involves transfer of the silicon atom 
from the oxygen of the enol ether component to the oxygen atom of the 
electrophilic aldehyde or ketone partner (see Scheme 6.4.5).
Scheme 6.4.5
An in-depth mechanistic investigation of this reaction has been reported by 
Bosnich and Hollis. 188 They found that trimethylsilyltriflate (TMSOTf) is a 
very powerful catalyst for the reaction. TMSOTf is often produced via 
hydrolysis of other species originally thought to be catalysts themselves e.g.
Since the Mukaiyama coupling is such a powerful bond forming process, it has 
been extensively studied for catalysis by chirally modified Lewis acids. This 
approach has been very successful, leading to a number of stereoselective 
processes.189-191
Illustrative of the advances already made in this field is Kobayashi’s chiral 
Lewis acid-controlled synthesis of both individual diastereomers, in high 
enantiomeric excess from the same starting material, as a function of choice of 
chiral Lewis acids. The reaction studied was the tin(II) Lewis acid coupling of 
enol silane 6.4.6.1 with various aldehydes giving syn and anti 2,3-dihydroxy 
ester derivatives (Scheme 6.4.6).
OSi(R3)3 Lewis acid (R3V,SO  o
[Ti(Cp)2(OTf)2].
89
O OSiMe3
Jl + Bn0 ^ k oph
OH O
R ^V^ ^ ' OPhSn(OTf>2 + 
chiral diamine
+
Bu2Sn(OAc)2 OH O
6.4.6.1 CH2CI2, -78°C
OPh
OBn
R chiraldiamine
yield
(%)
synl
anti
ee
(%)
Ph 6.4.6.4 85 95/5 91
CgHn 6.4.6.4 90 94/6 94
CH3CH=CH 6.4.6.4 89 >99/1 98
PhCH=CH 6.4.6.4 89 >99/1 98
2-furyl 6.4.6.4 88 >99/1 94
Ph 6.4.6.2 80 9/91 90
C5H n a 6.4.6.3 88 8/92 92
CH3CH=CH 6.4.6.2 51 7/93 92
PhCH=CHa 6.4.6.2 63 12/88 94
2-furyl 6.4.6.3 77 12/88 91
a Bu3SnF was used instead of BugSnfOAc^
Q ^ c P
Me
6.4.6.4
Table 6.4.6
9^0
R
R = Et 6.4.6.2 
R = Pr 6.4.6.3
From the table it can be seen that almost complete control over the symanti 
ratio has been achieved with very high enantiomeric excesses of the major 
products. Another 10 diamines were also studied but the 3 shown were 
superior.
Yamamoto achieved 96% ee for a chiral BLA (Bronsted acid assisted chiral 
Lewis acid) promoted aldol-type reaction of silyl enol ether 6.4.7.2 with imine 
6.4.7.1192 (Table 6.4.7).
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H O ^ P *
(+)-(S)-Dihydroperiphylline 
spermidine alkaloid
OSiMe3
PhMe-CH2CI2 (1:1), -78°C, 20 h
(S)-BLA 6.4.7.3 (1 eq)
pKJ k ^ c° 2Me
6.4.7.1 6.4.7.2 6.4.7.4
Scheme 6.4.7
This unusual concept of a BLA is very effective but in this case one whole 
equivalent of 6.4.7.3 is required which is considerable since 2 molecules of 
BINOL are required per molecule of 6.4.7.3.
Yamamoto utilised 6.4.7.4 in the synthesis of the spermidine alkaloid (+)-(£)- 
dihydroperiphylline.
Bulky 5-coordinate titanium chiral Lewis acid 6.4.8.1191 and four boron-centred
Lewis acids 6.4.8.2193,194, 6.4.8.3195, 6.4.8.4196 and 6.4.8.5197,198 have also been 
used for the Mukaiyama aldol reaction (Figure 6.4.8).
t- Bu
f-Bu
6.4.8.1
p-N0 2CeH4
6.4.8.3
Figure 6.4.8
6.4 .8.4 6 .4 .8.5
6.4.4 The Sakurai Reaction
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An reaction analogous to the Mukaiyama, but as yet less versatile, is that 
reported by Sakurai and now known by that name. 199>200 He found that Lewis 
acids promoted the reaction of ally lie silanes with aldehydes, ketones, acetals, 
ketals and orthoesters as shown in Scheme 6.4.9.
Lewis acid 
Si(R )3  ►
OSi(R3)3
R2
Scheme 6.4.9
Lewis acid  ►
OR"
R
R*
+  (R4)3SiOR3
Mechanistically, the Sakurai reaction is similar to the Mukaiyama aldol 
reaction188 and may be catalysed by simliar Lewis acids.
For example, the boron Lewis acid 6.4.8.2 was employed by Yamamoto to 
accomplish a 96% ee for the reaction shown in Scheme 6.4.10. 201’202
o
SiMe3 
6.4.10.1
hPrO O CO2H o
6.4.8.2 (20 mol%) 
MeCN
H
TBAF
74% yield, 96% ee
6.4.10.2
Scheme 6.4.10
With allylstannanes, the reaction is known as the Keck allylation, named after 
its discoverer. An example of the achievable level of stereocontrol is shown in 
Scheme 6.4.11. 203
+ ^v /S n B u 3
Molecular sieves 4A, CH2CI2
6.4.11.2 (10 mol%)
6.5.2.5 6.4.11.1 90% yield, 98% ee 6.4.11.3
Scheme 6.4.11
Although the Sakurai reaction is a useful process, it is far outweighed by the 
next reaction.
6.4.5 The Diels-Alder Reaction
The [4+2] cycloaddtion to form a 6 -membered ring is a standard method which 
is known as the Diels-Alder reaction. It allows, in principle, the formation of 
four contiguous stereogenic centres. Relative stereochemistry is usually well 
defined because of the formation of a cyclic transition state arising from orbital 
interactions, with endo approach.204
Useful reviews are available on the catalytic asymmetric Diels-Alder 
reaction.205*207 A few examples of more recent and useful applications of chiral 
Lewis acids to the Diels-Alder reaction now follows.
In 1994, Corey reported the use of boron-centred Lewis acids 6.4.12.3 and 
6.4.8.3, which are derived from cheap and easily recyclable N-(p- 
tolylsulfonyl)tryptophan, in syntheses of the antiulcer substance cassiol and the 
plant growth regulator gibberellic acid (Scheme 6.4.12) .208 
Hence, [4+2] cycloaddition of diene 6.4.12.1 with 2-methylacrolein (6.4.12.2), 
catalysed by boron chiral Lewis acid 6.4.12.3, leads to cyclohexene 6.4.12.4 in 
an impressive 83% yield and 97% ee. 6.4.12.4 is then further elaborated to 
Cassiol in short order. In the same paper, Corey goes on to apply previously 
described catalyst 6.4.8.3 to the synthesis of key bicyclic intermediate 6.4.12.7 
for the synthesis of Gibberellic acid. Cycloaddition of cyclopentadiene 6.4.12.5 
with bromoacrolein (6.4.12.6) proceeds in a stunning 81% yield and 99% ee 
with additional superb control over the exo\endo ratio.
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antiulcer OH
■OH
HO'
Gibberellic Acid 
plant growth regulator
OTIPS OTIPS
CHO Tos
OHC6.4.12.2 6.4.12.3 (25 mol%) 
---------------------------------------
1:1 CH2Cl2:PhMe, -78°C, 42 h 6.4.12.4 
83% yield, 97% ee
6.4.12.1
O
N-B,
BuTos
6.4.8.3 (10 mol%)CHO
CH2CI2, -78°C, 16 h6.4.12.6 6.4.12.7
6.4.12.5
Scheme 6.4.12
Tartrate-derived diols (TADDOLS) have also found use as ligands for chiral 
Lewis acids of titanium.209-211 In 1992, Narasaka described an approach to 
chiral boron species 6.4.13.4 through an enantioselective Diels-Alder reaction 
catalysed by Ti-TADDOLate 6.4.13.3.211
Qy o
o
6.4.13.1 6.4.13.2
Ph
PI
6.4.13.3 (10 mol%)
Molecular sieves 4A 
PhMe 
78% yield, >98% ee
6.4.13.4
Scheme 6.4.13
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There has been much work carried out with TADDOLS. Recent studies which 
have expanded our understanding of these reactions have been carried out by 
Seebach et aP09 and DiMare et al. 210
Further examples of impressive BINOL derivatives (c.fi Figure 6.4.2) have 
been reported by Yamamoto212 and Wulff. 213 Scheme 6.4.14 shows 
Yamamoto’s extremely bulky ligand 6.4.14.3 which, when complexed with 
titanium, gives an 82% yield and 92% ee for the cycloaddition of 
cyclopentadiene (6.4.14.1) with acrolein (6.4.14.2), The product 6.4.14.4 is a 
mixture of 13:1 of endo\exo isomers.
Scheme 6.4.14
Wulff has applied chiral Ms-phenanthrene 6.4.15.1 with diethylaluminium 
chloride (only 0.5 mol% of chiral Lewis acid!) for the cycloaddition of 
cyclopentadiene with 2-methylacrolein (Scheme 6.4.15). A quantitative yield, 
high ee and exo'.endo ratio make this reaction very attractive indeed.
V"^ Sif-BuPh2
10H+ TiCI2(0'Pr)2
<DH
X . S i f - B u P h 2
CH2CI2i 82% yield
+  Et2AICI
6.4.15.2
97.7% ee 
exo:endo = 32:1
CH2CI2) 100% yield
Scheme 6.4.15
In 1989 Corey et al reported chirally modified aluminium Lewis acid 6.4.16.3 
for use in the Diels-Alder reaction of cyclopentadiene 6.4.16.1 with dieneophile 
6.4.16.2,214 The product 6.4.16.4 was elaborated to a key intermediate in 
Corey's prostaglandin synthesis.
Scheme 6.4.16
6.5 Conclusions
In this chapter, a cursory survey of recent literature has been discussed for areas 
relevant to the forthcoming methodology study: p-lactone and silylketene 
chemistry have been introduced followed by an overview of some important 
chiral Lewis acid mediated C-C bond forming processes.
+OBn
6.4.16.1
CH2CI2, 94% yield
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Chapter 7
The Discovery of a Novel, Enantioselective Chiral Lewis Acid 
Catalysed [2+2] Cycloaddition of Aldehydes with 
(Trimethylsilyl)ketene and its Application to the Construction of
the /3-Lactone Portion of 1233A
7.1 Introduction
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This chapter will discuss the discovery of the first enantioselective [2+2] 
cycloaddition of achiral aldehydes with (trimethylsilyl)ketene. Application of 
this new methodology for the synthesis of the ft-lactone moiety in 1233A will 
then be tackled. Figure 7.1.1 shows the target compound 7.1.1.1 derived from 
the new methodology.
Figure 7.1.1
Before any piece of scientific research is to be undertaken, it is wise to survey 
the literature works on the subject and outline a sensible plan in order to 
maximise the possibility of success in the shortest possible time.
Firstly, the problem itself should be clearly defined: in this case a [2+2] 
cycloaddition of an aldehyde with a silylketene producing a 4-membered fi- 
lactone ring, the reaction being catalysed by a chirally modified Lewis acid, 
ML*n (Scheme 6.5.1).
Scheme 7.1.2
For a methodology study to bear fruit, a coherent plan must be formulated 
which takes into consideration all the variables present in the initial problem. 
From scheme 7.1.2, the variables are: the aldehyde, the silylketene, the Lewis 
acid (which metal? which ligand?) and any reaction parameters such as solvent 
and temperature. Of course the reactions should be conducted under conditions 
as similar to each other as possible so accurate comparisons of any results may 
be made. After consideration, the plan of action was set:
,o
o
chiral Lewis acid
(i) Select 3 or 4 achiral aldehyde substrates.
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(ii) Select one silylketene.
(iii) Develop model [2+2] cycloadditions with available achiral Lewis acids 
e.g. BF3, EtAlCl2-
(iv) Chirally modify the Lewis acid in order to make the reaction 
enantioselective.
(Trimethylsilyl)ketene (6.2.10.2) was chosen as a simple and easy to prepare 
ketene (see Scheme 6.2.11) but also because of ease of analysis of the 
cycloadducts (see below). The aldehydes were chosen as in figure 7.1.3. This 
selection will be used for various studies depending on the outcome of their 
cycloadditions with 6.2.10.2. The aromatic aldehydes 7.1.3.1, 7.1.3.2 and
7.1.3.3 could yield some mechanistic information due to the differences in the 
electronic distribution within the carbonyl group. The other 2 aromatic ring- 
containing aldehydes, 7.1.3.4 and 7.1.3.5, could be of use in a chiral study 
examining the importance of the proximity of an aromatic ring to the reacting 
centres. Dodecanal (7.1.3.6) is a simple long-chain aldehyde, arguably the 
greatest challenge for an enantioselective reaction due to the lack of any 
sterically encumbering groups. Cyclohexane carboxaldehyde (7.1.3.7) is a 
simple a-branched aldehyde and the influence of the saturated ring could be 
studied with 7.1.3.8 and 7.1.3.9.
o o o o
7 .1.3.1 7 .1 .3.2 7 .1.3.3 7.1.3.4 7.1.3.5
O O o
7.1.3.6 7.1.3.7 7.1.3.8 7.1.3.9 6.2 .10.2
Figure 7.1.3
The following discussion will chronicle efforts to synthesise the ketene, explore 
model studies with achiral Lewis acids and then bring these studies to a point 
where various chiral ligands can be tested for enantioselectivity.
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7.2 Preparation of (Trimethylsilyl)ketene (6.2.10.2)
The most practical method for the preparation of 6.2.10.2 involves pyrolysis of 
(trimethylsilyl)ethoxyacetylene (6.2.11.1)111’151 which is formed by quenching 
of metallated ethoxyacetylene with trimethylsilyl chloride. Although 
ethoxy acetylene (7.2.1.3) is commercially available, it is expensive and often 
requires purification before use, so it must be prepared freshly215 rendering the 
synthesis of 6.2.10.2 a 3 step procedure. In order to increase the efficiency of 
this synthesis, two attempts at quenching an in situ formed metallated 
ethoxyacetylene with TMSC1 were carried out: firstly, formation of 7.2.1.2 
from chloroacetaldehyde diethylacetal (7.2.1.1)215 and quenching with TMSC1 
to hopefully give 6.2.11.1; secondly, formation of lithiated ethoxyacetylene 
from 7.2.1.1 and methyl lithium and quenching with TMSC1. Unfortunately, 
neither process was successful so without further investigation 6.2.10.2 was 
prepared from the literature method111’151 (Scheme 7.2.1).
>Et
Cl 
7.2.1.1
Fe(N03)3 (cat.) 
NaNH2) NH3(I)
-  [EtO-
NaCI (aq)
-Naj ------------------- EtO- -H
7.2.1.2
60%
7.2.1.3
(i) MeLi, Et20  
0°C, 1 h
(ii) TMSCI
68-80%
MegSL A (120°C bath)
y — «—O ^ ------------------ EtO— ---- —SiMe3
H 50%
6.2.10.2 6 .2.11.1
Scheme 7.2.1
Preparation of 7.2.1.3 by treatment of 7.2.1.1 with 3 equivalents of sodamide in 
liquid ammonia gave a 60% yield. Lithiation of acetylene 7.2.1.3 and 
quenching with TMSCI gave 6.2.11.1 in 6 8 % yield. This low yield is probably 
due to loss of some product on evaporation of the solvent in vacuo. Crude
6.2.11.1 was pyrolysed at 120°C: 6.2.10.1 distilled at 79-82°C in 50% yield. 
The product was redistilled through a 10cm Vigreux column in order to remove 
all traces of 6.2.11.1 which were detectable in the crude NMR and IR of 
6.2.10.2, Overall yield from 7.2.1.3 was only 25% (lit.151 65%).
The key step in this preparation is the pyrolysis of trimethylsilyl
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ethoxyacetylene 6.2.11.1 to the ketene 6.2.10.2. Observations led to the 
conclusion that the method of achieving the pyrolysis reaction by heating
6.2.11.1 at 120°C was resulting in significant decomposition. Since it takes a 
finite time for any liquid to be completely vaporised by boiling, and the product 
ketene is thermally unstable under the pyrolysis conditions, it was necessary to 
devise a method of pyrolysis where the materials were exposed to high 
temperatures for shorter periods of time. Such a technique is flash pyrolysis: 
acetylene 6 .2 .1 1 .1  was added dropwise via syringe into an empty, dry 
distillation flask immersed in a silicone oil bath at 180°C (Scheme 7.2.2).
EtO—= —SiMe3 
6 .2.11.1
Scheme 7.2.2
6 .2 .11 .1  pyrolysed rapidly (or "flashed") and could be condensed as normal. 
The rate of addition of 6.2.11.1 into the hot flask equalled the rate of 
condensation of the product 6 .2 .1 0 .2  so that only a small amount of material 
was boiling at any one time, minimising decomposition dramatically. A lower 
temperature bath gave incomplete conversion. Any traces of unreacted 6.2.11.1 
may be removed with a simple Kugelrohr distillation at atmospheric pressure. 
Using this technique, the yield of ketene increased to 50% overall from 
ethoxyacetylene.
7.3 Model [2+2] Cycloadditions
Note: All reactions were conducted with 1.2-1.5 equivalents of ketene unless 
otherwise stated.
Initial attempts at [2+2] cycloaddition with 6.2.10.2 were made with the aryl 
aldehydes benzaldehyde 7.1.3.1 and para-nitrobenzaldehyde 7.1.3.3 (Table
7.3.1).
180°C (bath) Me3SL
-------------- ► > = «= o
flash pyrolysis H
80% 6.2.10.2
101
0  M EtAICIs _ / >1 + fl — t x
R HA SiMe3 E,2°  r  SiMe3
R = Ph 7.1.3.1 6.2.10.2 R = Ph, p-N02-C6H4
p-N02-C6H4 7.1.3.3
Entry Aldehyde Eq of Yield cis:trans
(R =) 6.2.10.2 (%) ratio
1 Ph 0.9 NDa -
2 P-NO2-Q H 4 1.2 NDa -
ND = not determined; aPolar material formed.
Table 7.3.1
Conducted in ether solvent and using ethylaluminium dichloride as Lewis 
acid,216 these reactions were quenched with water at 0°C, after consumption of 
starting material. Cycloaddition took place as evidenced by isolation of polar 
products: a,jfr-unsaturated carboxylic acids or silylstyrene decarboxylation 
products (see Mechanistic Considerations, below). An in situ formed 2- 
oxetanone has probably further reacted either under the reaction conditions or 
during work-up. 145 Considering that Zaitseva110 and more recently Brady168 
worked without solvent and directly distilled the product 2 -oxetanones from the 
reaction mixture, it may be concluded that these aryl aldehydes are unsuitable 
as models under the chosen conditions although their relative reaction rates will 
later become useful when the mechanism is considered.
Some of the other aldehydes from figure 7.1.3 were more successful (Table
7.3.2).
Table 7.3.2 shows that dodecanal (7.1.3.6) cycloadds in moderate to good yield 
with both EtAlCh and BF3*OEt2 as the Lewis acid mediator (entries 1 and 4), 
the former in a variety of solvents (entries 1-3). However, the ratio of cis:trans 
product isomers are quite different: with the aluminium Lewis acid total cis 
selectivity was observed but with boron, this selectivity was completely 
destroyed. This difference may be due to the greater steric bulk of the 
aluminium, (see later mechanistic discussions for an explanation)
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O
J
R = C11H23 
o-hex
PhCH2CH2
7.1.3.6
7.1.3.7 
7.1.3.5
O
II
•
Jl
H SiMe3 
6 .2 .10.2
Lewis
acid
solvent T tR SiMe3
R = CnH 23 7.3.2.1
ohex 7.3.2.2
PhCH2CH2 7.3.2.3
Entry Aldehyde
(R =)
Lewis 
acid (1.1 eq)
Solvent Yield
(%)a
cis: trans 
ratio
1 C11H23 EtAlCl2 Et20 68 100:0
2 C11H23 EtAlCl2 CH2CI2 54 100:0
3 C11H23 EtAlCl2 PhMe 52 100:0
4 C11H23 BF3«OEt2 Et20 81 53:47
5 C11H23 AICI3 Et20 56 100:0
6 C11H23 Me3Al CH2CI2 15c 77:23
7 c-Hex EtAlCl2 Et20 l?b -
8 PhCH2CH2 EtAlCl2 PhMe 62 81:19
9 PhCH2CH2 Me3Al CH2C12 18d 100:0
Notes: a refers to yield after column chromatography unless otherwise stated;  ^ Isolated yield of decarboxylated 
product (silyl alkene); c 19% of decarboxylated product (silyl alkene) also isolated in addition to Me attack on 
the carbonyl; d major product was 4-phenyl butan-2-ol derived from Me attack on the aldehyde carbonyl (64%).
Table 7.3.2
A few other aluminium Lewis acids were also examined since this metal 
appears to give better stereoselectivity. Trimethylaluminium was found to give 
side products e.g. addition of a methyl group to the carbonyl of the aldehyde 
(entries 6  and 9). AICI3 also performed well for 7.1.3.6 (entry 5). For 
cyclohexane carboxaldehyde (7.1.3.7) only polar products were isolated as for 
the aromatic aldehydes discussed above. However, a suitable model reaction 
with dodecanal has been found for initial forays into enantioselective reactions.
7.4 Development of a Suitable Method of Analysis of the Product 
Enantiomers
The products of a typical [2+2] cycloaddition with aldehydes and silylketenes 
may be composed of up to 4 stereoisomers: two cis and two trans enantiomers.
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Since the cis and trans geometrical isomers are separable by chromatography, 
the problem is reduced to determining the ratio of enantiomers in each sample 
of cis and/or frans-/3-lactones. Available modem methods include:217
(i) NMR Methods
(a) Chiral Lanthanide Shift Reagents (CLSRs)
(b) Chiral Solvents
(c) Chiral Solvating Agents
(ii) Chemical Derivatisation
(iii) Chiral Chromatography
Since (iii) was not readily available at the outset of this study and (ii) requires 
and extra chemical step, methods (i) were investigated. Initially, the CLSR
7.4.1.1 (Figure 7.4.1) was tested at varying product/CLSR ratios.81
Figure 7.4.1
As this ratio increased, increasing line-broadening was observed in the lH 
NMR spectrum at 270 or 360 MHz but no enantiomeric signals became 
sufficiently separate for an accurate integration analysis. Chiral solvents are 
expensive and infrequently of use and were not studied. However, option (i) (c) 
proved to be of some utility: a chiral solvating agent is a substance whose 
chirality influences solute spectral behaviour.218 Typically, these agents are 
added to an achiral solvent containing the solute (racemic, enantiomerically 
enriched or even a single enantiomer). Model analyses were probed with 
racemic /3-lactones: on addition of 1 equivalent of (S)-(-)-BINOL to the 
deuteriochloroform NMR solution of /3-lactone enantiomers, the doublets at 
approximately <53.3 ( /  = 6.1Hz for the cis isomer) for the CHTMS proton 
became sufficiently separate for an accurate integration analysis (±10% ee) at 
360 MHz (compound 7.3.2.1), This method was employed for analyses in 
initial studies (see notes under the following tables) but often the lH NMR 
spectrum required resolution enhancement in order to effectively fully separate
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the signals of interest. A resolution enhanced spectrum cannot be accurately 
integrated therefore greater errors are introduced into the enantiomer analysis. 
However, it was later found that Pirkle’s anthracene derivative (R)-(-)-2,2,2- 
trifluoro-l-(9-anthryl)ethanol (7.4.2.1) (figure 7.4.2) was more effective.
Figure 7.4.2
When 2 equivalents of 7.4.2.1 were added to the deuteriochloroform or 
deuteriobenzene solutions of the target /3-lactone, effective separation of the 
CHTMS doublet was usually obtained without resolution enhancement.
Later, in the chiral studies discussed below, chiral HPLC chromatography 
became available. Notes below tables indicate which methods have been used 
for the determination of ee.
7.5 Studies Towards an Enantioselective [2+2] Cycloaddition
7.5.1 Introduction
In situ formed chirally modified Lewis acids have been found to efficiently 
direct many carbon-carbon bond forming reactions (see Chapter 6). Ligands 
used with aluminium include the binaphthyls 7.5.1.1-7.5.1.3,219 220 tartrate 
derived diols 7.5.1.4-7.5.1.6209'211 and fris-sulfonamides such as 7.5.1.7221 or 
7.5.1.8222’223 (see Figure 7.5.1).
7.4.2.1
R
R = H 7.5.1.1 
R = Me 7.5.1.2 
R = SiPh3 7.5.1.3
R
R = Ph 7.5.1.4
R=1-naphthyl 7.5.1.5 
R = 2-naphthyl 7.5.1.6
SO2CF3 
7.5.1.7
SO2CF3
NH kOH
7.5.1.8
SO2CF3
7.5.1.9 7.5.1.10 7.5.1.11
Figure 7.5.1
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Potentially, the aluminium Lewis acid could be complexed with any chiral 
alcohol, e.g. 7.5.1.9 or 7.5.1.10, diol, aminol, e.g. 7.5.1.11 (easily accessible 
from L-proline) or diamine.
Since there is an adequate supply of these chiral ligands the object of this work 
is not to redesign new catalysts but to simply utilise existing ones in order to 
create a chiral Lewis acid which might enantioselectively catalyse the [2+2] 
cycloaddition in question.
7.5.2 Results of Preliminary Chiral Study
Dodecanal was identified, above, as a suitable model for initial chiral studies. 
Using a selection of chiral ligands from figure 7.5.1, some successful 
enantioselective reactions were carried out. Table 7.5.2 shows these results 
which amount to the first ever enantioselective chiral Lewis acid catalysed 
reactions of aldehydes with a silylketene.
Chiral
0 Lewiso
ChH23^
II
+  A
H SiMe3
Acid
CH2CI2
7.1.3.6 6.2.10.2
C 1 1 H2 3  SiMe3
7.3.2.1
Entry Chiral Lewis acid Yield
(%)
cis:trans
ratio
eea
(%)
1 EtAlCl2/7.5.1.1b 83d 100:0 11
2 EtAlCl2/7.5.1.4b 11 100:0 10
3 Ti(Oi-Pr)2Cl2/7.5.1.8b 0 - -
4 EtAlCl2/7.5.1.8b 48e 100:0 0
5 EtAlCl2/7.5.1.9b 69f 100:0 22
6 EtAlCl2/7.5.1.10b 61 100:0 18
7 EtAlCl2/7.5.1.10° 4 0:100 ND
a ees were determined by 360MHz NMR: addition of 1 equivalent of (S)-(-)-B INO L to the NM R solution 
and integration of the CHTMS doublets; b 1:1 ratio; c 1:2 ratio; ^ Yield based on recovered aldehyde; e Also 
11% of the aldehyde + product mixture(l: 1 )T  Also 65% of R*OCOCH2TMS; ND = not determined.
Table 7.5.2
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However, as suspected from previous work,216 the titanium system was just too 
strong and destroyed the products as they formed.
All chiral ligands were used in stoichiometric quantities. The first attempt was 
with (S)-(-)-BINOL 7.5.1.1: this chiral diol was complexed with EtAlC^ 
(liberating HC1) at -30°C then dodecanal was added and finally the ketene
6.2.10.2 (entry 1). The reaction yielded 56% of exclusively cis-2-oxetanone
7.3.2.1 (and 18% recovered aldehyde, 83% yield of product based on recovered 
starting material). A slight enantioselective effect of 11% ee was detected 
using chiral BINOL in the *H NMR i.e. 55.5% of one enantiomer and 44.5% of 
the other. Although very slight this experiment is highly significant since it 
demonstrates that the reactions can be conducted enantioselectively. Some 
BINOL-derived side products were also isolated but not fully identified.
Further studies with the tartrate derived diol 7.5.1.4 (TADDOL) (entry 2) gave 
a very poor reaction but the isolated product exhibited a slight ee of about 10%. 
R/s-sulfonamide 7.5.1.8222 was studied with a titanium Lewis acid but resulted 
in no reaction (entry 3). Although the EtAlCl2 complexed 7.5.1.8 resulted in 
some desired product with exclusive cis selectivity, disappointingly there was 
no enantioinduction (entry 4).
Chiral alcohols (+)-i,sopinocainpheol 7.5.1.9 and (-)-menthol 7.5.1.10 were 
available and experiments were conducted with 1 equivalent of each with 
EtAlCL (entries 5 + 6, respectively). These cycloadditions progressed rapidly 
and resulted in good yields of cycloadduct with slightly better enantioselection 
than 7.5.1.1 (22 and 18% for 7.5.1.9 and 7.5.1.10, respectively). The alcohols 
were also acylated in good yield by the ketene 6.2.10.2 to give a-silyl esters 
derived from the chiral alcohol, a typical reaction of alcohols with silylketenes 
(see Chapter 6). This previously reported221 side reaction could be due to the 
presence of HC1 in the reaction mixture rendering the chiral aluminium 
complex formation reversible. Therefore eliminating HC1 from the equation 
may prevent acylation of the alcohol. One attempt is shown in Scheme 7.5.3.
BuLi
(R*0)2AIEt +  2LiCI
FTOH ^  R*0"Li+ EtAICI2 (0.5 eq)
7.5.1.9
[R*OAIEtCI2p j + "aluminate'
Scheme 7.5.3
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Lithiation of the alcohol 7.5.1.9 with n-butyl lithium then reaction with EtAlCl2 
in ether did not result in the expected product with liberation of lithium chloride 
(a driving force for completion of complexation) but instead gave a solid gel 
which could be an aluminate complex. Other methods of preventing acylation 
of the chiral alcohols could be use of MesAl or EtsAl (liberation of methane or 
ethane) or formation of the trimethylsilyl protected alcohol and removal of 
volatile trimethylsilyl chloride (bp 57°C) by distillation on reaction with 
EtAlCh in a suitable solvent, e.g. toluene.
Enantioselectivity is likely to be improved if two chiral alcohol units modify 
the Lewis acid so the [2+2] cycloaddition was also attempted with 2 equivalents 
of 7.5.1.10 (with 1 equivalent of EtAlCl2) but resulted in large quantities of a-
silyl ester derived from the chiral alcohol and very little 2-oxetanone product.
7.5.3 Discovery that Chiral Lewis Acids Derived from 7.5.1.7 Catalyse the 
[2+2] Cycloaddition with High Enantioselectivity
Recently Corey has developed a new class of chiral Lewis acid catalyst 6.4.16.3 
(see Scheme 6.4.16) for the Diels-Alder reaction. 214-224 These catalysts are 
aluminium derivatives of b/s-sulphonamide 7.5.1.7 and have been fully 
characterised (including X-ray studies) by Corey. 225 In our [2+2] 
cycloaddition, such catalysts were found to be useful due to rapid screening of 
ligands through ease of ligand synthesis. Such attributes are lacking in many 
other ligands such as BINOLs or TADDOLs (see Chapter 6). The following 
sections will discuss previous applications of 6/s-sulfonamide ligands in 
asymmetric synthesis, the preparation of the ligands and the development and 
optimisation of chiral catalysts for the [2+2] cycloaddition of aldehydes and 
silylketenes.
7.5.3.1 Previous Methodology with Bis-sulfonamides as Ligands for Chiral 
Lewis Acids
Good precedent for their use is evidenced in their application to several 
stereoselective processes. Firstly, Corey reported the above Diels-Alder 
chemistry which led to enantioselective and diastereoselective allylations of 
aldehydes mediated by stoichiometric quantities of boron-centred bis- 
sulfonamide 7.5.4.2 (Scheme 7.5.4).226
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PH. ,Ph 
/—(
T oI S C V ^ 'b '  S 0 2Tol
7.5.4.2 V
(1.1 eq) fl 
O M OH
toluene 
>90%, 95% ee
7.5.4.1 7.5.4.3
Scheme 7.5.4
Highly stereoselective aldol reactions may be performed with propionate ester 
enolates and aldehydes mediated by boron-centred chiral Lewis acid 7.5.5.3 
(Scheme 7.5.5). 227’228
CF*
p \ / h Ar =
I \. .
ArS02' 'NvB<' ^s°2Ar
Br 7.5.5.3
O (1 eq)
+  CH3CH2C 02f-Bu------------------------------------- ^  pK^ ^ v ^ C°2 ^ Bu
Pit" EtaN, toluene:hexane (1:2)
-78°C , 1.5 h
7.5.5.1 7.5.5.2 7.5.5.4
81%, 98% ee  
99:1 anthsyn
Scheme 7.5.5
The first example of an enantioselective Diels-Alder reaction of an achiral C2v- 
symmetric dienophile and an achiral diene was reported by Corey in 1994. In 
this instance, the aryl groups from the parent diamine were modified with 3,5- 
dimethyl substitution to give catalyst 7.5.6.3 which catalysed the [4+2] 
cycloaddition of diene 7.5.6.1 with the dienophile 7.5.6.2 in 98% yield and 93% 
ee (Scheme 7.5.6). 229
Ar\  Ar
Ar=
F3C S 0 2" % r N' S °2C F 3  X '
I
Me
7.5.6.3 (20 mol%) 
 ►-
MeO ^  N— J  toluene,-78°C
q  98%, 93% ee
7.5.6.1 7.5.6.2 7.5.6.4
109
Scheme 7.5.6
Another reaction which is possible to influence enantioselectively with bis- 
sulfonamides is the addition of alkyl groups to aldehydes using a titanium- 
dialkylzinc system. 222 The example shown in scheme 7.5.7 is impressive since 
almost complete control of the product stereochemistry is achieved with linear 
pentanal.
o
7.5.7.1
a NHTfNHTf
7.5.1.8 (4 mol%) 
---------------------
Ti(0/-0Pr)4 (0.6 eq) 
Et2Zn (2.2 eq) 
-20°C, 5 h 
78%, 99% ee
7.5.7.2
Scheme 7.5.7
In a similar vein, Knochel has prepared 1,4-diols by the catalytic 
enantioselective addition of functionalized dialkylzincs to y-oxyaldehydes. For 
example TIPS protected 4-hydroxybutanal (7.5.8.1) undergoes addition from a 
variety of organozincs in the presence of 8 mol% of titanium chiral Lewis acid
7.5.8.2 (Scheme 7.5.8). 223
Tfa: /i(OAOPr)2
Tf
7.5.8.2 (8 mol%) 
R2Zn, toluene
T|p S 0 ^ ^ * °   ^  T ,P S 0
7.5.8.1 _60-»-15°C  43-87%
89-99% ee
Scheme 7.5.8
More recently, Kobayashi has demonstrated good enantioselectivity for the 
Simmons-Smith cyclopropanation of allylic alcohols catalysed by various bis- 
sulfonamide-zinc-complexed species. One of the better examples is shown in 
scheme 7.5.9 where 0.12 equivalents of para-nitrobenzenesulfonamide 7.5.9.2 
was employed giving a quantitative yield and 82% ee. 230’231
7.5.9.1
SO;
NH
n o2
7.5.9.2 (0.12 eq) H
Et2Zn (2 eq), CH2I2 (3 eq) 
CH2CI2-hexane 
-23°C, 5 h 
quant, 82% ee
H
7.5.9.3
OH
Scheme 7.5.9
Lanthanide-6/.s-triflamides have been employed for the hetero-Diels-Alder 
reaction of Danishefsky's diene 7.5.10.1 with butyl glyoxalate (7.5.10.2) 232 
(Scheme 7.5.10).
TBDMSO
7.5.10.1
OMe
C 02Bu 
7.5.10.2
Pf) Ph
(0 )—(
TfNH NHTf
7.5.1.7 (10 mol%)
Y(OTf)3, H20  (11 eq)
toluene
(ii) CF3C02H
XX C 02Bu
7.5.10.3
Scheme 7.5.10
The lanthanide-6*s-sulfonamide complex is formed by deprotonation of the 
acidic sulfonamide protons with sodium hydride then addition of the lanthanide 
triflate (ytterbium triflate gave the best results). The interesting point about this 
study is the beneficial influence of water as an additive in increasing not only 
the enantioselectivity but also the chemical yield. Other reactions catalysed by 
lanthanide complexes in the presence of water have been studied. 233 
Very recently, Evans reported the application of chiral magnesium-bis- 
sulfonamide 7.5.11.2 for the enantioselective amination of N -  
acyloxazolidinones such as 7.5.11.1234 (Scheme 7.5.11).
I l l
ArS02
P
„NS02Ar X
O O
j LO N
BocN=NBoc 
p-TosNHMe (20 mol%) 
CH2CI2-Et20  
-75°C, 48 h
7.5.11.2 (10 mol%)
^— '  BocN
NHBoc
7.5.11.1 7.5.11.3
92%, 86% ee 
(99% ee after a single 
recrystallisation)
Scheme 7.5.11
The product 7.5.11.3 may be upgraded to >99% ee after only a single 
recrystallisation. The role of the iV-methyl-/?-toluenesulfonamide has not been 
completely elucidated but a kinetic study revealed a first-order dependence of 
this addend on the reaction rate.
Finally, also very recently, an enantioselective Claisen rearrangement was 
reported using boron chiral Lewis acid 7.5.12.2235 (Scheme 7.5.12).
Scheme 7.5.12
This chemistry has the considerable disadvantages of requiring stoichiometric 
quantities of 7.5.12.2 and being very slow.
7.5.3.2 Synthesis of the Bis-sulfonamide Ligands
TolS02^ N' B' N" s °2Tol
i
Et3N, CH2CI2 
-45°C, 4 d
89%, 94% ee
7.5.12.2 7.5.12.3
Hope was initially offered when an opportunity was taken to evaluate this class 
of Lewis acid by experimentation with aluminium cyclohexane &/s-triflamide
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7.5.13.1 for the [2+2] cycloaddition of dodecanal with (trimethylsilyl)ketene 
(6.2.10.2) (Scheme 7.5.13, c.f Table 7.5.2, entry 4).
s o 2CF3
AhMe
O 7.5.13.1 s ° 2c f 3 oj + j (1^ __  ^ rf
C 11 h 23 H ^ S i M e 3 ,0l^ c j ° h ^  C 11H23 SiM e3
7.1.3.6 6.2.10.2 53% cis
10% ee
Scheme 7.5.13
Lewis acid 7.5.13.1 was formed by addition of 1 equivalent of 
trimethylaluminium in toluene to the to-triflamide 7.5.1.8 and heating at 80°C 
for 1 h (Corey conditions214). Scheme 7.5.13 shows that 7.5.13.1 successfully 
mediated the reaction of dodecanal (7.1.3.6) with 6.2.10.2 in 53% yield but 
importantly a slight enantiomeric excess was detected (BINOL added to lH 
NMR and analysis of CHTMS doublets). With this result in hand, the synthesis 
of Corey's 1,2-diphenylethylene diamine-based ligand could be attempted. The 
phenyl groups could be important electronically and sterically. 236 
Hence the synthesis of parent diamine 7.5.14.4 was undertaken as in scheme 
7.5.14. 237-238
ptr "o
7.5.14.1
M M O A r  p k  (i) Li, THF/NH3(!)
/ -----V NH40/^  — \  —70°C, 2 h Pll ___/
' ' AcOH, A — >
1 h, 83%
7.5.14.2 7.5.14.3
Ph
EtOH, 0.5 h, H2N NH2 
-60°C
(iii) NH4CI (±)-frans-7.5.14.4
(iv) HCI
(v) NaOH
70% (i) (+)-tartaric acid
(ii) Recryst.
(iii) NaOH, extract
59%
 f h
.N .N—,-rf
t K  Y  Tf
Me
6.4.16.3
Me3AI >h Ph (
M  -
(CF3S 0 2 )20
*Vf
PhMe jfHN NHTf Et3N, DMAP H2N NH2 
80°C’1 h CH2CI2, -80°C
7.5.1.7 rt. 1 h, 74% (S,S)-(-)-7.5.14.4
Scheme 7.5.14
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Spiro-imidazole intermediate 7.5.14.3 was obtained by reaction of 1 equivalent 
each of benzil (7.5.14.1), cyclohexanone (7.5.14.2) and ammonium acetate in 
refluxing acetic acid (83% yield after recrystallisation from hexane). 7.5.14.3 
was stereoselectively reduced with lithium metal in 1:1 THF: liquid ammonia 
to give exclusively the trans racemic diamine (±)-7.5.14.4 in 70% yield. 
Resolution of (±)-7.5.14.4 with (+)-tartaric acid in 2 recrystallisations followed 
by extraction of the free amine from aqueous sodium hydroxide solution 
yielded the optically pure (S,S)-(-)-7.5.14.4. This compound along with its 
enantiomer is commercially available but prohibitively expensive. At this stage 
any sulphonamide desired may be prepared from 7.5.14.4 by reaction with the 
appropriate sulphonyl chloride or anhydride. Initially the triflamide 7.5.1.7 was 
prepared since this has been studied widely by Corey. Aluminoimidazoline
6.4.16.3 forms easily when 7.5.1.7 is exposed to trimethylaluminium in toluene. 
It was subsequently found that heating this mixture to 80°C (as for Corey’s 
conditions214 was not necessary in order to form the catalyst: stirring at room 
temperature for 10 minutes results in evolution of methane). A toluene solution 
of 6.4.16.3 may be stored under an inert atmosphere and used when required 
but it is a simpler matter to prepare the catalyst in situ.
Modifications to the catalyst structure proved to be facile. The sulfone of 
choice may be attached to the parent chiral diamine 7.5.14.4 using standard 
methodology (sulfonyl chloride (2 equivalents), triethylamine (3 equivalents) 
and catalytic DMAP in dichloromethane at rt). Some non-C2-symmetric
variants were also prepared. For these, addition of one equivalent of sulfonyl 
chloride followed by the other after consumption of the first was necessary to 
avoid mixtures of products (see later).
7.5.3.3 [2+2] Cycloadditions Catalysed by 6.4.16.3 with a Range of 
Aldehydes
Cycloaddition reactions were studied with 6.4.16.3 as chiral Lewis acid. Firstly 
the reaction of dodecanal (7.1.3.6) with 6.2.10.2 was investigated with 1.01 
equivalents of 6.4.16.3 (Table 7.5.15, entry 1).
J oII,JL
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SiMe3
V<Ph
Tf"Ny N'Tf
Me
6.4 .16 .3  
 >
toluene  
- 8 0  -»  -20°C R " 7 \  R7 H SiM e3
R = C i i H23 7 .1 .3 .6
PhCH2CH2 7 .1 .3 .5
PhCH2 7 .1 .3 .4
Ph 7.1.3.1
£>hexCH2CH2 7 .1 .3 .9
c-hexCH2 7 .1 .3 .8
o-hex 7 .1 .3 .7
p -N 0 2C6H4 7 .1 .3 .3
p-MeOC6H4 7 .1 .3 .2
R7 = H 6 .2 .10 .2  
CeHi3 6.2.12.2
Ci i H23 R7 = H 7.3.2.1
PhCH2CH2 H 7.3.2.3
PhCH2 H 7.5.15.1
Ph H 6.2 .10 .4
ohexCH2CH2 H 7.5 .15 .2
ohexC H 2 H 7.5.15.3
o h e x H 7.3 .2 .2
p -N 0 2C6H4 H 7.5 .15 .4
p-MeOCgH4 H 7.5 .15 .5
PhCH2CH2 C6Hi 3 7 .5 .15 .6
PhCH2 C6Hi 3 7.5 .15 .7
o-hexCH2CH2 c 6h 13 7 .5 .15 .8
Entry RCHO 
(R =)
Ketene
(R'=)
Equivalents 
of 6.4.16.3
Yield
(%)a
Cis :Trans eeh (%) 
(cis)
1 C11H23 H 1.01 53 100:0 0
2 C11H23 H 0.51 52 100:0 <5
3 C11H23 H 0.20c 53 100:0 <5
4 PhCH2CH2 H 0.20 81 95:5 15
5 PhCH2 H 0.20 81 84:16 15
6 Ph H 0.20 70d 100:0 20
7 c-HexCH2CH2 H 0.20 75 97:3 5
8 c-HexCH2 H 0.20 73 96:4e 10
9 c-Hex H 0.20 71 88:12 0
10 P-NO2C6H4 H 0.20 75* 100:0 f
11 p-MeOC6H4 H 0.20 678 - -
12 PhCH2CH2 C6H 13 0.20 77 86:14 ND
13 PhCH2 C6H 13 0.20 73 82:18 ND
14 c-HexCH2CH2 C6H 13 0.20 ND ND ND
Notes: ND: not determined; a refers to yield after column chromatography unless otherwise stated; b 19% of 
decarboxylated product (silyl alkene) also isolated; c no reaction with 15, 10 or 1 mol%; d crude /3-lactone 
isolated but hydrolysed on silica to give 70% of the a,/3-unsaturated acid; e inseparable 96:4 mixture 
characterised;f decomposed on treatment with BENOL; 8 yield of a,/3-unsaturated acid derived from /3-lactone; 
b ee s were determined by 360MHz *H NMR: addition of 1 equivalent of (S)-(-)-BINO L to the N M R  solution 
and integration of the CHTMS doublets;1 yield of crude product.
Table 7.5.15
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Complete reaction was achieved rapidly and with 100% cis selectivity 
(although no enantioselectivity). When a catalytic quantity of 6.4.16.3 was 
employed (50 then 20 mol%, entries 2 and 3 and see note c) it was discovered 
that the reaction progressed efficiently with no loss in yield, cis'.trans selectivity 
or reaction rate. Hence the reaction has successfully been made catalytic. In 
fact these reactions progressed more rapidly and cleanly than studies with 
achiral Lewis acids such as EtAlCl2.
Considering the relative Lewis acidity of the catalyst with Lewis basicity of the 
aldehyde starting material and /3-lactone product may help in our understanding 
of the catalytic cycle. Strong Lewis acids such as EtAlCl2 and Me3Al co­
ordinate strongly to the Lewis basic sites on the aldehyde and /3-lactone 
carbonyl groups. Hence a full equivalent of Lewis acid is required for complete 
conversion to the product. For a successful catalyst, effective binding to the 
aldehyde substrate is required in order to induce reaction but the products 
should bind less tightly so that the Lewis acid may detach itself and thereby 
become available to initiate another cycle. In the case of 6.4.16.3, tempering of 
the Lewis acidity of the aluminium centre by the to-sulfonamide ligand seems 
to have occurred in a favourable direction so that its interaction with the weakly 
Lewis basic /3-lactone carbonyl has been rendered small enough so that the
6.4.16.3 molecule remains free to assist the reaction of a second molecule of 
aldehyde with the ketene, etc. In addition there is likely to be an unfavourable 
steric factor involved in the interaction between the /Llactone and the catalyst.
Successful reactions were also achieved with the other aldehydes chosen for the 
study (see Figure 7.1.3). This series compares aldehydes with electronically 
and sterically significant groups at varying positions (0, 1 and 2 carbon spacers) 
relative to the carbonyl group. All reactions progressed rapidly and remarkably 
cleanly. The product /3-lactones were isolated in good yield by chromatography 
and fully characterised. Most yields were greater than 70% and useful cis'.trans 
ratios were obtained (entries 4-9). Evidence supporting the mild nature of the 
catalyst is offered in entry 10: para-nitrobenzaldehyde (7.1.3.3) gave a 75% 
yield of /Llactone 7.5.15.4, This product was sufficiently sensitive to react with 
BINOL during the ee analysis! However the electronically challenging para- 
methoxybenzaldehyde (7.1.3.2) was not so fortunate: only /3-lactone derived 
products were isolated, perhaps due to the higher temperature required to 
induce cycloaddition with such an unreactive carbonyl.
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In order to understand these differences a mechanistic argument can be put 
forward for the greater instability of the expected product 7.5.16.3 compared to
7.5.15.4 (Scheme 7.5.16).
Nuc attack here 
very favourable 
(c.f note f, 
[2+2] Table 7.5.15)
7.5.16.2
very mild 
l acidic 
\  conditions7.1.3.3 7.5.15.4 /  Peterson 
olefination
7.5.16.1
[2+2]
Me'
7.5.16.3
Me'
7.5.16.4
Me'
7.1.3.2
Me'
7.5.16.5
Scheme 7.5.16
The strong electron donating character of the methoxy group in the para 
position pushes electrons through the aromatic ring in 7.5.16.3. This results in
7.5.16.4 which loses TMS to give 7 .5 .16 .5 , the driving force being 
aromatisation and formation of the lower energy fully conjugated system. Of 
course, the highly reactive nature of the carbonyl group in 7.5.15.4 is due to the 
powerful electron withdrawing nitro group on the aromatic ring. The 
decomposition is probably due to Peterson olefination (7.5.16.1 —» 7.5.16.2).
Studies with hexyl(trimethylsilyl)ketene (6.2.12.2) were also carried out 
(entries 12-14). Some of this material was available from studies on
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tetrahydrolipstatin (6.2.1.3). Reactions are still clean (although slower, taking 
about 1 h) and high yielding although the cis or trans stereochemistry is 
unknown due to loss of coupling constant information with replacement of the 
CHTMS proton with a six-carbon chain.
The best enantiomeric excesses so far are only around 20% so some 
modification of the catalyst structure will be necessary.
At this point we became aware of a publication detailing the [2+2] 
cycloaddition of some aldehydes with ketene itself employing aluminium 
modified with to-sulfonamides (Scheme 7.5.17).221
Scheme 7.5.17
Although this work uses ketene (7.5.17.1) which is a reactive gas and requires 
special equipment for its preparation, the principle of aluminium modified with 
a b /^-sulfonamide ligand was established confirming that our work was 
progressing in a positive direction. The use of an ethyl group on aluminium 
will also be explored later.
7.5.3.4 Optimisation of the Aluminoimidazoline Structure
7.5.3.4.1 Study of the Sulfone Group
Figure 7.5.18 shows the structural analogues of 6.4.16.3 tested in table 7.5.19. 
Aromatic sulfones were realistically the best choice for ease of synthesis and 
fine-tuning of the steric and electronic properties of the catalyst.
ArS02Nv NS02ArA I
toluene, 75%, 74% ee
7.1.3.7 7.5.17.1 7.5.17.3
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 f>h
RS02-"NxArN"S02RI
Me
(S, S) or (R, fl)
R = 7.5.18.1(S,S)
7.5.18.2
(R,R)
7.5.18.3
(S,S)
7.5.18.4
(S,S)
F F
F 7.5.18.5
7.5.18.6
Br 7.5.18.7
7.5.18.8
7.5.18.9
(S ,S)
Table 7,5.18
The nine sulfonamide ligands in scheme 7.5.18 were prepared easily from 
enantiomerically pure diamine 7.5.14.4 and the appropriate sulfonyl chloride 
(Et3N and catalytic DMAP in dichloromethane) in 90% yield. Some sulfonyl 
chlorides also had to be prepared (see Experimental Section).
Unfortunately some ligands were so insoluble in a range of organic solvents 
(petrol, toluene, ether, dichloromethane, THF, ethyl acetate) that they were 
effectively useless for application as chiral modifiers of trimethylaluminium. 
These fos-sulfonamides would have given catalysts 7.5.18.5 to 7.5.18.8, It 
appears that already valuable information has been gained on the nature of the 
ligand which will be required for a successful catalyst: aromatic nuclei directly 
substituted with a halogen appear to be generally useless due to solvation 
problems. This is almost as disappointing as the failure of naphthyl substituted 
7.5.18.8 since the larger ’’plates" of the naphthyl group may have been powerful
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directors in the catalyst epicentre. However, the remaining ligands did not 
present any immediate problems with their physical properties.
o
J
Pf\ Ph
n
R'so2- % r N"s02R/
Me
9xH^SiMe3
(S, S )or(fl.fl) 
 >
toluene 
-80 —> -20°C
tf + tf
R SiMe3 P ?  'SiMe3
R = Ci -|H23 7.1.3.6
PhCH2CH2 7.1.3.5
PhCH2 7.1.3.4
c-hex 7.1.3.7
p-MeOCehUCI-k 7.5.19.1
6.2.10.2
R = CiiH23 7.3.2.1
PhCH2CH2 7.3.2.3
PhCH2 7.5.15.1
c-hex 7.3.2.2
p-MeOCeH^I-t 7.5.19.2
Entry RCHO
(R=)
Catalyst
(mol%)
Yield cis:trans eeb (%) 
(cis)
Abs.
Config.f
1 PhCH2 7.5.18.1 (25) 48 80:20 0C -
2 PhCH2CH2 7.5.18.1 (21) 44 90:10 5C ND
3 c-Hex 7.5.18.1 (20) ND 77:23 20c ND
4 PhCH2 7.5.18.2 (44)a 43 100:0 58d (5, R)
5 PhCH2CH2 7.5.18.2 (61)a 43 100:0 44d (S, R)
6 c-Hex 7.5.18.2 (98)a 57 95:5 64d (5, R)
7 PhCH2 7.5.18.3 (100) - - - (R,S)
8 PhCH2 7.5.18.4 (50) 56 83:17 83d (R,S)
9 PhCH2CH2 7.5.18.4 (30) 80 90:10 44d (R,S)
10 c-Hex 7.5.18.4 (33) 32 85:15 68d (R,S)
11 C nH 23 7.5.18.4 (29) 67 94:6 47e (R,S)
12 p-MeOC6H4CH2 7.5.18.4 (30) 77 99.3:0.7 83e (R,S)
13 PhCH2 7.5.18.9 (50) 29 91:9 9 ND
ND = not determined; a (/?, R) catalyst; b ee determined as indicated; c ee determined by NM R  analysis of
the C//TM S doublet in the presence of 1 equivalent of (/?)-(+)-BINOL; d ee determined by chiral HPLC (Daicel 
Chiralpak AD, 2% wo-propyl alcohol-hexane, 1.0 mL/min, 210 nm); e ee determined by NM R analysis of
the C/ZTMS doublet in the presence of 2 equivalents of (/?)-(-)-2,2,2-trifluoro-l-(9-anthryl)ethanol;f absolute 
configurations determined by independent synthesis (see later).
Table 7.5.19
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The results from Table 7.5.19 are very encouraging. Optimum enantiomeric 
excesses were obtained with catalyst 7.5.18.4 which possesses a 4-tert-butyl- 
2,6-dimethyl substituted benzene sulfonamide (entries 8-12). Aldehydes with 
an aromatic group in the a-position such as phenylacetaldehyde (7.1.3.4) and 
para-methoxyphenylacetaldehyde (7.5.19.1) gave an ee of 83% (entries 8 and 
12). This is a ratio of enantiomers of 11:1, which is approaching synthetic 
utility.
When the aromatic ring is moved further away from the aldehyde carbonyl, into 
the /3-position, a drop in enantioselectivity to 44% ee is suffered (entry 9). This 
is somewhat disappointing since the obvious conclusion is that some form of n- 
stacking is occurring between the phenyl rings of the substrate and the 
catalyst.239
Even with the most challenging linear chain of dodecanal (7.1.3.6), an ee of 
47% has been achieved (entry 11). The simple alkyl-a-substituted aldehyde 
cyclohexane carboxaldehyde (7.1.3.7) yielded 64-68% ee with either catalysts
7.5.18.2 or 7.5.18.4 (entries 6 and 10), suggesting that a sterically encumbered 
aldehyde is of some benefit but not as extensive as an a-positioned aromatic 
nucleus.
The steric limits of the system have been reached with 2,4,6-triz\s<9- 
propylbenzene-derived catalyst 7.5.18.3: no reaction occurred even with one 
whole equivalent of Lewis acid (entry 7).
As previously published with ketene (7.5.17.1), an ee of 74% was obtained with 
chiral catalyst 7.5.18.1 (with an ethyl group on Al, see Scheme 7.5.17). 
However, with (trimethylsilyl)ketene (6.2.10.2) poor results were obtained 
(with a methyl group on Al, entries 1-3). Alkyl substitution on Al will be 
explored in a later section.
In conclusion, a vast step forward has been achieved in the quest for a generally 
applicable enantioselective catalyst for the [2+2] cycloaddition of aldehydes 
with (trimethylsilyl)ketene. However, there are other features of the catalyst 
which remain to be investigated and these studies now follow.
7.5.3.4.2 Study of the Parent Phenyl Ring
A study of the phenyl groups of the sulfonamide sub-structure of the catalyst 
revealed the importance of the type and position of the substitution. Similarly, 
on the western side of the catalyst there reside 2 phenyl rings originating with
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the parent diamine 7.5.14.4. In light of the importance of the nature of the 
sulfonamide it would be desirable to examine more closely the effect of simple 
substitutions on these rings.
Recently, Corey published some general experimental procedures leading to 
substituted benzils236 which could then be further elaborated to the chiral 
diamine of interest. Using this chemistry 3,5-dimethyl-substituted benzil
7.5.20.5 was prepared and elaborated to the diamine 7.5.20.6 (Scheme 7.5.20).
*fjJH 
7.5.20.1
Et
7.5.20.2
IPA
50%
7.5.20.3
1T^TXAr = Y
as Scheme7.5.20.3Br f-BuLi, THF . ~ * mu
—75°C 2 h 7.5.14 Ap,,f .,NH2
- X, x
7.5.20.4
Scheme 7.5.20
then rt 
O/N 
83%
0  Ar 30% 
7.5.20.5
a r  ' n h2
B-7.5.20.6
Similar chemistry was attempted with the ce-naphthyl group in place of 3,5- 
dimethylphenyl but this was found to be overly impractical with low yields and 
insoluble intermediates.
Figure 7.5.21 shows the catalysts studied with the new substitution and Table 
7.5.22 exhibits the results.
Ak Ar
(S, S)Ar'S02"'N^Af' ^ S 0 2Ar' 
file
7.5.21.1 7.5.21.2
Figure 7.5.21
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Although only 2 catalysts were looked at in this C2-symmetric series, enough 
data has been gathered to draw some conclusions.
v<
Ar'S02''Nvy\r 1S° 2Ar/
toluene 
-80 -> -20°C
R = PhCH2CH2 7.1.3.5 
PhCH2 7.1.3.4
c-hex 7.1.3.7
6.2.10.2
R = PhCH2CH2 7.3.2.3 
PhCH2 7.5.15.1
c-hex 7.3.2.2
Entry RCHO 
(R =)
Catalyst
(mol%)
Yield cis:trans eeb (%) 
(cis)
Abs.
Config.d
1 PhCH2 7.5.21.1 (21) 76 76:24 22° ND
2 PhCH2CH2 7.5.21.1 (23) 66a 90:10 8C ND
3 c-Hex 7.5.21.1 (39) 15 73:27 0C ND
4 PhCH2 7.5.21.2 (30) 61 93:7 75c (R,S)
5 PhCH2CH2 7.5.21.2 (58) 46 97:3 40c (R,S)
6 c-Hex 7.5.21.2 (49) 36 100:0 55c (R,S)
ND = not determined; a isolated yield of cis isomer only; b ee determined as indicated; c ee determined by 
NM R analysis of the CZ/TMS doublet in the presence of 2 equivalents of (/?)-(-)-2,2,2-trifluoro-l-(9- 
anthryl)ethanol; d absolute configurations determined by independent synthesis (see later).
Table 7.5.22
A slight improvement in ee from 58 to 75% was found with catalyst 7.5.21.2 
with phenylacetaldehyde (entry 4, c.f entry 4 in Table 7.5.19) but the changes 
in the other results were not statistically significant.
These small improvements do not justify the extra effort required to synthesise 
these ligands.
7.5.3.4.3 Study of the Substitution at Aluminium
Since the metal atom in the catalyst is at the centre of the system, it would be 
reasonable to expect profound changes to occur on alteration of the group 
bonded directly to the aluminium centre.
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Figure 7.5.23 shows the catalysts tested and table 7.5.24 shows results obtained 
with various alkyl substitutions on some of the catalysts.
>K Ph
V c
ArS02 vAf S° 2ArI
R
(S, S) or (ft R)
Ar = R = Et R = i- Bu
7.5.23.1
7.5.23.2
Ar = R = Et 7.5.23.3
Figure 7.5.23
Available trialkylaluminiums Et3Al and /-BU3AI were used to derivatise two
catalyst ligands leading to catalysts 7.5.23.1-3. Experimental procedures were 
identical to that for the Me3Al derived catalysts. Table 7.5.24 shows the
reactions progressed in variable yields but with good cis:trans ratios.
Ph. Ph
V f '
o
J
oII
ArS02' ' 'NvAfN' ’S° 2Ar1
R'
(S, S) or (ft R)x -----H^"SiMe3 toluene -80 —> -20°C R° d SiMe3 y "SiMe3
R = PhCH2CH2 7.1.3.5
PhCH2 7.1.3.4
c-hex 7.1.3.7
Ch H23 7.1.3.6
6.2 .10.2
R = PhCH2CH2 
PhCH2 
c-hex
ChH23
7.3.2.3
7.5.15.1 
7.3.2.2
7.3.2.1
Entry RCHO
(R=)
Catalyst
(mol%)
Yield cis:trans eed (%) 
(cis)
Abs.
Config.f
1 PhCH2 7.5.23.1 (50) 59a 79:21 47e ND
2 PhCH2 7.5.23.2 (20) 41b 80:20 36 ND
3 PhCH2CH2 7.5.23.2 (21) 72 92:8 24 ND
4 c-Hex 7.5.23.2 (21) 8C 100:0 54 ND
5 C nH 23 7.5.23.2 (40) 60 92:8 15 ND
6 PhCH2CH2 7.5.23.3 (78) 35 90:10 37e (5, R)
ND = not determined; a +20% aldehyde dimer; b +33% aldehyde dimer; c +52% aldehyde dimer; d ee 
determined by NM R analysis of the C //TM S  doublet in the presence of 2 equivalents of (/?)-(-)-2,2,2- 
trifluoro-l-(9-anthryl)ethanol unless otherwise noted; e ee determined by chiral HPLC (Daicel Chiralpak AD, 
2% wo-propyl alcohol-hexane, 1.0 mL/min, 210 nm);  ^absolute configurations determined by independent 
synthesis (see later).
Table 7.5.24
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Enantiomeric excesses were moderate and variable, the highest being 
cyclohexane carboxaldehyde with catalyst 7.5.23.2 (54% ee, entry 4). As 
hoped, this is probably a result of increased steric interaction at aluminium in 
the transition state (c./. only 20% ee for entry 3 in table 7.5.19 using the 
methylalumino catalyst 7.5.18.1).
Other comparisons which may be made are the one result with catalyst 7.5.23.1 
of 47% ee (entry 1, c.f. 0% ee for entry 1 in table 7.5.19). This result is a 
significant improvement but not as enantioselective as catalyst 7.5.18.4 (83% 
ee, entry 8 in table 7.5.19). Using iso-butyl (catalyst 7.5.23.2) instead of ethyl 
(catalyst 7.5.23.1) led to a slight drop to 37% ee, so these selectivities are not 
based on steric interactions alone.
Clearly there is another mechanism operating in these reactions, possibly a 
redox process suggested by the isolation of aldehyde dimer 7.5.25.1 (Scheme
7.5.25).
R
dimerisatio
R
7.5.25.1
Postulated Mechanism:
R
C
4-membered 
transition state
A
6-membered 
transition state
B
R
R
E
6-membered 
transition state
D
Scheme 7.5.25
This unusual self-coupling of an aldehyde was not entirely unexpected due to 
the presence of protons in the jfr-position with respect to the aluminium atom.
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This dimerisation was a severe problem with the three catalysts in this section. 
A postulated mechanism is shown in scheme 7.5.25. Initial co-ordination of an 
aldehyde molecule to the catalyst (A) may be followed by reductive transferral 
of the /3-proton to the aldehyde carbonyl with expulsion of ethylene (or iso- 
butylene in the case of 7.5.23.2), The product shown in B may be further co­
ordinated with another aldehyde molecule to give C. From here, product D 
could be formed via a 4-membered transition state. Yet another aldehyde 
molecule could co-ordinate to the aluminium giving E and the product could 
then detach via another 6-membered transition state, leaving the third aldehyde 
molecule connected as in structure B and ready to start another cycle.
This mechanism is, of course, unsubstantiated but nonetheless the problem of 
aldehyde dimerisation renders the ethyl and wo-butyl groups less useful than the 
simpler methyl group.
Therefore, the best way forward would be further investigation of the 
sulfonamide groups, perhaps non-C2-symmetric analogues.
7.S.3.4.4 Non-C2-Symmetric Variants: a Novel Class of Chiral Lewis Acid
If two different sulfonamides are engineered into one catalyst, the new catalyst 
will have reduced symmetry i.e. be non-C2-symmetric. Although more
complex, this is a new class of chiral Lewis acid. If one sulfonamide was larger 
than the other, there may be exclusively one avenue of approach for the 
reagents, in effect, an asymmetric box.
Figure 7.5.26 shows the various non-C2-symmetric catalysts prepared.
The extremely bulky 2,4,6-trii50-propyl benzene group was used along with 
four other groups to create a small selection of non-C2-symmetric catalysts for
testing in the [2+2] cycloaddition. These ligands were prepared by a similar 
procedure to the C2-symmetric ones: the first sulfonyl chloride was added and
allowed to be consumed before the second sulfonyl chloride was added. In this 
way, undesired C2 -symmetric by-products were minimised. See the
experimental section for more details. The trifluoromethyl group, which 
previously produced the most active C2-symmetric catalyst was used as the first
test group with the bulky wa-propyl ligand. Table 7.5.27, entry 1, shows that
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Ph, Ph
1 N-cn r 2 (St ^R1S 0 2‘ xa (  2 I
Me
R2 = CF3 7.5.26.1
7.5.26.3
7.5.26.4
Figure 7.5.26
this catalyst gives a moderate 57% yield and good cis'.trans ratio but the ee was 
only 17%.
Pentafluorobenzene derived 7.5.26.2 was even more disappointing yielding 
only 25% of a 10% ee product. However, this lack of success was short-lived 
since 2,4,6-trimethylbenzene-derived catalyst 7.5.26.3 (29 mol%) gave a useful 
82% yield and 62% ee. This result compares well with the C2-symmetric 
catalyst 7.5.18.2 (58% ee) although the extra bulk of the larger group in
7.5.26.3 has not had much impact. The other examples with 7.5.26.3 tell a 
similar story. Finally, with the most successful group from the C2-symmetric 
series, 4-terf-2,6-dimethyl-butylbenzene, some better results were obtained. 
However, a similar story resulted: these catalysts gave remarkably similar
Me
O °i (S, S) 0 -J *  o - /*
J  +  II ------------------ ►  j _ J  +  Q
R H ^ S iM e a  ^ o " ° C  R<^ ^ SiMe3 R 'SiMe3
R = PhCH2CH2 7.1.3.5
PhCH2 7.1.3.4
c- hex 7.1.3.7
Ch H23 7.1.3.6
p-MeOCeHUCI-b 7.5.19.1
6.2 .10.2
R = PhCH2CH2 7.3.2.3
PhCH2 7.5.15.1
£>hex 7.3.2.2
Ch H23 7.3.2.1
p-MeOCeH^h^ 7.5.19.2
Entry RCHO
(R=)
Catalyst
(mol%)
Yield cis:trans eea (%) 
(cis)
Abs.
Config.c
1 PhCH2 7.5.26.1 (51) 57 90:10 l?b (R,S)
2 PhCH2 7.5.26.2 (48) 25 100:0 10b (R,S)
3 PhCH2 7.5.26.3 (29) 82 79:21 62 (R,S)
4 PhCH2CH2 7.5.26.3 (25) 85 90:10 30 (R,S)
5 c-Hex 7.5.26.3 (51) 57 77:23 53 (R,S)
6 PhCH2 7.5.26.4 (30) 72 75:25 82 (R,S)
7 PhCH2CH2 7.5.26.4 (29) 82 94:6 36 (R,S)
8 c-Hex 7.5.26.4 (33) 43 69:31 67 (R,S)
9 C nH 23 7.5.26.4 (30) 67 82:18 48b (R,S)
10 p-MeOC6CH2 7.5.26.4 (29) 81 70:30 75b (R,S)
a ee determined by chiral HPLC (Daicel Chiralpak AD, 2% iso-propyl alcohol-hexane, 1.0 mL/min, 210 nm) 
unless otherwise noted; b ee determined by NM R analysis of the C //T M S  doublet in the presence of 2 
equivalents of (/?)-(-)-2,2,2-trifluoro-l-(9-anthryl)ethanol unless otherwise noted; c absolute configurations 
determined by independent synthesis (see later).
Table 7.5.27
enantioselectivities to the C2-symmetric catalyst 7.5.18.4 (c.f Table 7.5.19, 
entries 8-12). 
In summary, these non-C2-symmetric catalysts are no better or worse than their 
C2-symmetric counterparts.
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7.5.3.5 Conclusion of the Bis-sulfonamide Study
From the work done on the optimisation of the bis-sulfonamide catalyst, a 
pictorial summary aptly describes the results (Figure 7.5.28).
Scheme 7.5.28
7.6 Determination of the Absolute Stereochemistry of the Products
In order to draw any mechanistic conclusions and to relate the stereochemistry 
of a catalyst to the products, the absolute stereochemistry of the /3-lactone 
products must be determined.
Since the products are novel there is no literature for comparisons. Therefore 
the products must be chemically derivatised to known compounds.
The method of choice consisted of initial desilylation (TBAF, THF, -90°C) of 
the silyl /3-lactones 7.5.15.1, 7.3.2.3 and 7.3.2.2 followed by selective acyl 
cleavage with sodium hydroxide56 giving /3-hydroxy acids 7.6.1.4 to 7.6.1.6 
(Scheme 7.6.1).
Substitution on these rings 
critical. Ortho groups 
required for high ee s but too 
large and catalyst deactivated. 
No great benefit from using 2 
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7.6.1.5
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{R) configuration from (S, S) catalyst 
(S) configuration from (R, R) catalyst
Scheme 7.6.1
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These hydroxy acids were independently synthesised by the route shown in 
Scheme 7.6.2. Acylation of Meldrum's acid 7.6.2.1 gave intermediate 7.6.2.2 
which was methanolysed to the ft-keto esters 7.6.2.3, 7.6.2.4 and 7.6.2.5 in 
moderate yield. Catalytic, enantioselective reduction of the /3-keto groups with 
[(R j-(+)-2,2'-^w-(diphenylphosphino)-1,1 '-binaphthyl]chloro(/?-cymene)- 
ruthenium chloride (0.2 mol%) led to good yields of chiral alcohols 7.6.2.6,
7.6.2.7 and 7.6.2.8.
The enantioselectivities of these reductions were checked by 19F NMR analysis 
of the MTPA esters of alcohols 7.6.2.6-8 and found to be 94-97%. Both MTPA 
esters of each alcohol were made in order to establish their absolute 
configurations. 240 Comparison of analogous reactions in the literature 
confirmed these assignments.
o p
pyr, 0-5°C, 1 h MeOH, A O O
then RCOCI, 1 h 26-58%
O OH
7.6.2.1 7.6.2.2 R = PhCH2 7.6.2.3PhCH2CH2 7.6.2.4 
ohex 7.6.2.5
OH O
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MeOH/H2o \  
rt, 1 h, 83-99%
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H2 (120psi), HCI (cat), 
MeOH, 40°C, 2-3 d 
63-74%, 94-97%ee
OH O
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DMAP (cat), CH2CI2, 7.6.2.6-8
rt, 18 h, 81-100%(S,R) 
7.6.2 A
(R) - MTPA, DCC, 
Et3N, DMAP (cat.), 
CH2CI2, rt, 18 h 
60-100%
(R.R)
7.6.2.12-14
Scheme 7.6.2
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Alkaline hydrolysis of methyl esters 7.6.2.6-8 with sodium hydroxide in 
aqueous methanol gave good yields of acids 7.6.1.4-6 which were compared 
with those derived from the [2+2] cycloaddition products. These compounds 
were found to have opposite signs of specific optical rotation therefore the 
assignments shown in the schemes could be made: (.R, R) catalysts resulted in 
(2S, 3R) /3-lactones and (S , S) catalysts gave (2R, 3S) /3-lactones (Scheme 
7.6.3).
Therefore it can be concluded that reaction takes place between the Re face of 
the aldehyde and the Re face of the ketene for catalysts with configuration 
(R,R) (vice versa for catalysts with (S,S) configuration) (Scheme 7.6.3).
(S, S) catalyst ------
(R, R) catalyst
Scheme 7.6.3
7.7 Mechanistic Considerations
The mechanism of the [2+2] cycloaddition between a ketene and carbonyl 
compound or alkene is not well understood. However, a hypothesis may be 
made based on limited information.
One important piece of data derives from the 13C NMR spectrum of 
(trimethylsilyl)ketene: the ketene carbon bearing the silicon atom has a 
chemical shift of 18 ppm. This is quite remarkable for a carbon atom which is 
considered similar to an alkene (5100-120). Clearly, there resides a large share 
of electron density on this carbon, leading to the conclusion that the ketene is 
the nucleophilic partner in the cycloaddition.
Further evidence in support of this postulate is shown in scheme 7.5.16 where a 
more polarised carbonyl system (more 5+- carbonyl carbon) leads to an increase 
in reaction rate, e.g. /?<zra-nitrobenzaldehyde, whereas an aldehyde possessing a 
deactivated carbonyl (less 5+) is extremely sluggish, e. g.  para- 
methoxybenzaldehyde.
otf
R SiMe3 
(2 R, 3 S)
£>t f
R' SiMe3 
(2S, 3 R)
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If the assumption is made that the first bond to be formed is the C-C bond of 
the /3-lactone and that the ketene is the nucleophilic partner, then the aldehyde 
must be co-ordinated to the Lewis acid. It is highly probable that the Lewis 
acid will co-ordinate with the Lewis basic lone pair of electrons of the carbonyl 
oxygen atom anti to the aldehyde R group in order to minimise unfavourable 
steric interactions. With a chirally modified Lewis acid, the additional 
dimension of chirality is added to the transition state.
Considering all these factors, an initial transition state 7.7.1.1 may be proposed 
(Scheme 7.7.1).
H J i jSiMe3 R SiMe3
H-H—( . sA -A r0 2S-\X 0 2S - V Mr - c - r 0‘\c\r ° " "Vri/'
Ar 7.7.1.1 Ar 7.7.1.2
£>
XLSiMe3
t
-Ar° 2S
R
Ar
/S02 Me
7.7.1.3
SiMe3
Scheme 7.7.1
Complex 7.7.1.1 is depicted with the silylketene and aldehyde approaching in a 
•syn-periplanar fashion with the silicon on the same side as the aldehyde R 
group.
If the silicon group were rotated through 180° a large steric interaction with the 
Lewis acid ligand would occur creating instability. Although some trans /3- 
lactone is usually isolated, there is a strong preference for the cis isomer. 
Theoretical studies by Pons et a l241,using AMI and ab initio calculations, have 
shown that one favourable low energy pathway is a closed-shell, quasi­
concerted but asynchronous process where priority is given to the C-C bond 
formation. This near coplanarity of the four participating atoms is in accord 
with recent ab initio242>243 and semi-empirical calculations.244 The
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asynchronous but concerted nature of the process indicates that the two new 
bonds are formed at the same time but not to the same extent.
Structure 7.7.1.2 shows this postulate in an exaggerated manner. Completion of 
the bond forming process leads to co-ordinated /3-lactone product 7.7.I.3. On 
detachment of the product, the Lewis acid is available to once again enter the 
catalytic cycle.
Although scheme 7.7.1 explains the absolute stereochemistry of the products, 
there is still little evidence to support the mechanism.
Consideration of frontier orbital interactions leads to another postulate. In 1969 
Woodward and Hoffman published their landmark work The Conservation of 
Orbital Symmetry.245'246 Addition modes for specific K interactions were 
described as either suprafacial or antarafacial. The former has the bonds being 
made or broken on the same side of the reacting system whereas the latter has 
these bonds on opposite sides of the system. For [2+2] cycloadditions, 
approach of the orbitals along the geometrically most facile route produces only 
one orbital overlap (Scheme 7.7.2, left-hand diagram). Therefore, an 
antarafacial approach is necessary to enable the bonding orbitals for the other 
orbitals to overlap efficiently (Scheme 7.7.2, right-hand diagram).
antarafacial
LUMO LUMO
antibonding
interaction
HOMO HOMOsuprafacial
[2+2] cycloaddition [it2a + rf2^ cycloaddition
-only one easily developed 
bonding overlap
Scheme 7.7.2
The required overlap can only be obtained if the two interacting n  systems 
approach in an orthogonal style i.e. at approximate right-angles to each other 
(Scheme 7.7.3). The plan view shows this more clearly.
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HOMO
LUMO
preferred geometry for a 
[jt2.a + cycloaddition
plan view
Scheme 7.7.3
For the interaction between a carbonyl and ketene it is likely that contributions 
from both HOMO (carbonyl)/LUMO (ketene) and LUMO (carbonyl)/HOMO 
(ketene) are important247 (Scheme 7.7.4).
O o Q
HOMO
(carbonyl)
LUMO
(ketene)
LUMO HOMO 
(carbonyl) (ketene)
Both these interactions are likely to be important
Scheme 7.7.4
Applying these predicted geometries to the cycloaddition between an aldehyde 
and (trimethylsilyl)ketene results in 4 possible approaches (Scheme 7.7.5).
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Only one transition state geometry is likely to be heavily favoured. All the 
others are destabilised by unfavourable steric interactions between either the 
TMS group and Lewis acid or the TMS group and aldehyde R group. The 
favoured approach clearly places the bulky TMS group in an area of space as 
far away as possible from the larger groups.
7.8 Application of the [2+2] Cycloaddition to 1233A
Conversion of the protected diene 5.3.11.1 into the required aldehyde for the 
[2+2] cycloaddition progressed smoothly. Two equivalents of TBAF in THF at 
room temperature yielded 90% of primary alcohol 7.8.1.1 (Scheme 7.8.1).
OTBS
.Of-Bu
TBAF, THF
 ?
rt, 2 h  
90%
Of-Bu
5.3.11.1 7.8.1.1
Scheme 7.8.1
Oxidation of 7.8.1.1 to the desired aldehyde was effected with the Dess-Martin 
periodinane reagent (7.8.2.1) which was prepared according to the literature.248- 
250 This oxidation was complete in 1 hour and provided 90% of aldehyde
7.8.2.2 (Scheme 7.8.2).
Of-Bu
AcQ OAc 
v/ -OAc
7.8.2.1 O
CH2CI2) rt, 1 h 
90%
Of-Bu
7.8.1.1 7.8.2.2
Scheme 7.8.2
Earlier model studies most closely resembling aldehyde 7.8.2.2 were with 
dodecanal (7.1.3.6), With C2-symmetric catalyst 7.5.18.4 (29 mol%) a good
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cis'.trans ratio of 94:6 was obtained with a good yield (67%) and an ee of 47% 
(Table 7.5.19). Similarly, non-C2-symmetric catalyst 7.5.26.4 (30 mol%) gave 
the same yield, a good cis'.trans ratio and a 48% ee. It is reasonable to expect 
that 7.8.2.2 will behave similarly to dodecanal since the functionality in the 
chain is too distant to have any significant effect.
Indeed, when the enantioselective [2+2] cycloaddition was performed with
7.8.2.2 and (trimethylsilyl)ketene in the presence of 50 mol% of catalyst 
7.5.18.4 in toluene, a smooth conversion to the desired product, with a trace of 
trans isomer, was obtained (Scheme 7.8.3).
f-Bu
7.Q.2.2
75% yield 
7 A A A  dsi trans 94:6
( trans not shown)
H SiMe3 
6.2.10.2
P!^ f h
y-sor\fN^s°2-4
rile
7.5.18.4 (50 mol%) 
toluene, -70 -20°C, 2 h
-f-Bu
7.8.3.1
Scheme 7.8.3
The cis'.trans ratio was determined to be 94:6 by lH NMR analysis of the crude 
product. After column chromatography, a 67% yield of a mixture of 7.1.1.1 and
7.8.3.1 were obtained with the other 8% being a 1:1.3 cis'.trans ratio. Since the 
signals were coincidental, even with resolution enhancement at high field, their 
ratio was determined using a previously described analysis of the C//7MS 
protons with Pirkle's chiral solvating agent (see Table 7.5.27 for more details). 
From this analysis it was found that a 50% ee had been achieved as expected.
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This result should be correctly termed a 50% diastereomeric excess (de) due to 
the presence of the methyl group.
Unfortunately these isomers were inseparable using conventional flash 
chromatographic techniques. Therefore, it will be important to separate the 
isomers at some later stage in order to remove the unwanted diastereoisomer.
7.9 Conclusions
In this chapter, the first chiral Lewis acid catalysed enantioselective reactions 
have been developed between an aldehyde and (trimethylsilyl)ketene, attaining 
up to 83% ee. This new methodology has been applied successfully to the 
synthesis of the /3-lactone portion of 1233A. In order to complete the synthesis 
of the natural product, all that remains is conversion of the silyl group for a 
hydroxymethyl and cleavage of the terf-butyl ester to reveal the free carboxylic 
acid.
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Chapter 8
i
Conclusion of the Synthesis
8.1 Introduction
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This chapter will discuss the remaining steps in the synthesis where, finally, the 
natural product 1233A will be revealed. At the end of this chapter the total 
synthesis will be shown on one page to clarify the overall strategy.
In this end game, the first problem to be tackled was conversion of the 
trimethylsilyl group on the ft-lactone ring into a hydroxymethyl group with 
inversion of stereochemistry at the silicon-bearing carbon (Scheme 8.1.1).
Scheme 8.1.1
Before any of the work so far described towards the natural product was 
undertaken, this problem had to be solved. This was necessary since there is no 
obvious method to employ for such a transformation. Using model p-lactones, 
various ideas were investigated.
8.2 Model Studies
The closest model to the natural product fragment 7.1.1.1 was dodecanal 
derived P~lactone 7.3.2.I. Delving into the literature revealed only one piece of 
relevant work by Mead. l71’172«251 He described the aldol-type reaction of 3- 
trimethylsilyl-j3-lactone 8.2.1.1 with benzaldehyde using TBAF (Scheme 8.2.1).
.OH
7.1.1.1 8 .1.1.1
PhCHO
TBAF
+
8.2.1.2
88
8 .2.1.3
12
80%
Scheme 8.2.1
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After initial TBAF de-silylation, a /3-lactone enolate is probably formed which 
is quenched predominately on the more sterically accessible side by the 
aldehyde giving a ratio of 88:12 for the products 8.2.1.2 and 8.2.I.3. However, 
Mead warns that, unless the reaction is carefully conducted with slow addition 
of the /3-lactone to the TBAF/benzaldehyde mixture, large quantities of de- 
silylated /3-lactone are obtained (H-quenched /3-lactone enolate).
Similarly, the model dodecanal-derived /3-lactone 7.3.2.1 was transformed to a 
mixture of secondary alcohols 8.2.2.1 and 8.2.2.2 with some de-silylated 
material 8.2.2.3 (Scheme 8.2.2).
TBAF
PhCHO
8.2.2.1 8.2.2.2 8.2.2.3
91 9
65% 23%
Scheme 8.2.2
|
It appears to be quite difficult to totally suppress the formation of 8.2.2.3 but
j
| using a syringe pump to control the addition offers the best chance of success.
; Having verified the literature precedent, attention was turned to the natural
I product sub-structure itself. Installation of a hydroxymethyl group would
require a one-carbon electrophile, the most obvious being formaldehyde. Since 
formaldehyde is usually supplied as the hydrate, the polymeric form 
paraformaldehyde would have to be used. Unfortunately, when 
paraformaldehyde was used in the reaction, only de-silylated product 8.2.2.3 
was isolated. Apparently, paraformaldehyde was not sufficiently reactive to 
quench the postulated /3-lactone enolate derived from the TBAF de-silylation. 
Attempts at using gaseous formaldehyde, prepared from paraformaldehyde, 
were unsuccessful due to rapid polymerisation of the monomer.
Since TBAF induces the aldol reaction between two aldehydes possessing a- 
protons, a more elaborate strategy concerning a higher aldehyde followed by 
cleavage to leave a one carbon unit behind (e.g. periodate cleavage of a diol) 
was not easily implemented.
The next one-carbon electrophile to be tested was carbon dioxide. Obviously, 
the product of a CO2 quench will be a carboxylic acid but these may be
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selectively reduced with borane. Thankfully CO2 was sufficiently reactive to 
quench the /3-lactone enolate but the product 8.2.3.1 was found to be unstable, 
undergoing decarboxylation when chromatographed on silica (Scheme 8.2.3).
Scheme 8.2.3
Fortunately there was only a trace of desilylated product, reflecting the reactive 
nature of the CO2 . With less reactive benzaldehyde a significant quantity of
8.2.2.3 was isolated. From a practical point of view it was found that either 
gaseous or solid CO2 could be used. Either the gas from a cylinder of CO2 was 
constantly bubbled through the reaction mixture or powdered dry ice was added 
in small quantities every 15 minutes.
Due to the instability of 8.2.3.1 it had to be freshly used crude. A smooth 
reduction with borane gave alcohol 8.2.4.1 in 48% yield over the 2 steps 
(Scheme 8.2.4).
TBAF
o
S.2.3.2 8.2.3.1 8.2.2.3
trace
BH3*THF
THF or GH2CI2 C1 iH23*
48%
8.2.3.1
crude
8.2.4.1
Scheme 8.2.4
Despite attempts with various borane species (BH3*THF, BH3#SMe2) with 
different solvents (CH2CI2, THF) and quenching procedures the yield could not
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be improved. However a selective reduction of the carboxylic acid in the 
presence of the ft-lactone has been achieved.
8.3 Application of the Carbon Dioxide Quench to 1233A
Application of the above methodology to the natural product synthesis 
progressed successfully although in slightly lower yield than with the model 
(Scheme 8.3.1).
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Ot-Bu
8.3.1.3
Ot-Bu
8 .1 .1.1
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Scheme 8.3.1
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Acid mixture 8.3.1.1 and 8.3.1.2 was immediately reduced with BH3*THF 
complex over 1 h. Experiments showed that using excess borane (> 2 
equivalents) resulted in extensive hydroboration of the diene moiety. This 
problem was circumvented by optimising the quantity of borane required (1.6 
equivalents or 4.8 hydride equivalents). Alcohol diastereomers 8.1.1.1 and 
8.3.1.3 fortunately proved to be separable using standard flash chromatography. 
Overall yields for these two reactions ranged from 32-42% for 1.2 mmol and 
0.13 mmol scale reactions respectively, after chromatographic separation. 
Using this route, 5 mg batches of pure 1233A tert-butyl ester 8.1.1.1 were 
prepared.
The CO2 quenching procedure appears to proceed through a planar
intermediate. Experiments have shown that when separate samples of cis and 
trans /3-lactones are subjected to the same CO2 reaction conditions, identical
products result. Therefore it is not a simple inversion of configuration but an 
attack at the more sterically accessible side of a planar intermediate, most likely 
the /3-lactone enolate proposed above.
8.4 Deprotection of the Ester Protecting Group
Earlier studies, not discussed until this point, centred on finding a suitable ester 
protecting group for the terminal dieneoic acid. Both methyl and allyl esters 
were considered: the methyl ester of 1233A was prepared but all attempts at 
revealing the free carboxylic acid in the presence of the /3-lactone failed. These 
attempts included enzymatic techniques (porcine pancreatic lipase and pig  
liver esterase in various solvents and buffers) and lithium iodide in pyridine. In 
every case complete ring-opening of the /3-lactone was observed with no trace 
of the desired product.
An allyl ester may be deprotected under mild conditions using palladium 
acetate. However when the allyl ester in the natural product series was 
prepared it was found, not unexpectedly, to be incompatible with the borane 
reducing conditions. Therefore the terr-butyl ester was employed as in previous 
syntheses of 1233A (see Chapter 2). Trifluoroacetic acid (TFA) was first used 
and found to successfully unmask the acid moiety rapidly but in 
disappointingly low yield (Scheme 8.4.1).
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Efforts to improve the yield included using a scavenger for the expunged tert- 
butyl cation. A large excess of 1,3-dimethoxybenzene (20 equivalents) 
succeeded only in slowing the reaction to about 2 hours duration with no effect 
on yield. Another commonly used reagent for the selective deprotection of tert- 
butyl esters is hydrofluoric acid. All attempts at using HF resulted in total 
recovery of the starting material, even when a fresh bottle was used! Strangely, 
Wovkulich used HF efficiently in his synthesis of 1233A (see Scheme 2.5.3). 
Limitations on quantities of material at such a late stage meant little 
experimentation could be done to improve the yield of the final step.
8.5 Synthesis of a Phenyl Analogue of 1233A
One advantage of total synthesis of complex molecules is the possibility of 
synthesising analogues of natural products for biological screening. In order to 
demonstrate the versatility of our route to 1233A, we endeavoured to synthesise 
the phenyl analogue of the hydroxymethyl side chain.
From the [2+2] cycloadduct 7.1.1.1 (along with diastereomeric impurity 
7.8.3.1) a benzaldehyde quench was used instead of CO2 (Scheme 8.5.1).
7 .1.1.1
7 .8 .3.1.Ot-Bu
TBAF
PhPhCHO .Of-Bu,Of-Bu
8.5.1.1 8.5.1.2
53% + 29%
14% other isomers
Scheme 8.5.1
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Due to the less reactive nature of the benzaldehyde versus CO2 , some more 
proton quenched material 8.5.1.2 was isolated (29%). Nevertheless, the desired 
product 8.5.1.1 was isolated in 53% yield with 14% of a mixture of isomers. It 
was hoped that the product would be crystalline but this was not the case and no 
further attempt was made to establish the stereochemistry of 8.5.I.I.
8.6 Conclusions
A short and stereoselective synthesis of 1233A has been achieved employing 
novel methodology for the enantioselective synthesis of /3-lactone rings. 
Scheme 8.6.1 depicts the shortest and most efficient route to the natural 
product. The overall number of steps is only 12 and overall yield is 2.9% 
which compares favourably with the previous total syntheses described in 
chapter 2. All these syntheses were lengthy (from 19 to 24 steps) and yields 
ranged from <1% to 2%. The crippling factor in our synthesis is the final 3 
steps which proceed in only 11% yield. In addition, the selectivity of only 3:1 
for the [2+2] cycloaddition step is not satisfactory. Fortunately, the isomers 
created were separable with ease rendering the synthesis, at least, practical.
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Some of the weaker steps in our synthesis of 1233A deserve further work. 
Particularly, the [2+2] cycloaddition step needs further development since there 
is great promise for a practical and synthetically generally useful process. 
Although enantiomeric excesses are good for aldehydes possessing a-aromatic 
substitution, the natural product example was only 50% diastereoselective. 
Linear aldehydes arguably pose the ultimate challenge in asymmetric synthesis 
and with better catalysts our [2+2] cycloaddition could be controlled at will.
The features of our catalyst which were important (see Chapter 7) could be used 
to design new better catalysts. For example, it would be wise to retain the 
metal-sulfonamide linkage since this system is easily synthesised using various 
metals and appears stable under the reaction conditions.
New ligands and metals could be investigated in a program of systematic study. 
Mono, bi, or tn-dentate ligands could be used with different metals such as 
magnesium, gallium or zinc. The general structures shown highlight some of 
these ideas (Figure 9.1).
Aro2s
Ar
/S02
bidentate ring systems of 
various sizes (n =1, 2) with 
one chiral group but retaining 
the easily modified 
bis-sulfonamide
More rigid 
sulfonamide 
within a ring.
Figure 9.1
Some examples are shown in figure 9.2.
Figure 9.2
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Complex 9.2.1 is similar to the Pfaltz catalyst 4.2.1.2 but, of course, doesn't 
possess any bulky groups close to the metal centre. This would be difficult to 
engineer into the structure without destroying the necessary sulfonamide 
moiety. Magnesium based 9.2.2 is a simple structure with a terf-butyl group in 
the position previously occupied by a phenyl ring. The extra bulk of the tert- 
butyl group could be significant if transition state 7.7.1.1 (Scheme 7.7.1) is 
envoked. A less rigid ligand structure, such as 9.2.3, may also be worthwhile 
testing. Other metals, mono or bidentate, could be used, e.g. magnesium, so 
that rapid screening of metals would be possible using one ligand.
An innovation which has synthetic promise is the conversion of the silyl group 
to a carboxylic acid with inversion of configuration as in the final steps of the 
1233A synthesis. Although attractive from a synthetic point of view, the yields 
were rather low. Further work could improve this chemistry and access to a 
wide range of chiral segments with contiguous stereogenic centres would be 
available through ring-opening of the /3-lactone ring in two different ways 
(Scheme 9.3).
TBAF
C 02R'
from O-acyl 
cleavge
from attack 
by R"2CuLi
Scheme 9.3
The usefulness of /3-lactones has been grossly underestimated, primarily due to 
difficulties in their synthesis, but with a robust asymmetric [2+2] cycloaddition 
this area of organic synthesis could be revolutionised.
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10.1 General Experimental Details
Reactions requiring anhydrous conditions were conducted in flame-dried apparatus under a 
static atmosphere of dry argon or nitrogen. Organic extracts were dried over MgS0 4  unless 
otherwise specified and evaporated at electric pump (5-10 mmHg) or water pump (20 
mmHg) using a Buchi rotary evaporator. Distillations in which the bath temperature is 
recorded were performed with a Kugelrohr apparatus.
Where appropriate, solvents and reagents were dried by standard methods,252 i.e. by 
distillation from the usual drying agent prior to use: diethyl ether ("ether") and 
tetrahydrofuran were distilled from Na/benzophenone and used fresh. Acetonitrile, pentane, 
cyclohexane, pyridine, benzene, dichloromethane, A,A-dimethylformamide, toluene, 
triethylamine, A-methylpyrrolidinone (NMP) and terf-butanol were distilled from CaH2 and 
stored over 4 A molecular sieves under nitrogen. Methanol was distilled from the 
corresponding magnesium alkoxide. Petroleum ether bp 40-60°C ("petrol") for 
chromatography was distilled from KOH before use. Trimethylsilyl chloride and 
benzaldehyde were distilled freshly before use. Dodecanal was purified by flash column 
chromatography and stored under nitrogen at -20°C. Iodine was sublimed at 0.5 mmHg and 
stored under nitrogen. Carbon tetrabromide was sublimed freshly before use. For best 
results, copper (I) iodide was extracted with THF in a soxhlet apparatus and stored in the 
dark. The Dess-Martin periodinane reagent was prepared according to the literature250 and 
stored at -20°C under nitrogen. terf-Butyltrichloroacetimidate was prepared according to the 
literature procedure.93 4-terf-Butyl-2,6-dimethylbenzenesulfonyl chloride was prepared 
according to the general procedure.253 (Trimethylsilyl)ketene was prepared by flash 
distillation of ethoxy(trimethylsilyl)acetylene at atmospheric pressure. Commercial 
organometallics were used as supplied and alkyllithium reagents were titrated against 1,3- 
diphenylacetone p-tosy lhy drazone.254
All reactions were magnetically stirred and were monitored by Thin Layer Chromatography 
(TLC) using Macherey-Nagel Diiren Alugram Sil G/UV254 pre-coated aluminium foil sheets, 
layer thckness 0.25 mm. Compounds were visualised by UV (254 nm), then with 20 wt% 
phosphomolybdic acid (PMA) in ethanol with heating. Flash chromatography was 
performed on Merck silica gel 60 (0.04-0.063 mm, 230-400 mesh) and run under low 
pressure.255
Optical rotations were recorded on an Optical Activity AA-100 polarimeter at approximately 
:20°C.
Melting points were measured on a Griffin electrothermal apparatus and are uncorrected.
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IR spectra were recorded on a Perkin Elmer 1600 series FTIR spectrometer as thin films 
supported on sodium chloride plates. Absorptions are reported as values in cm-1 and defined 
as either strong (s), medium (m). Broad absorptions are designated (br). Weak absorptions 
are not reported.
Proton NMR spectra were recoreded in Fourier Transform mode on a Jeol JNX-GX-270 (270 
MHz), Bruker AC 300 (300 MHz) or Bruker AM 360 (360 MHz) spectrometer in either 
chloroform-d or benzene-*/#. Chemical shifts are reported in ppm relative to residual CHCI3 
(8 = 7.27) or benzene (8 = 7.18). Multiplicities are described using the following 
abbreviations: (s) singlet, (d) doublet, (t) triplet, (q) quartet, (m) multiplet, (br) broad.
Carbon-13 NMR spectra were recorded on a Jeol JNX-GX-270 (68 MHz), Bruker AC 300 
(75 MHz) or Bruker AM 360 (90 MHz) spectrometer in either chloroform-*/ (8 = 77.2) or 
benzene-*/# (8 = 128.7). Chemical shifts are reported in ppm relative to the solvent. 
Multiplicities were determined using the Distortionless Enhancement by Phase Transfer 
(DEPT) spectral editing technique, with secondary pulses at 90° and 135°. C-H coupling is 
indicated by an integer 0-3 in parenthesis following the 13C chemical shift value denoting the 
number of coupled protons.
Mass spectra were run on a VG 70-250-SE or JEOL MStation JMS-700 spectrometer. Ion 
mass/charge (m/z) ratios are reported as values in atomic mass units followed, in parentheses, 
by the peak intensity relative to the base peak (100%) and where shown, the proposed signal 
assignment. All compounds submitted for mass spectral analysis were purified by either 
distillation or column chromatography and estimated to be at least 95% pure by NMR and 
thin layer chromatography.
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7-Hydroxy-2-heptanone (3.3.4.2):
O (i) MeLi (1.4M, Et20) 
THF, -1 05°C OH
(ii) Me3SiCI (108.6, d 0.856)
(iii) HCI
73%
O
4.3.2.1
C6Hi 0Q2 = 114.2
3.3.4.2
C7H140^ = 130.2
Methyl lithium (1.4 M in ether, 96 mL, 134.4 mmol) was added over 20 minutes to a 
mechanically stirred -105°C solution (liquid N2 bath) of e-caprolactone (4.3.2.1) (11.4 g, 
100 mmol) in THF (450 mL). The internal temperature was maintained between -100 and 
-110°C at all times during the addition. The reaction was stirred for 20 minutes then 
trimethylsilyl chloride (39 mL, 33.4 g, 307 mmol, 3 eq) was added dropwise. The reaction 
was allowed to warm to 0°C and quenched with 2 N HCI (200 mL). The biphasic mixture 
was vigorously stirred for 1 h then poured onto sodium hydrogen carbonate (60 g). The 
phases were separated and the aqueous phase was concentrated in vacuo to remove THF then 
extracted with ethyl acetate (3 x 100 mL). The combined organic phases were then washed 
with brine (100 mL), dried, filtered and concentrated in vacuo to a colourless oil which was 
purified by short path distillation (10 mmHg, 122-126°C) to give 3.3.4.2 as a colourless oil 
(10.98 g, 84.3 mmol, 84%), exhibiting spectral characteristics according to the literature.63
IR (film): v=  3411 (br s), 2937 (s), 2867 (s), 1709 (s), 1414 (m), 1364 (m), 1269 (m), 1167 
(m), 1053 (m) cm-1.
13C NMR (68 MHz, CDCI3): 8= 23.5 (2), 25.3 (2), 29.9 (3), 32.4 (2), 43.6 (2), 62.4 (2),
209.5 (0).
7-[(te/t-butyldimethylsilyl)oxy]-2-heptanone (4.3.1.2):
lU NMR (270 MHz, CDCI3): <5= 1.30 (2H, m), 1.52 (4H, m), 2.08 (3H, s), 2.39 (2H, t, J  =
7.5 Hz), 2.53 (1H, br s, OH), 3.55 (2H, t, J  = 6.9 Hz).
f-BuMe2SiCI (150.7) 
imid (68.1)
DMAP (122.2)
O
3.3.4.2
C7H140 2 = 130.2
CH2CI2, 0°C -> rt O 
97% 4.3.1.2
Ci3H2g02Si = 244.5
To a solution of 7-hydroxy-2-heptanone (3.3.4.2) (4.18 g, 32.1 mmol) in CH2CI2 (30 mL) at 
rt was added imidazole (6.5 g, 96.3 mmol, 3 eq) and DMAP (0.4 g, 3.27 mmol, 0.1 eq). The
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suspension was stirred at rt for 5 minutes then a solution of terf-butydimethylsilyl chloride 
(5.33 g, 35.4 mmol, 1.1 eq) in CH2CI2 (20 mL) was added dropwise. The reaction was 
stirred at rt for 1 h then poured into 1 N HCI (50 mL). The aqueous phase was extracted with 
CH2CI2 (20 mL). The combined organic layers were washed with brine (50 mL), dried, 
filtered and concentrated in vacuo to a colourless oil which was purified by column 
chromatography (SiC>2, petrol:Et2 0  = 90:10) to give ketone 4.3.1.2 (7.61 g, 31.1 mmol, 97%) 
as a colourless oil. An analytical sample may be prepared by Kugelrohr distillation (110°C 
(bath) @10 mmHg).
We were unable to obtain a satisfactory microanalysis.
IR (film): v= 2931 (s), 2858 (s), 1720 (s), 1472 (m), 1360 (m), 1255 (s), 1100 (s), 1006 (m), 
836 (s) cm-1.
>H NMR (270 MHz, CDCI3): 8= 0.01 (6H, s, HI'), 0.86 (9H, s, H2'), 1.30 (2H, m, H5), 1.52 
(4H, m, H4,6), 2.10 (3H, s, H 1), 2.40 (2H, t, 7  = 7.3 Hz, H3), 3.57 (2H, t, J  = 6.3 Hz, H7).
13C NMR (68 MHz, CDCI3): 5= -5.2 (3), 18.4 (0), 23.8 (2), 25.7 (2), 26.1 (3), 29.9 (3), 32.7
(2), 43.9 (2), 63.1 (2), 209.1 (0).
Ethyl (£)-8-[(te/*f-butyIdimethylsilyl)oxy]-3-methyl-2-octenoate (3.3.4.1):
(224.2)
4.3.1.2 3.3.4.1
c l3H28P2Si = 244.5 C-|7H3403Si = 314.5
Sodium hydride (5.5 g of 60% dispersion in oil = 3.3 g NaH, 0.138 mol, 2.2 eq) was washed 
with dry petrol (3 x 20 mL) and dried under argon. THF (80 mL) was added and the 
suspension was cooled to 0°C. A solution of triethylphosphonoacetate (35.3 g, 0.157 mmol,
2.5 eq) in THF (40 mL) was added dropwise over 15 min. The resulting clear tan solution 
was warmed to rt and stirred for 5 min. Then a solution of the ketone (4.3.1.2) (15.4 g, 63 
mmol) in THF (80 mL) was added dropwise. The reaction mixture was refluxed for 1.5 h 
then cooled to rt and poured into ether (500 mL) and water (200 mL). The aqueous phase 
was extracted with ether (100 mL). The combined ethereal extracts were washed with water 
(100 mL), brine (100 mL), dried, filtered and concentrated to a colourless oil (27.2 g) which 
was repeatedly chromatographed (SiC>2, petrol:Et2 0  = 97:3) to give (£)-3.3.4.1 (14.1 g, 44.5 
mmol, 71%) and (Z)-3.3.4.1 (4.0 g, 12.6 mmol, 20%) as colourless oils.
An analytical sample may be prepared by Kugelrohr distillation (110°C (bath) @ 0.5 
mmHg).
Data for the (E) isomer:
154
IR (film): v = 2933 (s), 2858 (s), 1718 (s), 1649 (s), 1472 (s), 1386 (m), 1367 (s), 1256 (s),
1222 (s), 1147 (s), 1100 (s), 1044 (m), 836(s) cm -'.
>H NMR (300 MHz, CDCI3): S =  0.03 (6H, s, H4'), 0.88 (9H, s, H50, 1.26 (3H, t, 7 = 7.2 
Hz, HI'), 1.32-1.50 (6H, m, H5-7), 2.13 (2H, t, 7 = 8.8 Hz, H4), 2.14 (3H, d, 7 = 1.1 Hz, 
H3'), 3.59 (2H, t, 7  = 6.5 Hz, H8), 4.13 (2H, q,7 = 7.2 Hz, H2'), 5.64 (1H, sextet, 7=  1.1 Hz, 
H2).
13C NMR (75 MHz, CDCI3): S =  -5.3 (3), 14.6 (3), 18.5 (0), 18.8 (3), 25.6 (2), 26.1 (3), 27.3 
(2), 32.7 (2), 41.0 (2), 59.5 (2), 63.1 (2), 115.7 (1), 160.2 (0), 167.0 (0).
LRMS (Cl mode, NH3): m/z = 315 [(M+H)+, 95%], 286 (25), 269 (40), 257 [(M+H-C4H9)+, 
100],
Anal. Calcd for C i7H3 4 0 3Si: C, 64.92; H, 10.90. Found: C, 64.91; H, 10.94.
Data for the (Z) isomer:
IR (film): v = 2932 (s), 2857 (s), 1714 (s), 1645 (s), 1474 (s), 1377 (m), 1256 (s), 1226 (s),
1146 (s), 1098 (s), 1045 (m), 1006 (m), 837 (s), 776 (s) cm -1.
>H NMR (270 MHz, CDCI3): S =  0.03 (6H, s, H4'), 0.87 (9H, s, H50, 1.25 (3H, t, 7 = 7.2 
Hz, H10, 1.45 (6H, m, H5-7), 1.85 (3H, d, 7 = 1.1 Hz, H30, 2.61 (2H, t, 7 = 6.8 Hz, H4), 
3.59 (2H, t, 7 = 6.4 Hz, H8), 4.11 (2H, q, 7 = 7.1 Hz, H20, 5.63 (1H, m, H2).
13C NMR (68 MHz, CDCI3): S =  -5.1 (3), 14.5 (3), 18.5 (0), 25.3 (3), 25.6 (2), 26.1 (3), 28.2 
(2), 32.9 (2), 33.5 (2), 59.5 (2), 63.3 (2), 116.2 (1), 160.6 (0), 166.5 (0).
Ethyl (Zs)-8-[(terf-butyldimethylsiIyI)oxy]-3-methyl-2-octenoate (3.3.4.1):
OTBS
TBSO(CH2)5Cu(Me3SiCH2)l>Lil 
E t02C—= E   -------------------------------------------
Et20:pentane, -90°C, 5 min 
68%, 100% (E)-selective
4.3.5.3
C6HsQ2 = 112.1
To a solution of 5-iodo-(9-(terf-butyldimethylsilyl)-pentanol* (4.3.5.3) (377 mg, 1.15 mmol) 
in Et2 0  (5 mL):pentane (3 mL) at -75°C was added fer/-butyllithium (1.4 mL of a 1.7 M 
solution in hexanes, 2.38 mmol, 2 eq). The pale yellow solution was warmed to 0°C and
EtO.
3.3.4.1
CiyHjuCkSi = 314.5
THF (200 |iL, 2.46 mmol) was added. The mixture of 5-lithio-0-(terf-butyldimethylsilyl)- 
pentanol was stirred for 10 min then cooled to -20°C and added via cannula to another 
reaction flask containing a -80°C solution of trimethylsilylmethylcopper prepared as follows: 
to a suspension of copper (I) iodide (220 mg, 1.16 mmol) in Et2 0  (10 mL) at -75°C was 
added trimethylsilylmethyllithium (1.15 mL of a 1.0 M solution in pentane, 1.15 mmol). The 
pale yellow mixture was warmed to 0°C and stirred for 10 min.
After addition of the alkyl lithium to the cuprate the resulting mixed cuprate was warmed to 
0°C and stirred for 10 min. During this time the mixture became orange and finally pale tan. 
The solution was then cooled to -90°C and ethyl tetrolate (112 mg, 1.0 mmol) was added as 
a solution in Et2 0  (0.5 mL + 2 x 0.5 mL rinses). The internal temperature was maintained at 
or slightly below -90°C during the addition. The reaction was stirred for 5 min then 
quenched (at -90°C) with saturated aqueous NH4CI solution (5 mL) and warmed to room 
temperature over 1 h. The mixture was poured into Et2 0  (100 mL):water (50 mL). The 
organic phase was washed with water (2 x 25 mL) and brine (25 mL) then dried, filtered and 
concentrated in vacuo to a colourless oil which was chromatographed (SiC>2, petrol:Et2 0  = 
97:3) to give (£)-3.3.4.1 (214 mg, 0.68  mmol, 68%) as a colourless oil.
* prepared by mono TBS protection of pentan-diol then tosylation and treatment with 
sodium iodide in acetone:
P. G. McDougal, J. G. Rico, Y. Oh, B. D. Condon J. Org. Chem., 1986,51, 3388.
E. A. Mash, S. B. Hemperly, K. A. Nelson, P. C. Heidt, S. van Densen J. Org. Chem., 1990, 
55, 2045.
See preceeding experiment for characterisation data.
(R)-(+)-Ethyl 8-[(terf-butyldimethylsilyl)oxy]-3-methyloctanoate (3.3.3.4):
EtO.
O
OTBS
TBSOCH2
4.2.1.2
(463.8 
5.25 mol%)
CH2OTBS
3.3.4.1
^ 17^340381 = 314.5
CoCl2*6H20  
(237.9,4.4 mol%) 
NaBH4 (37.8,2 eq) 
EtOH, DMF, rt, 5 d 
96% er >9:1
3'
O -S i
3.3.3.4
CiyHaeOaSi = 316.5
Into a glass tube fitted with a vacuum tight Young's tap was placed 3.3.4.1 (9.62 g, 30.6 
mmol) in ethanol (12.5 mL) under argon. To the magnetically stirred solution was added 
cobalt chloride hexahydrate (319 mg, 1.34 mmol, 4.40 mol%) in ethanol (4 mL) followed by 
semi-corrin 4.2.1.2 (746 mg, 1.61 mmol, 5.26 mol%) in ethanol (5.5 mL). On addition of the 
semi-corrin the reaction mixture changed from a blue to a deep purple colour. To the
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mixture was finally added a slightly turbid solution of sodium borohydride (2315 g, 61.2 
mmol, 2 eq) in DMF (19 mL). The now brown reaction mixture was thoroughly degassed 
via 4 freeze-thaw cycles then sealed under vacuum,* allowed to warm to rt and stirred for 5 
days. After this time, the internal pressure was eased by careful opening of the teflon tap and 
water (100 mL) was added. The product was extracted with CH2CI2 (3 x 100 mL). The 
combined organic extracts were washed with water (2 x 100 mL), brine (100 mL), dried and 
concentrated in vacuo to a brown oil which was chromatographed (SiC>2, petrol:Et2 0  = 95:5) 
to give the ester 3.3.3.4 (9.31 g, 29.4 mmol, 96%) as a colourless oil (ee >90%, chiral 
lanthanide shift reagent, see Chapter 4).
* The sealed reaction mixture, under argon, was frozen in liquid nitrogen and evacuated with 
an oil pump (0.5 mmHg). After 5 min, the tube was re-sealed and allowed to warm to rt and 
thaw. Argon was re-introduced and the whole process repeated. The final cycle ends with 
the reaction mixture being sealed under vacuum while still frozen.
[a]D = +2.8° (c = 3.42 in CHCI3).
IR (film): v = 2931 (s), 2857 (s), 1738 (s), 1255 (s), 1098 (s), 837 (s) cm ~K
*H NMR (270 MHz, CDCI3): S = 0.03 (6H, s, H4'), 0.88 (9H, s, H5'), 0.91 (3H, d, J = 6.3 
Hz, H3'), 1.24 (3H, t, J = 7.1 Hz, HI7), 1.29 (6H, br m, H4-6), 1.48 (2H, m, H7), 1.90 (1H, br 
m, H3), 2.07 (1H, dd, J  = 14.5, 7.9 Hz, H2), 2.27 (1H, dd, J = 14.3, 6.0 Hz, H2), 3.58 (2H, t, 
J = 6.9 Hz, H8), 4.11 (2H, q, J = 7.1 Hz, H27).
13C NMR (68 MHz, CDCI3): 5= -5.1 (3), 14.4 (3), 18.5 (0), 19.9 (3), 26.1 (3), 26.9 (2), 30.5 
(1), 33.0 (2), 36.9 (2), 42.1 (2), 60.2 (2), 63.3 (2), 173.4 (0).
LRMS (Cl mode, NH3): m/z = 317 [(M+NH4)+, 100%], 259 (20), 57 (28).
Anal. Calcd for Ci7H360 3 Si:C, 64.51; H, 11.46. Found: C, 64.44; H, 11.57.
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(2£)-(+)-8-[(ter^butyldimethylsilyl)oxy]-3-methyloctanal (5.2.3.1):
•TBS
3.3.3.4
/-Bu2AIH, PhMe 
-80°C, 30 min 
-------------------
93%
C17H36O3S1 = 316.5
J  5.2.3.1
CisHazOgSi = 272.5
Diiso-butylaluminium hydride (10.1 mL of a 1.5 M solution in toluene, 15.15 mmol) was 
added dropwise to a solution of ester 3.3.3.4 (4.7 g, 14.85 mmol) in toluene (60 mL) at 
-80°C. The reaction was stirred for 30 min then quenched by addition of methanol (40 mL). 
The mixture was warmed to 0°C then poured into a solution of sodium potassium tartrate (75 
g) in water (300 mL). The mixture was stirred vigorously for 30 min then poured into Et2 0  
(300 mL) and brine (100 mL). The aqueous phase was extracted with Et2 0  (100 mL) and 
combined organic layers were washed with brine (100 mL), dried and concentrated in vacuo 
to a colourless oil which was chromatographed (SiC>2, petrol:Et2 0  = 95:5) to give 5.2.3.1 as a 
colourless oil (3.812 g, 13.99 mmol, 94%).
[a]D = +9.0° (c = 3.535 in CHCI3).
IR (film): v = 2930 (s), 2857 (s), 1728 (s), 1463 (s), 1387 (s), 1361 (m), 1255 (s), 1099 (s), 
835 (s) cm-1.
*H NMR (270 MHz, CDCI3): 8 = 0.02 (6H, s, H2'), 0.87 (9H, s, H30, 0.93 (3H, d, J = 6.7 
Hz, HI'), 1.29 (6H, m, H4-6), 1.50 (2H, m, H7), 2.03 (1H, m, H3), 2.19 (1H, ddd, J = 15.8,
7.5, 2.3 Hz, H2), 2.37 (1H, ddd, J = 15.8, 5.6, 2.1 Hz, H2), 3.57 (H, t, J = 6.3 Hz, H8), 9.73 
(1H, t, 7 = 2.3 Hz, HI).
13C NMR (50 MHz, CDCI3): 8 = -5.3 (3), 18.4 (0), 20.0 (3), 25.95 (2), 26.00 (3), 26.8 (2),
28.1 (1), 32.8 (2), 36.9 (2), 51.1 (2), 63.1 (2), 202.8 (0).
LRMS (Cl mode, NH3): m/z = 289 [(M+NH4)+, 100%].
Anal. Calcd for Ci5H320 2 Si: C, 66.12; H, 11.84. Found: C, 66.19; H, 11.79.
An analytical sample may be prepared by Kugelrohr distillation (85°C (bath) @ 0.8 mmHg).
The aldehyde is not stable over days at room temperature but may be stored in the freezer for 
short periods.
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(R)-(-)-0-(te/*-butyldimethylsilyl)-9,9-dibromo-6-methyl-8-nonen-l-ol (5.3.3.1):
O
OTBS
CH2CI2, rt, 5 mins 
95%
PPh3 (262.3) 
CBr4 (331.6)
5.2.3.1
Ci5H3202Si = 272.5
5.3.3.1
Ci6H32Br20Si = 428.3
To a slightly turbid orange solution of triphenylphosphine (1.94 g, 7.40 mmol, 4 eq) and 
freshly sublimed carbon tetrabromide (1.22 g, 3.68 mmol, 2 eq) in CH2CI2 (10 mL) at 0°C 
was added the aldehyde 5.2.3.1 (503 mg, 1.85 mmol) in CH2CI2 (10 mL). The reaction was 
stirred for 5 min then the solvent was removed in vacuo and the residue was 
chromatographed (SiC>2, petrol:Et2 0  = 98:2) to give 5.3.3.1 as a colourless oil (752 mg, 1.76 
mmol, 95%).
[a]D = -1.6° (c = 3.45 in CHCI3).
IR (film): v = 2929 (s), 2856 (s), 1462 (m), 1255 (s), 1100 (s), 835 (s), 776 (s) cm - 1.
'H NMR (270 MHz, CDCI3): S = 0.05 (6H, s, H2'), 0.90 (9H, s, H3'), 0.92 (3H, d, 7 = 6.5 
Hz, HIO, 1.3-1.5 (9H, m, H2-6), 1.95 (1H, dt, 7 = 14.8,7.4 Hz, H7), 2.10 (1H, ddd, 7=  14.5,
7.1.6.0 Hz, H7), 3.60 (2H, t, 7 = 6.4 Hz, HI), 6.40 (1H, t, 7=  7.3 Hz, H8).
13C NMR (68 MHz, CDCI3): 8= -5.1 (3), 18.5 (0), 19.7 (3), 26.2 (3), 27.0 (2 x 2), 32.6 (1),
33.0 (2), 36.7 (2), 40.3 (2), 63.4 (2), 89.1 (0), 137.9 (1).
LRMS (Cl mode, NH3): m/z = 446 [(M+NH4)+, 50%], 429 [(M+H)+, 100], 388 [(MNH4-  
C4H9)+, 30], 349 [(M-Br)+, 15], 317 (25), 265 (35).
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(J?M+)-0-(terf-butyldimethyteilyl)-6-methyl-8-nonyn-l-ol (3.3.3.3):
OTBS
n-BuLi, THF, -70°C, 1 h y 
 ''
94%
O -S i
5.3.3.1
Ci6H32Br20Si = 428.3
3.3.3.3
C16H32OSi = 268.5
w-Butyllithium (7.4 mL of a 2.0 M solution in hexanes, 14.80 mmol, 3 eq) was added 
dropwise over 30 min to a -78°C solution of dibromide 5.3.3.1 (2.12 g, 4.95 mmol) in THF 
(20 mL). The yellow mixture was was stirred at -75°C for 1 h then warmed to -40°C when 
it was quenched with saturated aqueous ammonium chloride (20 mL). The biphasic mixture 
was warmed to 0°C and poured into Et2 0  (100 mL) and water (50 mL). The aqueous phase 
was extracted with ether (20 mL) and combined organic layers were washed with brine (50 
mL), dried and concentrated in vacuo to a colourless oil which was chromatographed (SiC>2, 
petrol:Et2 0  = 98:2) to give 3.3.3.3 as a colourless oil (1.25 g, 4.66 mmol, 94%).
[a]D = +0.8° (c = 2.9 in CHC13).
IR (film): v = 3314 (m), 2955 (s), 2923 (s), 2857 (s), 2118 (w), 1472 (m), 1255 (s), 1099 (s), 
836 (s), 775 (s) cmr1.
*H NMR (270 MHz, CDCI3): 8 = 0.05 (6H, s, H2'), 0.89 (9H, s, H30, 0.98 (3H, d, /  = 6.9 
Hz, HI'), 1.15-1.75 (9H, m, H4-8), 1.93 (1H, t, / =  2.5 Hz, HI), 2.05 (1H, ddd, / =  16.7, 6 .6 ,
2.5 Hz, H3), 2.16 (1H, ddd, J = 16.7, 5.7, 2.5 Hz, H3), 3.60 (2H, t, J=  6.4 Hz, H9).
13C NMR (68 MHz, CDCI3): 8 = -5.1 (3), 18.5 (0), 19.6 (3), 25.9 (2, 2), 26.2 (3), 27.0 (2),
32.5 (1), 33.0 (2), 36.1 (2), 63.4 (2), 69.2 (0), 83.5 (1).
LRMS (Cl mode, NH3): m/z = 286 [(M+NH4)+, 15%], 269 [(M+H)+, 100].
Anal. Calcd for Ci6H32OSi: C, 71.57; H, 12.01. Found: C, 71.69; H, 12.09.
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(l?)-(+)-0-(terf-butyldimethyIsilyl)-6-methyl-8-nonyn-l-ol (3.3.3.3):
OTBS
(MeO)2
O
O
N2
5.3.3.2 (192.1)
K2C 03, MeOH 
82%
5.2.3.1
Ci5H3202Si = 272.5
OTBS
3.3.3.3
C16H32OSi = 268.5
To a 0°C solution of aldehyde 5.2.3.1 (291 mg, 1.07 mmol) and 1-diazo-l- 
(dimethylphosphono)propan-2-one (5.3.3.2) (307 mg, 1.6 mmol, 1.5 eq) in dry methanol was 
added anhydrous K2CO 3 (310 mg, 2.24 mmol, 2.1 eq). The yellow reaction mixture was 
warmed to rt and stirred for 14 h. The reaction was quenched by addition of saturated 
aqueous NH4CI (5 mL) and extracted with petrol (20 mL). The organic layer was dried 
(MgS0 4 ), filtered and concentrated in vacuo to a yellow oil which was chromatographed 
(SiC>2, petrol:Et2 0  = 95:5) to give 3.3.3.3 as a colourless oil (236 mg, 0.879 mmol, 82%).
An analytical sample may be prepared by Kugelrohr distillation (50°C (bath) @ 0.5 mmHg).
The diazophosphonate was prepared according to:
P. Callant, L. D’Haenens, M. Vandewalle Synth. Commun., 1984,14, 155.
(/?)-(ZO-(-)-0-(ter/-butyldimethylsilyl)-9-iodo-6,8-dimethyl-8-nonen-l-ol (3.3.3.1):
OTBS
3.3.3.3
Ci6H32OSi = 268.5
(i) Cp2ZrCi2 (292.3) 
Me3AI, (CH2CI)2
rt, 12 h 
 ►
(ii) l2 (253.8), THF 
-20°C, 1 h
88%
O -S i
3.3.3.1
C17H35IOSi = 410.45
To a suspension of zirconocene dichloride (1.09 g, 3.72 mmol, 1 eq) in 1,2-dichloroethane 
(10 mL) was added trimethylaluminium (5.6 mL of a 2.0 M solution in toluene, 11.2 mmol, 3 
eq). The lemon yellow solution was stirred at rt for 15 min then the acetylene 3.3.3.3 (1.00 
g, 3.72 mmol) in 1,2-dichloroethane (10 mL) was added. After stirring for 12 h the reaction 
had become a darker yellow colour. The reaction was cooled to -20°C and iodine (1.51 g, 
5.95 mmol, 1.6 eq) added as a solution in THF (8 mL). The reaction was carefully quenched 
with 1:1 THF:H2 0  (20 mL) at -10°C and warmed slowly to rt over 30 min. The mixture was 
poured into Et2 0  (100 mL) and water (50 mL). The aqueous phase was extracted with Et2 0
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(20 mL) and the combined organic layers were washed with brine (50 mL), dried and 
concentrated in vacuo to a colourless turbid oil which was chromatographed (SiC>2 , 
petrol:Et2 0  = 98:2) to give 3.3.3.1 as a colourless oil (1.35 g, 3.29 mmol, 88%).
[<x]D = - 1.1° (c = 3.185 in CHC13).
IR (film): v = 2928 (s), 2856 (s), 1462 (m), 1255 (s), 1099 (s), 836 (s), 775 (s) cm"1.
*H NMR (270 MHz, CDC13): 5=  0.04 (6H, s, H30,0.81 (3H, d, J = 6 .6  Hz, H2'), 0.90 (9H, 
s, H4'), 1.0-1.7 (9H, m, H2-6), 1.79 (3H, br s , HI'), 1.98 (1H, dd, 7=  13.5,8.4 Hz, H7), 2.19 
( 1H, dd, J  = 13.5,5.9 Hz, H7), 3.60 (2H, t, J = 6.3 Hz, HI), 5.82 (1H, s br, H9).
13c NMR (68 MHz, CDCI3): <5 = -5.1 (3), 18.5 (0), 19.5 (3), 23.9 (3), 26.2 (3, 2), 27.0 (2),
31.1 (1), 33.0 (2), 36.9 (2), 47.8 (2), 63.4 (2), 75.4 (1), 147.3 (0).
LRMS (Cl mode, NH3): m/z = 428 [(M+NH4)+ 40%], 411 [(M+H)+, 100], 370 (70).
HRMS (Cl mode, NH3): found, (M+NH4)+, 428.1823. Ci7H35lOSi + NH4 requires 
428.1847 (error-5.3 ppm).
(J?)-0E*EM--)-ter/-BiityI-12-[(terf-butyIdiinethylsilyl)oxy]-3,5,7-trimethyl-2,4- 
dodecadieneoate (5.3.11.1):
t-BuO.ITTSnBu3
5.4.3.3
C20H40O2Sn = 431.2
5.4.1.2
(190.7) 
OTBS (1 5 eq)
\ s ^ C 0 2Cu 
 ►
NMP, rt 
10 min 
85%
3.3.3.1
Ci7H35IOSi = 410.45
O -S i
3' o
5.3.11.1
C25H4803Si = 424.7
To a solution of the iodide 3.3.3.1 (1.21 g, 2.95 mmol, 2 eq) in NMP (5 mL) was added 
copper (I) thiophenecarboxylate (422 mg, 2.21 mmol, 1.5 eq). To this suspension was added 
a solution of the vinyl tin 5.4.3.3 (632 mg, 1.47 mmol) in NMP (3 mL). The reaction 
mixture was stirred for 5 min then diluted with ether (50 mL) and filtered through a bed of 
celite. The resulting clear ethereal solution was washed with water (3 x 25 mL), brine (25 
mL), dried, filtered and concentrated to a pale yellow oil which was chromatographed (SiC>2, 
petrol:Et2 0  = 99:1 —> 96:4) to yield the diene 5.3.11.1 (535 mg, 1.25 mmol, 85%) as a 
colourless oil and recovered iodide 3.3.3.1 (652 mg, 1.59 mmol, 93% recovery) as a 
colourless oil.
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[ex]d  = -11.2° (c = 3.12 in CHCI3).
IR (film): v = 2929 (s), 2856 (s), 1710 (s), 1625 (m), 1472 (m), 1462 (m), 1380 (m), 1366 
(s), 1250 (s), 1141 (s), 1099 (s), 836 (s), 775 (s) cm-1.
]H NMR (270 MHz, CDCI3): 8= 0.05 (6H, s, H60, 0.82 (3H, d, 7 = 6.5 Hz, H5'), 0.89 (9H, 
s, H7'), 1.05-1.75 (9H, m ,H 7-ll), 1.48 (9H, s, HI'), 1.98 (3H, d, J=  1.0 Hz, H4'), 1.80 (1H, 
dd, J = 13.0,7.8 Hz, H6), 2.07 (1H, dd, J  = 12.8, 5.6 Hz, H6), 2.19 (3H, d, J  = 1.0 Hz, H3'), 
3.60 (2H, t, J  = 6.3 Hz, H12), 5.58 (1H, br s, H4), 5.66 (1H, br s, H2).
13C NMR (68 MHz, CDCI3): 8= -5.1 (3), 18.3 (3), 19.4 (3, 3,0), 26.0 (3), 26.1 (2), 26.8 (2),
28.3 (3), 30.9 (1), 32.9 (2), 36.9 (2), 49.0 (2), 63.2 (2), 79.4 (0), 119.3 (1), 129.5 (1), 140.5
(0), 152.7 (0), 166.7 (0).
LRMS (Cl mode, NH3): m/z = 442 [(M+NH4)+, 50%], 425 [(M+H)+, 100], 386 [(M+NH4-  
C4H8)+, 5], 369 [(M+H-C4H8)+, 10), 311 [(M+H-C8H i8)+, 30).
HRMS (Cl mode, NH3): found, (M+NH4)+, 442.3743. C25H480 3Si + NH4 requires
442.3716 (error +6.0 ppm).
(R)-(i?,E)-(-)-te7tf-Butyl-12-hydroxy-3 ,5 ,7 -trimethyl-2 ,4 -dodecadieneoate (7.8.1.1):
OTBS OH
TBAF*3H20(261.47) 5'
THF, rt, 2 h
------------------------
90%.Of-Bu
5.3.11.1 7.8.1.1
C25H48O3S1 = 427.1 C19H34Q3 = 310.5
To a solution of the silyl ether 5.3.11.1 (210 mg, 0.494 mmol) in THF (7 mL) at 0°C was 
added a solution of TBAFOH2O (314 mg, 1.2 mmol, 2.4 eq) in THF (3 mL). The yellow 
solution was warmed to rt, stirred for 1 h then quenched with water (1 mL). The organic 
phase was diluted with ether (5 mL) and the aqueous phase was extracted with ether (5 mL). 
Combined ethereal extracts were washed with brine (5 mL), dried, filtered and concentrated 
to a colourless oil which was chromatographed (SiC>2, petrol:Et2 0  = 80:20 -> 60:40) to yield 
the alcohol 7.8.1.1 (138 mg, 0.444 mmol, 90%) as a colourless oil.
[a]D = -12.6° (c = 3.15 in CHCI3).
IR (film): v = 3365 (br s), 2929 (s), 2858 (s), 1708 (s), 1622 (s), 1456 (s), 1391 (s), 1367 (s), 
1291 (m), 1240 (s), 1141 (s), 1043 (m), 888 (m) cm-1.
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!H NMR (270 MHz, CDCI3): 8 = 0.80 (3H, d, J  = 6.5 Hz, H5'), 1.1-1.7 (9H, m, H7-11), 1.46 
(9H, s, HI'), 1.76 (3H, d , / =  1.2 Hz, H4'), 1.79 (1H, dd, 7=  12.7, 8.1 Hz, H6), 1.93 (lH ,br 
s, OH), 2.05 (1H, dd, J = 12.7, 5.8 Hz, H6), 2.17 (3H, d, J = 1.2 Hz, H3), 3.61 (2H, t, J = 6.6 
Hz, H12), 5.55 (1H, m, H4), 5.65 (1H, s br, H2).
13C NMR (68 MHz, CDCI3): 8= 18.3 (3), 19.3 (3,3), 26.0 (2), 26.8 (2), 28.2 (3), 30.9 (1),
32.7 (2), 36.8 (2), 48.9 (2), 62.8 (2), 79.5 (0), 119.3 (1), 129.5 (1), 140.5 (0), 152.7 (0), 166.7
(0).
LRMS (Cl mode, NH3): m/z = 328 [(M+NH4)+, 100%], 311 [(M+H)+, 90], 272 [(M+NH4-  
C4H 8)+, 70], 255 [(M+H-C4H8)+, 15).
HRMS (Cl mode, NH3): found, (M+NR0+, 328.2842. Ci9H340 3 + NH4 requires 328.2851 
(error -2.7 ppm).
(J?)-(2?,EM-)-terf-Butyl-12-oxo-3,5,7-trimethyl-2,4-dodecadieneoate (7.8.2.2):
l—O Ac
OH Dess-Martin 
Periodinane:
CH2CI2, rt, 2 h 7 .8.2.1 (424) 
Of-Bu___________________________
87%
5'
7.8.1.1
C19H34Q3 = 310.5
7.8.2.2
C19H32Q3 = 308.5
To a solution of the alcohol 7.8.1.1 (385 mg, 1.24 mmol) in CH2CI2 (12 mL) was added the 
Dess-Martin periodinane (7.8.2.1) (873 mg, 2.06 mmol, 1.7 eq). The reaction mixture was 
stirred for 2 h then quenched with 1:1 saturated aqueous Na2S2C>3:saturated aqueous NH4C1 
(50 mL). The mixture was stirred vigorously for 10 min then the organic phase was diluted 
with CH2CI2 (20 mL) and water (20 mL). The aqueous phase was extracted with CH2CI2 
(25 mL) and the combined extracts were washed with saturated NaHCC>3 (5 mL), dried, 
filtered and concentrated to a colourless oil which was chromatographed (SiC>2, petrol:Et2 0  
= 90:10) to yield the aldehyde 7.8.2.2 (332 mg, 1.076 mmol, 87%) as a colourless oil.
[a]D = -13.7° (c = 3.41 in CHCI3).
IR (film): v = 2931 (s), 2716 (m), 1728 (s), 1708 (s), 1622 (m), 1456 (m), 1391 (m), 1367 
(m), 1239 (m), 1140 (s), 1016 (w), 889 (w) cm - 1.
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*H NMR (270 MHz, CDCI3): 8= 0.81 (3H, d, 7 = 6.4 Hz, H5'), Ll-1.6 (7H, m, H7-10), 1.48 
(9H, s, H10, 1.78 (3H, d, 7 = 1.1 Hz, H4'), 1.81 (1H, dd, 7=  12.8, 8.4 Hz, H6), 2.06 (1H, dd, 
7=  12.8, 5.6 Hz, H6), 2.19 (3H, d, 7=  1.1 Hz, H30, 2.43 (2H, dt, 7 = 6.2, 1.5 Hz, H ll), 5.56 
(1H, m, H4), 5.66 (1H, br s, H2), 9.77 (1H, t, 7=  1.6 Hz, H12).
13C NMR (68 MHz, CDCI3): 8= 18.5 (3), 19.5 (3), 19.6 (3), 22.5 (2), 26.8 (2), 28.5 (3), 31.0 
(1), 36.7 (2), 44.1 (2), 49.1 (2), 79.7 (2), 119.5 (1), 129.8 (1), 140.5 (0), 152.8 (0), 166.9 (0),
202.9 (1).
LRMS (Cl mode, NH3): m/z = 326 [(M+NH4)+, 100%], 309 [(M+H)+, 20], 270 [(M+NH4-  
C4H8)+, 70], 253 [(M+H-QH8)+ 5).
HRMS (Cl mode, NH3): found, (M+NH4)+, 326.2692. C19H32O3 + NH4 requires 326.2692 
(error- 1.1 ppm).
(2//?,3/5)-7R)-(£^)-(+)-^rf-Butyl-ll-[3/-trimethylsilyl-4'-oxo-2/-oxetanyl]-3,5,7- 
trimethy 1-2,4-undecadienoate (7.1.1.1):
>h Ph
Y ~ \ <(50 mol%)
Of-Bu +  jl 
0  H SiMe3
R 0 2S ' N- AI- N ' S ° 2 R
I
Me >-
PhMe, -60°C 
75%
7.8.2.2 6.2.10.2
C19H32Q3 = 308.5 CsHioOSi = 114.2
7.1.1.1
C24H4204Si = 422.7 
+ other isomer
To a solution of the bis-sulfonamide 7.5.18.4 (342 mg, 0.517 mmol) in toluene (20 mL) was 
added trimethylaluminium (0.25 mL of a 2.0 M solution in toluene, 0.50 mmol). The chiral 
Lewis acid was stirred at rt for 10 min then cooled to -70°C when the aldehyde 7.8.2.2 
(304 mg, 0.985 mmol) in toluene (5 mL + 2 x 1  mL rinses) was added dropwise. The 
mixture was stirred for 5 min then trimethylsilylketene (6.2.10.2) (146 mg, 1.28 mmol) in 
toluene (5 mL) was added dropwise. The reaction was stirred warming to 0°C over 2 h when 
it was quenched with saturated aqueous NH4C1 (5 mL). The organic phase was diluted with 
ether (20 mL) and the aqueous phase was extracted with more ether (20 mL). The combined 
extracts were washed with 1 N HC1 (10 mL), brine (20 mL), dried, filtered and concentrated 
to a colourless oil which was chromatographed (SiC>2, petrol:Et2 0  = 95:5 —> 80:20) to yield 
the cis /Llactones 7.1.1.1 and 7.8.3.1 (279 mg, 0.660 mmol, 67%) as a colourless oil (3:1 
ratio of cis diastereoisomers in favour of 7.1.1.1) and a 1:1.3 cis’.trans mixture (32 mg, 0.076 
mmol, 8%) also as a colourless oil. Total yield of p-lactone = 75%. Cis:trans = 94:6.
Data for cis isomer:
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[a]D = +17.1° (c = 2.765 in CHC13).
IR (film): v = 2929 (s), 2862 (s), 1805 (s), 1705 (s), 1623 (s), 1456 (s), 1390 (s), 1367 (s), 
1332 (m), 1292 (s), 1253 (s), 1141 (s), 1004 (m), 913 (m), 847 (s) cm"1.
•H NMR (270 MHz, CDC13): S = 0.20 (9H, s, H5'), 0.80 (3H, d, J  = 6.5 Hz, H5"), 1.0-1.6 
(9H, m, H7-11), 1.45 (9H, s, HI"), 1.75 (3H, d, J=  1.2 Hz, H4"), 1.80 (1H, dd, 7=  12.8,7.8 
Hz, H6 ), 2.03 (1H, dd, J = 12.8, 6.6  Hz, H6), 2.16 (3H, d, J  = 1.2 Hz, H3"), 3.31 (1H, d, J  =
6.1 Hz, H 30,4.54 (1H, ddd, J = 9.2,6.1,4.8 Hz, H2'), 5.54 (1H, m, H4), 5.63 (1H, br s, H2).
13C NMR (68 MHz, CDCI3): 8 = -1.0 (3), 18.4 (3), 19.4 (3), 19.5 (3), 26.7 (2, 2), 28.4 (3),
30.9 (1), 33.6 (2), 36.7 (2), 46.4 (1), 49.0 (2), 74.1 (1), 79.6 (0), 119.4 (1), 129.7 (1), 140.4
(0), 152.7 (0), 166.8 (0), 171.0 (0).
LRMS (Cl mode, NH3): m/z = 423 [(M+H)+, 100%], 367 (18), 349 (30). 
Anal. Calcd for C24H420 4Si:C, 68.20; H, 10.02. Found: C, 68.43; H, 9.97.
(2'R,3/^ >7R)-(jE^)-(+)-ter/-Butyl-ll-[3/-hydroxymethyl-4'-oxo-2'-oxetanyl]-3,5,7- 
trimethyl-2,4-undecadienoate (8.1.1.1):
(i) TBAF*3H20  (261.47) 
C 02 (g), THF, -78°C, 1 h
) BH3«THF, THF 
0°C -> rt, 1 h 
42%
.Of-Bu
5 ' O H
6
7.1.1.1
C24H420 4Si = 422.7
8.1.1.1
C22H36Q 5 = 380.5 
+ mixture of isomers
Through a solution of TBAF trihydrate (105 mg, 0.402 mmol, 1.1 eq) in THF (10 mL) was 
bubbled CO2 via a syringe needle for 10 min. The mixture was cooled to -78°C and CO2 
bubbling was continued. To this mixture was added the silyl /3-lactone 7.1.1.1 (110 mg, 
0.260 mmol) in THF (1.0 mL + 0.5 mL rinse) via a syringe pump over 1 h. CO2 bubbling 
was stopped and the reaction warmed to rt then poured into 1 N HC1 (10 mL). The product 
was extracted with CH2CI2 (3 x 10 mL) and the combined organic layers were washed with 
brine (10 mL), dried and concentrated to a colourless oil. Data for the crude carboxylic acid:
*H NMR (200 MHz, CDCI3): 6 (selected signals) = 0.80 (3H, d, J = 6.4 Hz, CHCJT3), 1.47 
(9H, s, C(CH3)3), 1.76 (3H, d, J=  1.0 Hz, 0 2CCH=CCH=CC//3), 2.05 (1H, dd, J = 13.1, 6.0
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Hz, CH3CCtf2CHCH3), 2.16 (3H, d, 7 = 1.0Hz, 02CCH=CCZ/3), 4.20 (1H, d, 7 = 4.3 Hz, 
C //C 02H), 4.78 (1H, m, C//CHC02H), 5.56 (1H, br s, C=C//), 5.65 (1H, br s, C=CH), 8.64 
(1H, vbr s, CO2H).
LRMS (El mode): m/z = 294 [(M-C02-C 4H8)+*, 15%], 277 (14), 125 (100), 122 (30), 95 
(15), 57(13).
HRMS (El mode): found, (M -C02-C 4H8)+‘, 294.1824. C22H340 6-C 0 2-C 4H8 requires 
294.1831 (error -2.4ppm).
The crude acid was split into 2 batches (c. 55mg each) for borane experiments. The 
following procedure is representative: to the crude acid (c. 55mg) in THF (5 mL) at 0°C was 
added borane THF complex (1.0 M in THF, 0.6 mL, 0.6 mmol, 1.6 eq). The reaction was 
warmed to rt and stirred for 1 h. The reaction was then quenched with methanol (5 mL) and 
stirred for 10 min. The volatiles were removed in vacuo and the resulting oil was 
chromatographed (Si02, petrol:Et20  = 60:40 —> 40:60) to yield the alcohol 8.1.1.1 (21 mg, 
0.055 mmol, 42%, over 2 steps) as a colourless oil.
[a]D = +9.2° (c = 1.515 in CHC13).
IR (film): v = 3497 (s br), 2929 (s), 1824 (s), 1705 (s), 1623 (s), 1456 (s), 1367 (s), 1330 
(m), 1240 (s), 1141 (s), 1043 (m), 885 (m), 834 (m) cm-1.
*H NMR (270 MHz, CDC13): 8 = 0.83 (3H, d, 7 = 6.4 Hz, H5"), 1.0-2.0 (9H, m, H7-11),
1.47 (9H, s, HI"), 1.78 (3H, d, 7 = 1.1 Hz, H4"), 1.83 (1H, dd, 7 = 12.8, 8.0 Hz, H6), 2.06 
(1H, dd, 7 = 12.8, 6.2 Hz, H6), 2.19 (3H, d, 7 = 1.1 Hz, H3"), 3.39 (1H, q, 7 = 4.6 Hz, H3'), 
3.88 (1H, dd, 7=  11.5, 4.1 Hz, H5'), 4.03 (1H, dd, 7=  11.7, 4.8 Hz, H 5 \  4.58 (1H, ddd, 7 = 
7.1, 5.7, 4.1 Hz, H2'), 5.57 (1H, br s, H4), 5.67 (1H, br s, H2).
13C NMR (50 MHz, CDC13): 8= 18.6 (3), 19.7 (3), 19.7 (3), 25.4 (2), 26.8 (2), 28.5 (3), 3,1.0 
(1), 34.2 (2), 36.7 (2), 49.1 (1), 58.3 (2), 58.8 (1), 75.1 (1), 79.9 (0), 119.5 (1), 129.8 (1),
140.6 (0), 152.9 (0), 167.0 (0), 169.9 (0).
LRMS (El mode): m/z = 324 [(M-C4H8)+#, 16%], 308 (15), 280 (5), 162 (10), 125 (100), 
122 (24), 95 (17), 57 (28).
HRMS (El mode): found, (M-C4H8)+% 324.1933. C i8H280 5 requires 324.1937 (error-1.2 
ppm).
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(2'/?,3'/?,7/?)-(£^)-ll-[3'-hydroxymethyl-4'-oxo-2/-oxetanyl]-3,5,7-trimethyl-2,4- 
undecadienoic acid (1233A, 1.5.1.1):
O
TFA, CH2CI2 3„ 
OH 0°C, 20 mins
--------
53%
2" I 1" O
8.1.1.1
C24H420 4Si = 422.7
1 .5.1.1
^18^28^% = 324.4
To a solution of the ester 8.1.1.1 (33 mg, 0.0087 mmol) in CH2CI2 (2 mL) at rt was added 
trifluoroacetic acid (1.5 mL). The reaction mixture was stirred at rt for 20 min then the 
volatiles were removed in vacuo. CH2CI2 (2 mL) was added and evaporated. This was 
repeated twice and the crude product purified by chromatography (SiC>2, CH2Cl2:MeOH = 
99:1 —> 92:8) to give the natural product 1233A (1.5.1.1) (15 mg, 0.0046 mmol, 53%) as a 
colourless oil.
[ a ]D = +28.8° (c = 0.25 in CHCI3) (lit.36 +28.6° (c = 0.62 in CHCI3).
UV: Xmax = 271 nm (e = 12,030) (lit.18 267nm, 12,150).
IR (film): v = 3500-2500 (br s), 3389 (br s), 2925 (s), 2855 (s), 1820 (s), 1689 (s), 1614 (s), 
1462 (m), 1379 (m), 1256 (m), 1142 (m) cm-1.
LRMS (El mode): m/z = 324 (M+#, 2%), 162 (8), 125 (100), 122 (24), 95 (22), 41 (27).
HRMS (El mode): found, M+\  324.1928. C18H28O5 requires 324.1937 (error -2.7 ppm).
*H NMR (diagnostic signals):
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lit:42 200 MHz, CDC13; ref. TMS
0.83 (3H, d, 7 = 6.4 Hz)
1.80 (3H, s)
2.08 (1H, dd, 7= 12.8, 6.3 Hz)
2.23 (3H, s)
3.39 (1H, q, 7 = 4.2 Hz)
3.87 (1H, dd, 7=  11.6,4.0 Hz)
4.04 (1H, dd, 7= 11.6, 5.0 Hz)
4.57 (1H, ddd, 7 = 7.0, 6.2,4.5 Hz) 
5.67 (1H, s)
5.71 (1H, s)
Synthetic: 360 MHz, CDCI3; ref. CHCI3
0.85 (3H, d, 7=  6.1 Hz, H3")
1.82 (3H, d, 7=  1.1 Hz, HI")
2.09 (1H, dd, 7=  12.8, 6.4 Hz, H6)
2.25 (3H, d, 7=  1.1 Hz, H2")
3.42 (1H, q, 7 = 4.3 Hz, H30
3.90 (1H, dd, 7=  11.4,4.0 Hz, H50
4.06 (1H, dd, 7=  11.6,4.6 Hz, H50
4.60 (1H, ddd, 7 =7.3, 5.8,4.1 Hz, H20
5.69 (1H, s,H2)
5.73 (1H, s,H4)
13C NMR:
lit:42 50 MHz, CDCI3; ref. TMS
18.5 (3)
19.4 (3)
19.9 (3)
25.1 (2)
26.6 (2)
30.9 (1)
33.9 (2)
36.5 (2)
48.9 (2)
58.0 (2) 
58.6(1)
74.9 (1) 
116.6(1)
129.5 (1)
142.1 (0)
157.0 (0)
169.8 (0)
171.7 (0)
Synthetic: 90 MHz, CDCI3; ref. CHCI3
18.7 (3)
19.6 (3)
20.2 (3)
25.4 (2)
26.8 (2)
31.1(1)
34.2 (2)
36.8 (2)
49.2 (2)
58.3 (2)
58.8 (1)
75.1 (1)
116.6(1)
129.7 (1)
142.3 (0)
157.2 (0)
169.9 (0)
171.0 (0)
tert-Buty 1-2-butynoate (5.4.3.2):
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CI3C Of-Bu
X  <2i8-5> 1'
4
HO.
5.4.3.1
C4 H4 O2  = 84.1
O CH2 CI2 , cyclohexane 
1 0  mins, rt 
88%
5 .4 .3 .2
C8 Hi2 Q2  = 140.2
O
To a solution of tetrolic acid (5.4.3.1) (1.268 g, 15.08 mol) in CH2CI2 (15 mL) at rt was 
added a solution of tert-butyltrichloroacetimidate (6.25 g, 28.60 mmol, 1.9 eq). The reaction
1:1 ether:petrol (20 mL). The filtrate was concentrated to a yellow oil by distillation, at 
atmospheric pressure, then chromatographed (SiC>2, petrol:Et2 0  = 95:5). The solvent was 
removed by distillation to give the ester 5.4.3.2 (1.58 g, 11.3 mmol, 75%) as a colourless oil. 
An analytical sample may be prepared by Kugelrohr distillation (100°C (bath) @ 20 mmHg). 
We were unable to obtain a satisfactory microanalysis.
IR (film): v = 2981 (s), 2248 (s), 1708 (s), 1370 (m), 1281 (s), 1162 (s), 1073 (s), 843 (m), 
755 (m) cm-1.
*H NMR (200 MHz, CDCI3): 8 = 1.43 (9H, s, HI'), 1.91 (3H, s, H4).
13C NMR (90 MHz, CDCI3): 8= 3.7 (3), 28.0 (3), 73.8 (0), 82.86 (0), 82.92 (0), 152.8 (0).
LRMS (El mode): m/z = 83 [(M-C4H9)+-, 75%], 67 (100), 57 (65), 41 (40).
HRMS (Cl mode, NH3): found, (M+H)+, 141.0910. C8H 12O2 + H requires 141.0916 (error 
—4.0 ppm).
te/f-Butyl-3-(tributylstannyl)-2-butenoate (5.4.3.3):
was stirred for 10 min when the crystals of trichloroacetamide were filtered and washed with
Cu(l)CN (89.56) 
n-BuLi (2.2 M)
/7-Bu3SnH (291.05, d 1.098)
f-BuOH (74.1)
THF, -80°C , 30 min
5.4 .3 .2
C8 H1 2 Q3  = 140.2
91% 5 .4 .3 .3
C2oH4cA S n  = 431.2
To a suspension of copper (I) cyanide (1.11 g, 12.4 mmol, 1.2 eq) in THF (30 mL) at -70°C 
was added n-BuLi (2.5 M in hexanes, 10.0 mL, 25.0 mmol, 2.5 eq). The mixture was
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warmed to -30°C and stirred until homogeneous (10 min). The yellow mixture was cooled 
back to -70°C and tributyltin hydride (6.6 mL, 7.247 g, 24.9 mol, 2.5 eq) added neat. Slight 
foaming of the solution occurred. The stannyl cuprate was stirred for 5 min at -75°C then 
?m-butanol (920 mg, 12.42 mmol, 1.2 eq) added as a solution in THF (6  mL). More 
vigorous foaming occurred. To the now red mixture was added the acetylene 5.4.3.2 (1.45 g, 
10.34 mmol) in THF (9 mL). The reaction was maintained at below -75°C for 30 min then 
quenched with a pH 8 solution of ammonia/saturated ammonium chloride (25 mL), warmed 
to rt and poured into ether/water. The emulsion was filtered through celite and the aqueous 
phase extracted with ether (2 x 100 mL). Combined ethereal layers were washed with brine 
(50 mL), dried and concentrated to a colourless oil whih was chromatographed (SiC>2, 
petrol:Et2 0  = 99:1 —> 96:4) to yield the product 5.4.3.3 (4.056 g, 9.4 mmol, 91%) as a 
colourless oil.
An analytical sample may be prepared by Kugelrohr distillation (100°C (bath) @
0.5 mmHg).
IR (film): v = 2958 (s), 2927 (s), 2872 (s), 2853 (s), 1711 (s), 1598 (m), 1457 (m), 1366 (s), 
1341 (m), 1148 (s), 865 (m) cm"1.
!H NMR (360 MHz, CDCI3): 8= 0.92 (15H, m, H5', 6 '), 1.32 (6H, m, H4'), 1.47 (6H, m, 
H3'), 1.49 (9H, s, HI'), 2.36 (3H, d,7 = 1.8 Hz, H4), 5.86 (1H, q, 7 = 1.8 Hz, H2).
13C NMR (90 MHz, CDCI3): 8 = 9.6 (2), 13.8 (3), 22.3 (3), 27.5 (2), 28.5 (3), 29.2 (2), 79.9
(0), 130.2 (1), 164.4 (0), 166.7 (0).
LRMS (El mode): m/z = 431 (M+°, 10%), 375 (100), 319 (100), 263 (30), 233 (10), 205 (30), 
177 (30), 135 (12), 121 (15), 57 (60), 41 (32).
Anal. Calcd for C2oH4o0 2Sn:C, 55.71; H, 9.35. Found: C, 55.73; H, 9.32.
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(S,SM-)-AyV'-£w-(2,6-diniethyl-4-terf-butylbenzenesulfonyl)-l,2- 
diphenylethylenediamine (7.5.18.4):
Et3N (101.2 
d 0.726) 
DMAP (122.2)
CH2CI2 
rt, 1 h
7.5.14.4 7 518  4
C 14H16N2 = 212.3 C-)2H-|5CI02S = 258.8 C3qH4qN204S2 = 660.9
To a solution of the diamine 7.5.14.4 (264 mg, 1.24 mmol) in CH2CI2 (6 mL) at rt was added 
triethylamine (0.57 mL, 4.09 mmol) and DMAP (24 mg, 0.2 mmol). The colourless solution 
was stirred at rt and a solution of 4-terf-butyl-2,6-dimethylbenzenesulfonyl chloride (648 mg,
2.48 mmol) in CH2CI2 (2 mL + 2 x 1  mL rinse) was added dropwise via syringe. The 
reaction stirred at rt for 1 h then poured into CH2CI2/I N HC1 (1:1, 50 mL). The aqueous 
layer was extracted with CH2CI2 (20 mL) and the combined organic layers were washed with 
brine (20 mL), dried, filtered and concentrated in vacuo to a solid foam which was 
chromatographed (SiC>2, petrol:Et2 0  = 90:10 —» 60:40) to give 7.5.18.4 as a white solid foam 
(738 mg, 1.12 mmol, 90%).
[a]D = -89.0° (c = 0.52 in CHCI3)
IR (CH2C12): v = 3374 (s), 3053 (s), 2968 (s), 1596 (m), 1421 (m), 1321 (m), 1265 (s), 1174 
(m), 1146 (m) cm_ l
*H NMR (270 MHz, CDCI3): 8= 1.23 (18H, s, H ll), 2.50 (12H, s, H10), 4.41 (2H, dd, 7 =
3.6, 2.0 Hz, H5), 6.00 (2H, dd, J  = 3.6, 2.2 Hz, NH), 6.61 (4H, d, J = 6.8 Hz, H8), 6.86  (10H, 
m, Hl-3).
13C NMR (68 MHz, CDCI3): <5= 23.3 (3), 31.0 (3), 34.6 (0), 62.5 (1), 127.4 (1), 127.8 (1),
128.0 (1), 128.2 (1), 134.1 (0), 136.3 (0), 138.8 (0), 155.0 (0).
LRMS (ES, +ve): m/z = 683 (MNa+).
Anal. Calcd for C38H48N2O4S2: C, 69.06; H, 7.32, N, 4.24. Found: C, 68.85; H, 7.19; N, 
4.09.
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£ra/is-4-Dodecyl-3-(hydroxymethyl)-2-oxetanone (8.2.4.1):
P  (i) TBAF#3H20  (261.47) 
C 02 (g), THF, -78°C, 1 h
O
SlMe3 (ii) BH3*SMe2, THF 
-30°C rt, 1 h 
48%
8,
1
I 1'
14
.OH
7.3.2.1
Ci7H340 2Si = 298.5
10 12
8.2.4.1
C15H28Q3 = 256.4
Through a solution of TBAF trihydrate (162 mg, 0.518 mmol, 1.1 eq) in THF (10 mL) was 
bubbled CO2 via a syringe needle for 10 min. The mixture was cooled to -78°C and CO2 
bubbling was continued. To this mixture was added the silyl /1-lactone 7.3.2.1 (149 mg, 
0.499 mmol) in THF (1.0 mL + 0.5 mL rinse) via a syringe pump over 1 h. CO2 bubbling 
was stopped and the reaction warmed to rt then poured into 1 N HC1 (10 mL). The product 
was extracted with CH2CI2 (3 x 10 mL) and the combined organic layers were washed with 
brine (10 mL), dried and concentrated to a colourless oil. Data for the crude carboxylic acid:
IR (film): v = 3413 (br s), 2924 (s), 2854 (s), 1823 (s), 1727 (s), 1641 (m), 1468 (m), 1381 
(m), 1266 (m), 1130 (m) cm-1.
LRMS (ES, -ve): m/z = 269 [(M-H)~, 30%], [(2M-H)-, 100].
To a portion of the crude acid (26 mg, 0.096 mmol) in THF (5 mL) at -30°C was added 
borane DMS complex (10 M, 0.08 mL, 0.8 mmol). The reaction was warmed to rt and 
stirred for 1 h. The reaction was then quenched with methanol (5 mL) and stirred for 14 h. 
The volatiles were removed in vacuo and the resulting oil was chromatographed (SiC>2, 
petrol:Et2 0  = 90:10 -» 60:40) to yield the alcohol 8.2.4.1 (12 mg, 0.049 mmol, 49%, over 2 
steps) as a colourless oil.
IR (film): v = 3419 (br s), 2924 (s), 2854 (s), 1811 (s), 1462 (m), 1127 (m), 910 (m) cm-1. 
>H NMR (270 MHz, CDCI3): 8= 0.90 (3H, t, 7 = 7.0 Hz, H14), 1.25 (18H, m, H5-13), 1.82
(2H, m, H4), 3.41 (1H, dt, 7 = 4.9, 4.1 Hz, H2), 3.89 (1H, dd, 7 = 11.7, 3.9 Hz, HI'), 4.07 
(1H, dd, 7=  11.5,4.6 Hz, HI'), 4.59 (1H, ddd, 7 = 7.2,6.1,4.1 Hz, H3).
■3C NMR (50 MHz, CDCI3): 8= 14.3 (3), 22.8 (2), 25.0 (2), 29.3 (2), 29.5 (2), 29.57 (2), 
29.62 (2), 29.7 (2, 2), 32.0 (2), 34.1 (2), 58.2 (2), 58.8 (1), 75.2 (1), 170.1 (0).
HRMS (ES, +ve): found, M+', 256.2035. C15H28O3 requires 256.2039 (error-1.4 ppm).
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(2//?,3'/?,7/?)-(jByB)-(+)-^rt-Butyl-ll-[3/-hydroxymethyl-l"-phenyl-4/-oxo-2/-oxetanyl]- 
3,5,7-trimethylundeca-2,4-dienoate (8.5.1.1) and
(37?,7/?)-(Z£,E)-(+)-terf-Butyl-ll-(4'-oxo-2'-oxetanyl)-3,5,7-trimethylundeca-2,4-dienoate
(8.5.1.2):
A solution of TBAF trihydrate (94 mg, 0.36 mmol, 1.2 eq) in THF (4 mL) was cooled until 
turbid (-20°C) when benzaldehyde (159 mg, 1.5 mmol, 5 eq) in THF (2 mL) was added. 
The mixture was cooled to -80°C and a solution of /Mactone 1.1.1.1 (127 mg, 0.300 mmol) 
in THF (2 mL) was added over 45 min with a syringe pump. After the addition, the reaction 
was quenched at -70°C with saturated aqueous ammonium chloride (5 mL). The mixture 
was diluted with ether (10 mL) and water (5 mL), warmed to rt and poured into ether 
(25 mL) : water (10 mL). The aqueous phase was extracted with ether (10 mL) and 
combined extracts were dried, filtered and concentrated in vacuo to a colourless oil (278 mg) 
which was chromatographed (Si0 2 , petrol:Et2 0  = 90:10 -> 70:30) to give 8.5.1.1 (72 mg, 
0.158 mmol, 53%) as a yellow oil, a mixture of other product isomers (19 mg, 0.042 mmol, 
14%) as a colourless oil and desilylated product 8.5.1.2 (30 mg, 0.086 mmol, 29%) as a 
colourless oil. Yield of desired products = 67%. Total yield 96%.
Data for 8.5.1.1:
[a]D = -8.9° (c = 3.7 in CHCI3)
n
TBAF*3H20  (261.47)
O
SiMe3 PhCHO (106.1)
THF, -78°C, 1 h
C28H40Q5 = 456.6 
53%
+
8.5.1.1
£>
isomers
14%
7.1.1.1
C24H42O4S i = 422.7
4" I 3" O
8.5.1.2
C21H34O4 = 350.5 
29%
IR (film): v = 3482 (br s), 2930 (s), 1822 (s), 1700 (s), 1652 (m), 1620 (m), 1456 (m), 1370 
(m), 1242 (m), 1142 (s), 1018 (m) cm -1.
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'H  NMR (360 MHz, CDC13): 5=  0.77 (3H, d, 7 = 6.5 Hz, H5"), 0.90-1.6 (9H, m, H7-11),
1.48 (9H, s, HI"), 1.76 (3H, d, 7 = 1.1 Hz, H3"), 1.78 (1H, dd, 7 = 12.2, 7.8 Hz, H6), 2.00 
(1H, dd, 7 = 12.2, 6.5 Hz, H6), 2.18 (3H, d, 7 = 1.1 Hz, H4"), 2.90 (1H, br s, OH), 3.50 (2H, 
t, 7 = 4.0 Hz, H30, 4.72 (1H, ddd, 7 = 11.1, 7.1, 4.4 Hz, H2'), 5.24 ( 1H, d, 7 = 4.0 Hz, H5'),
5.57 (1H, br s, H2), 5.64 (1H, br s, H4), 7.35 (5H, m, H7'-9').
13C NMR (90 MHz, CDCI3): 8 = 18.5 (3), 19.5 (3), 19.6 (3), 24.8 (2), 26.7 (2), 28.4 (3), 30.9
(1), 34.2 (2), 36.6 (2), 49.0 (2), 63.9 (1), 69.2 (1), 73.8 (1), 79.8 (0), 119.5 (1), 125.4 (1),
128.3 (1), 128.9 (1), 129.8 (1), 140.5 (0), 141.0 (0), 152.9 (0), 167.0 (0), 169.8 (0).
LRMS (Cl mode, NH3): m/z = 474 [(M+NK0+, 70%], 457 [(M+H)+, 30), 418 [(M- 
C4H8+NH4)+,100], 356 [(M-C4H8-C02+H)+, 60],
HRMS (Cl mode, NH3): found, (M+NH4)+, 474.3228. C28H44NO5 requires 474.3219 (error 
+1.9 ppm).
Data for 8 .5.1.2 :
[a]D = -1.5° (c = 1.45 in CHCI3)
IR (film): v = 2930 (s), 1830 (s), 1704 (s), 1622 (m), 1456 (m), 1368 (m), 1242 (m), 1142 (s) 
cm- 1.
>H NMR (360 MHz, CDCI3): 8 = 0.81 (3H, d, J  = 6.5 Hz, H5"), 0.85-1.80 (9H, m, H7-11),
1.48 (9H, s, HI"), 1.77 (3H, d, J  = 1.1 Hz, H3"), 1.81 (1H, dd, J  = 12.4, 7.8 Hz, H6 ), 2.06 
(1H, dd, 7=  12.4,6.4 Hz, H6), 2.18 (3H, d, 7=  1.1 Hz, H4"), 3.05 (1H, dd, 7=  16.2,4.2 Hz, 
H30, 3.50 (1H, dd, 7 = 16.2, 5.7 Hz, H3'), 4.50 (1H, dddd, 7 = 10.2, 7.3, 5.7, 4.2 Hz, H2'), 
5.56 (1H, br s, H2), 5.66 (1H, br s, H4).
13C NMR (50 MHz, CDCI3): 8= 18.5 (3), 19.5 (3), 19.6 (3), 25.3 (2), 26.7 (2), 28.4 (3), 31.0
(1), 34.8 (2), 36.7 (2), 43.0 (2), 49.1 (2), 71.4 (1), 79.7 (0), 119.5 (1), 129.8 (1), 140.5 (0),
152.8 (0), 166.9 (0), 168.5 (0).
LRMS (Cl mode, NH3): m/z = 718 [(2M+NH4)+, 30%], 368 [(M+NH4)+, 100], 350 [M+ 
H)+,40], 312 (60).
HRMS (Cl mode, NH3): found, (M+NH4)+, 368.2801. C2 iH340 4 + NH4 requires 368.2801 
(error +0.1 ppm).
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General Procedure for Cycloadditions
O
H SiMe3 toluene -80 -> -20°C
Lewis acid
R SiMe3 R SiMe3
Into a flame-dried round-bottomed flask was placed a solution of the appropriate bis- 
sulfonamide in dry toluene (10 mL/mmol), under nitrogen at rt, to which was added 
trimethylaluminium (2.0 M in toluene). The complex was stirred at rt for 10 mins. After 
cooling the catalyst to -70°C the aldehyde was added as a solution in toluene. After 5 min, 
trimethylsilylketene (6.2.10.2) in toluene was added dropwise. The reaction was stirred at 
-70°C initially then warmed until conversion took place, as indicated by TLC, when it was 
quenched with saturated aqueous ammonium chloride. The aqueous phase was diluted with 
1 N HC1 (10 mL) then extracted with ether (2 x 10 mL). The combined organic phases were 
washed with brine then dried, filtered and concentrated in vacuo to give the crude product 
which was purified by flash column chromatography on silica gel eluting with petrol:Et2 0  
mixtures to give the pure cis -/2-lactone and the recovered catalyst fos-sulfonamide ligand (up 
to 95% recovery). The cisitrans ratio was determined from the *H NMR of the crude 
product.
In some cases a stock solution of the chiral Lewis acid was used to facilitate performing 
several reactions at the same time. In these cases the molarity of the stock solution is given 
with the number of millimoles employed.
Example (Table 7.5.15, entry 2):
The general procedure was followed with dodecylaldehyde (7.1.3.6) (143 mg, 0.78 mmol); 
ketene 6.2.10.2 (130 mg, 1.14 mmol); catalyst 6.4.16.3 (made from ligand 7.5.1.7 (190 mg, 
0.40 mmol, 0.51 eq) and trimethylaluminium (0.2 mL of a 2.0 M solution in toluene, 0.40 
mmol, 0.50 eq); chromatography (petrol:Et2 0  = 96:4 —> 92:8); total yield: 52%, cis'.trans = 
100:0.
IR (film): v = 2925 (s), 2855 (s), 1806 (s), 1466 (m), 1253 (s), 1118 (s), 1003 (m), 847 (s)
O
c/s-4-Dodecyl-3-(trimethylsilyl)-2-oxetanone (7.3.2.1):
9
12 14
cm-1
*H NMR (270MHz, CDC13): 8= 0.22 (9H, s, H15), 0.88 (3H, t, J  = 6.1 Hz, H14), 1.20-1.60 
(18H, m, H5-13), 1.78 (2H, m, H4), 3.32 (1H, d, J = 6.1 Hz, H2), 4.57 (1H, ddd, J = 9.4, 6.1,
4.3 Hz, H3).
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13C NMR (75 MHz, CDCI3): 8= -0.9 (3), 14.3 (3), 22.9 (2), 26.5 (2), 29.8-^29.4 (6x2), 32.1
(2), 33.8 (2), 46.5 (1), 74.3 (1), 171.2 (0).
LRMS (Cl mode, NH3): m/z = 316 [(M+NH4)+, 100%], 299 [(M+H)+, 18], 281 (97), 256 
(8), 244 (6), 226 (25), 209 (57), 90 (44), 35 (55).
HRMS (Cl mode): found, (M+NH4)+, 316.26718. Ci7H340 2Si + NH4 requires 316.2668 
(error- 1.2 ppm).
trans- 4-Dodecyl-3-(trimethylsilyl)-2-oxetanone (7.3.2.1):
IR (film): v = 2926 (s), 2855 (s), 1804 (s), 1466 (m), 1253 (s), 1125 (m), 1097 (m), 849 (s) 
cm-1.
*H NMR (270MHz, CDC13): 8= 0.17 (9H, s, H15), 0.87 (3H, t, J = 7.0 Hz, H14), 1.20-1.45 
(18H, m, H5-13), 1.70 (1H, m, H4), 1.90 (1H, m, H4), 2.90 (1H, d, J  = 4.0 Hz, H2), 4.24 
(1H, dt, J = 9.0,4.0 Hz, H3).
13C NMR (75 MHz, CDC13): 8= -2.8 (3), 14.3 (3), 22.9 (2), 26.5 (2), 29.8->29.4 (6x2), 32.1
(2), 35.9 (2), 48.5 (1), 72.9 (1), 171.2 (0).
10
SiMe3
Example (Table 7.5.15, entry 4):
General procedure was followed with phenylpropionaldehyde (7.1.3.5) (145 mg, 1.08 mmol); 
ketene 6.2.10.2 (130 mg, 1.14 mmol); catalyst 6.4.16.3 (8 mL of 0.027 M in toluene, 0.22 
mmol, 0.20 eq); chromatography (petrol:Et2 0  = 90:10 —> 80:20); total yield: 81%, cis'.trans = 
95:5.
IR (film): v = 1801 (s), 1497 (m), 1455 (m), 1386 (m), 1298 (m), 1254 (s), 1114 (s), 1075 
(m), 1000 (s), 847 (s) cm"1.
!H NMR (270 MHz, C6D6): 8 = 0.05 (9H, s, H10), 1.72 (1H, dddd, J  = 13.8, 10.1, 7.8, 2.9 
Hz, H4), 1.97 (1H, dddd, J = 13.8, 10.9, 8 .6 ,4.8 Hz, H4), 2.53 (1H, m, H5), 2.75 (1H, ddd, J
c/s-4-(1'-Phenylethyl)-3-(trimethylsilyl)-2-oxetanone (7.3.2.3):
Ill
= 13.6, 9.2, 4.7 Hz, H5), 2.78 (1H, d, J = 6.2 Hz, H2), 4.12 (1H, ddd, J  = 10.9, 6.2, 2.9 Hz, 
H3), 7.15 (5H, m, H7-9).
13C NMR (68 MHz, C6D6): 8 = -0.8 (3), 32.9 (2), 36.1 (2), 46.7 (1), 72.7 (1), 127.0 (1),
129.2 (1), 129.3 (1), 141.3 (0), 171.0 (0).
LRMS (Cl mode, NH3)): m/z = 321 [(M+TMS)+, 15%], 291 (15), 266 [(M+NH4)+, 32], 249 
[(M+H)+, 22], 231 [(M+H-H20 )+, 62], 159 [(M+H-HOTMS)+, 100], 134 (20).
frans-4-(1'-Phenylethyl)-3-(trimethylsilyl)-2-oxetanone (7.3.2.3): SiMe<
IR (film): v = 2953 (m), 1805 (s), 1497 (m), 1455 (m), 1253 (s), 1107 (s), 849 (s) cm-1.
>H NMR (270 MHz, CDC13): 8 = 0.20 (9H, s, H10), 2.06 (1H, m, H4), 2.19 (1H, m, H4), 
2.69 ( 1H, ddd, J  = 14.0, 9.7, 6.5 Hz, H5), 2.80 (1H, ddd, J = 13.5, 10.0, 5.4 Hz, H5), 2.97 
(1H, d ,J  = 4.0 Hz, H2), 4.30 (1H, ddd, J = 7.3, 5.4,4.1 Hz, H3), 7.23 (5H, m).
13C NMR (68 MHz, CDCI3): 5=  -2.8 (3), 31.6 (2), 37.7 (2), 48.5 (1), 72.1 (1), 126.5 (1),
128.4 (1), 128.8 (1), 140.5 (0), 170.8 (0).
LRMS (Cl mode, NH3)): m/z = 266 [(M+NH4)+, 59%], 249 [(M+H)+, 48], 233 (20), 159 
[(M+H-HOTMS)+, 100], 143 (13), 134 (17), 130 (18), 115 (10).
c#s-4-(Pheny Imethy l)-3 -(trimethylsily l)-2-oxetanone (7.5.15.1):
Example (Table 7.5.15, entry 5):
The general procedure was followed with phenylacetaldehyde (7.1.3.4) (98 mg, 0.82 mmol); 
ketene 6.2.10.2 (130 mg, 1.14 mmol); catalyst 6.4.16.3 (6 mL of 0.027 M in toluene, 0.16 
mmol, 0.20 eq); chromatography (petrol:Et2 0  = 90:10); total yield: 81%, cis'.trans = 84:16.
Recrystallised from pentane:CH2Cl2 (2:1) in the freezer (-18°C) to give colourless needles.
mp: 100-101.5°C
IR (CH2C12): v = 2961 (m), 1803 (s), 1266 (s), 1111 (s), 1002 (m), 848 (s) cm-1.
lH NMR (270 MHz, C6D6): <5= 0.05 (9H, s, H9), 2.66 (1H, dd, J  = 14.7, 3.1 Hz, H4), 2.79 
(1H, d, J = 6.2 Hz, H2), 2.94 (1H, dd, J = 14.7, 10.4 Hz, H4), 4.32 (1H, ddd, J  = 10.5, 6.2,
3.1 Hz, H3), 7.15 (5H, m, H6-8).
13c NMR (68 MHz, C6D6): 8 = -0.8 (3), 40.6 (2), 47.1 (1), 73.9 (1), 127.6 (1), 129.3 (1), 
129.6(1), 137.9(0), 170.0 (0).
LRMS (Cl mode, NH3): m/z = 252 [(M+NH4)+, 21%], 235 [(M+H)+, 20], 217 [(M+H- 
H2O)+,70], 175 (10), 145 [(M+H-HOTMS)+, 100],
Anal. Calcd for C i3Hi80 2 Si:C, 66.62; H, 7.74. Found; C, 66.32; H, 7.67.
fra/is-4-(PhenyImethyl)-3-(trimethyIsilyl)-2 -oxetanone (7.5.15.1):
IR (film): v = 2967 (m), 1806 (s), 1265 (s), 1108 (s), 1001 (m), 849 (s) cm"1.
!H NMR (270 MHz, C6D6): 8= 0.15 (9H, s, H9), 2.50 (1H, dd, J = 13.5, 8.3 Hz, H4), 2.72 
(1H, d, J = 4.1 Hz, H2), 3.02 (1H, dd, J = 13.5, 5.6 Hz, H4), 4.16 (1H, ddd, J = 13.6, 7.7, 5.9 
Hz, H3), 7.15 (5H, m, H6 -8).
13C NMR (68 MHz, CDC13): 8=  -3.1 (3), 42.0 (2), 48.1 (1), 72.7 (1), 127.5 (1), 129.0 (1), 
129.4(1), 135.4 (0), 170.5 (0).
LRMS (Cl mode, NH3): m/z = 252 [(M+NH4)+ 72%], 235 [(M+H)+ 99], 217 [(M+H- 
H20)+, 20], 145 [(M+H-HOTMS)+, 100], 136 (28).
c/s-3-(p-Methoxyphenylmethyl)-3-(trimethylsilyl)-2-oxetanone (7.5.19.2): ?
Example (Table 7.5.27, entry 10):
The general procedure was followed with /?ara-methoxyphenylacetaldehyde (7.5.19.1) (74 
mg, 0.49 mmol); ketene 6.2.10.2 (74 mg, 0.65 mmol); catalyst 7.5.26.4 (made from bis- 
sulfonamide ligand (100 mg, 0.142 mmol, 0.29 eq) and trimethylaluminium (0.07 mL of a
2.0 M solution in toluene, 0.140 mmol, 0.29 eq); chromatography (petrol:Et20  = 95:5); total 
yield: 81%, cis'.trans = 70:30.
IR (CH2C12): v= 2958 (m), 1799 (s), 1612 (m), 1514 (s), 1251 (s), 1114 (m), 844 (s) cm-1.
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!H NMR (300 MHz, CDC13): 8 = 0.30 (9H, s, H10), 3.00 (1H, dd, 7 = 14.6, 3.6 Hz, H4), 3.09 
(1H, dd, 7 = 14.7, 10.1 Hz, H4), 3.43 (1H, d, 7 = 6.1 Hz, H2), 3.80 (3H, s, H9), 4.78 (1H, 
ddd, 7 = 9.9, 6.2, 3.5 Hz, H3), 6.85 (2H, dm, 7 = 8.7 Hz, H6), 7.17 (2H, dm, 7 = 8.7 Hz, H7),
13C NMR (68 MHz, CDCI3): 8= -0.9 (3), 39.1 (2), 46.6 (1), 55.4 (3), 74.5 (1), 114.2 (1),
129.0 (0), 130.0 (1), 158.8 (0), 170.7 (0).
LRMS (ES, +ve): m/z = 815 [(3M+Na)+], 551 [(2M+Na)+, 100%], 546 [(2M+NH4>+], 460 ,
282 [(M+NH4)+], 265 [(M+H)+], 175.
fra/?s-3-(p-Methoxyphenylmethyl)-2-(trimethylsilyl)-2-oxetanone (7.5.19.2): 7 6 9  h
9 10
MeO—^  SiMe3
IR (CH2C12): v = 2956 (m), 1806 (s), 1612 (m), 1514 (s), 1251 (s), 1102 (m), 1035 (m), 844 
(s) cm-1.
!H NMR (300 MHz, CDCI3): <5= 0.02 (9H, s, H10), 2.87 (1H, dd, J = 13.7, 7.3 Hz, H4), 2.98 
(1H, d, 7 = 4.0 Hz, H2), 3.25 (1H, dd, 7=  13.8, 5.7 Hz, H4), 3.80 (3H, s, H9), 4.39 (1H, ddd,
7 = 7.3, 5.7, 2.4 Hz, H3), 6.88 (2H, dm, 7 = 8.7 Hz, H6), 7.14 (2H, dm, 7 = 8.7 Hz, H7)
13C NMR (68 MHz, CDCI3): <5= -3.1 (3), 41.0 (2), 47.9 (1), 55.5 (3), 72.8 (1), 114.4 (1),
127.3 (0), 130.4 (1), 159.0 (0), 170.6 (0).
Example (Table 7.5.15, entry 6):
The general procedure was followed with benzaldehyde (7.1.3.1) (85 mg, 0.80 mmol); ketene
6.2.10.2 (113 mg, 0.99 mmol); catalyst 6.4.16.3 (2.1 mL of 0.0767 M in toluene, 0.16 mmol, 
0.20 eq); chromatography (petrol:Et2 0  = 90:10); total yield (crude): 84%, cis'.trans -  100:0.
This compound was unstable and was not purified.
IR (film): v = 1959 (m), 1801 (s), 1383 (s), 1253 (s), 1198 (s), 1148 (s), 849 (s) cm-1.
*H NMR (270 MHz, CDCI3): 8= -0.08 (9H, s, H8), 3.73 (1H, d, 7 = 6.5 Hz, H2), 5.72 (1H, 
d, 7= 6.5 Hz, H3), 7.30 (5H, m, H5-7).
c/s-4-Phenyl-3-(trimethy Isily l)-2-oxetanone (6.2.10.4):
SiMe-
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c/s-4-(1 '-Cyclohexy lethy l)-3-(trimethylsilyl)-2-oxetanone (7.5.15.2):
8
Example (Table 7.5.15, entry 7):
The general procedure was followed with cyclohexylpropionaldehyde (7.1.3.9) (106 mg, 0.76 
mmol); ketene 6.2.10.2 (111 mg, 0.97 mmol); catalyst 6.4.16.3 (2 mL of 0.0767 M in 
toluene, 0.153 mmol, 0.20 eq); chromatography (petrol:Et2 0  = 95:5); total yield: 75%, 
cis'.trans = 97:3.
Recrystallised from pentane in the freezer (-20°C) to give colourless needles, 
mp: 44-5°C.
IR (film): v = 2922 (s), 2851 (s), 1798 (s), 1450 (m), 1387 (m), 1282 (m), 1253 (s), 1122 (s), 
1005 (m), 846 (s) cm-1.
*H NMR (270 MHz, CDC13): 8 = 0.25 (9H, s, H10), 0.90 (2H, m, H9), 1.22 (5H, m, 
H4,5,7,8), 1.44 (1H, m, H6), 1.70 (7H, m, H4,5,7,8), 3.33 (1H, d, J =6.1 Hz, H2), 4.54 (1H, 
m, H3).
13C NMR (68 MHz, CDCI3): 5 =  -0.9 (3), 26.4 (2), 26.7 (2, 2), 31.1 (2), 33.3 (2), 33.4 (2),
33.9 (2), 37.4 (1), 46.5 (1), 74.6 (1), 171.1 (0).
LRMS (Cl mode, NH3): m/z = 327 [(M+TMS)+, 10%], 272 [(M+NH4)+, 35], 255 [(M+H)+, 
30], 237 [(M+H-H20)+, 100], 165 [(M+H-HOTMS)+, 95],
Anal. Calcd for C14H26O2SK C, 66.09; H, 10.30. Found: C, 66.07; H, 10.35.
, 0
trans-4-(1 '-Cyclohexy lethy l)-3-(trimethylsilyl)-2-oxetanone (7.5.15.2):
8 /
9
10
SiMe-a
■H NMR (270 MHz, CDCI3): 8= 0.20 (9H, s, H10), 0.88 (2H, m, H4-9), 1.22 (5H, m, H4-9), 
1.55 (1H, m, H4-9), 1.70 (7H, m, H4-9), 2.90 (1H, d, J  =4.1 Hz, H2), 4.23 (1H, dt, J  = 6 .6 ,
4.1 Hz, H3).
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13C NMR (68 MHz, CDC13): S = -2.8 (3), 26.4 (2), 26.7 (2), 32.7 (2), 33.3 (2), 33.4 (2), 37.5
(1), 48.5(1), 73.2(1), 171.0 (0).
LRMS (Cl mode, NH3): m/z = 327 [(M+TMS)+, 58%], 272 [(M+NH4)+, 31], 255 [(M+H)+, 
100], 239 [(M+H-H20)+, 38], 212 (19), 195 (22), 165 (47), 154 (13), 143 (20), 114 (18).
Example (Table 7.5.15, entry 8):
The general procedure was followed with cyclohexylacetaldehyde (7.1.3.8) (101 mg, 0.80 
mmol); ketene 6.2.10.2 (113 mg, 0.99 mmol); catalyst 6.4.16.3 (2.1 mL of 0.0767 M in 
toluene, 0.16 mmol, 0.20 eq); chromatography (petrol:Et2 0  = 98:2); total yield: 73%, 
cis'.trans = 96:4. Inseparable isomers. Characterised as mixture.
Recrystallised from pentane in the freezer (-20°C) to give colourless needles (note: crysyals 
dissolve in pentane at rt).
mp: 54-5°C.
IR (film): v = 2925 (s), 2853 (s), 1802 (s), 1449 (m), 1385 (m), 1195 (s), 847 (s) cm-1.
•H NMR (270 MHz, CDCI3): S= 0.22 (9H, s, H9), 0.95-1.65 (13H, m, H4-8), 3.33 (1H, d, J 
= 6.2 Hz, H2), 4.70 (1H, ddd, J  = 10.7,6.2,2.9 Hz, H3).
13C NMR (68 MHz, CDCI3): 8= -0.9 (3), 26.2 (2), 26.3 (2), 26.5 (2), 32.7 (2), 33.9 (2), 35.2
(2), 41.1 (1), 46.1 (1), 72.3 (1), 171.0 (0).
LRMS (Cl mode, NH3): m/z = 313 [(M+TMS)+, 25%], 258 [(M+NH4)+, 40], 241 [(M+H)+,
39], 223 [(M+HH20)+, 99], 151 [(M+H-HOTMS)+, 100].
Anal. Calcd for Ci3H24C>2Si: C, 64.95; H, 10.06. Found: C, 64.81; H, 10.01.
o
c/s-4-(1 '-Cyclohexylmethy l)-3-(trimethy lsilyl)-2-oxetanone (7.5.15.3):
O
c/s-4-Cyclohexyl-3-(trimethylsilyl)-2-oxetanone (7.3.2.2):
7
Example (Table 7.5.15, entry 9):
The general procedure was followed with cyclohexane carboxaldehyde (7.1.3.7) (82 mg, 0.73 
mmol); ketene 6.2.10.2 (91 mg, 0.80 mmol); catalyst 6.4.16.3 (5.5 mL of 0.027 M in toluene,
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0.15 mmol, 0.20 eq); chromatography (petrol:Et2 0  = 92:8); total yield: 71%, cis'.trans = 
88:12.
IR (film): v = 2930 (s), 2854 (s), 1804 (s), 1451 (m), 1275 (s), 1253 (s), 1188 (m), 1128 (s), 
848 (s) cm"1.
iH NMR (270 MHz, CDC13): 8= 0.25 (9H, s, H8), 0.90-1.70 (10H, m, H5-7), 1.99 (1H, d, J 
= 12.7 Hz, H4), 3.29 (1H, d, J = 6.0 Hz, H2), 4.21 (1H, dd, J = 10.4, 6.0 Hz, H3).
13C NMR (68 MHz, CDCI3): 8= -0.6 (3), 25.3 (2), 25.4 (2), 26.1 (2), 28.8 (2), 29.2 (2), 40.9
(1), 46.2(1), 78.2(1), 171.2 (0).
LRMS (Cl mode, NH3): m/z = 299 [(M+TMS)+, 10%], 244 [(M+NH4)+, 27], 227 [(M+H)+,
40], 209 [(M+H-H20)+, 70], 137 [(MfH-HOTMS)+, 100].
8
SiMe3
*H NMR (270 MHz, CDCI3): 8= 0.20 (9H, s, H8), 0.90-2.10 (11H, m, H4-7), 2.97 (1H, d, J 
= 4.1 Hz, H2), 3.93 (1H, dd, J=  8.1, 4.1 Hz, H3).
LRMS (Cl mode, NH3): m/z = 244 [(M+NH4)+, 28], 227 [(M+H)+, 100], 211 [(M+H- 
H20 )+, 14], 137 [(M+H-HOTMS)+, 36],
frans-4-Cyclohexyl-3-(trimethylsilyl)-2-oxetanone (7.3.2.2):
SiMe-c/s-4-(p-Nitrophenyl)-3-(trimethylsilyl)-2-oxetanone (7.5.15.4):
Example (Table 7.5.15, entry 10):
The general procedure was followed with /?ara-nitrobenzaldehyde (7.1.3.3) (116 mg, 0.77 
mmol); ketene 6.2.10.2 (107 mg, 0.94 mmol); catalyst 6.4.16.3 (2.0 mL of 0.0767 M in 
toluene, 0.15 mmol, 0.20 eq); chromatography (petrol:Et20  = 95:5); total crude yield: 75%, 
cis'.trans = 100:0 .
This compound was unstable and was not purified.
IR (film): v = 2959 (m), 1822 (s), 1522 (s), 1348 (s), 1254 (s), 1199 (s), 1147 (s), 1108 (s), 
853 (s) cm-1.
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!H NMR (270 MHz, CDCI3): 8= -0.02 (9H, s, H8), 3.91 (1H, d, J = 6.5 Hz, H2), 5.82 (1H, 
d, J  = 6.6 Hz, H3), 7.38 (2H, d, J = 8.1 Hz, H5), 8.76 (2H, d, J = 8.1 Hz, H6).
13C NMR (68 MHz, CDCI3): 8= -1.6 (3), 50.3 (1), 71.9 (1), 123.9 (1), 126.8 (1), 144.5 (0),
148.0 (0), 169.9 (0).
4-(1 '-Phenylethyl)-3-(trimethylsilyl)-3-(n-hexyl)-2-oxetanone (7.5.15.6):
SiMe<
Example (Table 7.5.15, entry 12):
The general procedure was followed with phenylpropionaldehyde (7.1.3.5) (102 mg, 0.76 
mmol); ketene 6.2.12.2 (186 mg, 0.94 mmol); catalyst 6.4.16.3 (2.0 mL of 0.0767 M in 
toluene, 0.15 mmol, 0.20 eq); chromatography (petrol:Et2 0  = 100:0 —> 96:4); total yield: 
77%, cis’.trans = 86:14.
IR (CH2C12): v = 2956 (s), 2930 (s), 2800 (m), 1795 (s), 1455 (m), 1252 (s), 1136 (m), 1120 
(m), 1093 (m), 1072 (m), 847 (s) cm"1.
NMR (270 MHz, CDCI3): 8 (selected signals) = 0.25 (9H, s, H10), 0.90 (3H, t, J = 7.0 
Hz, HI6), 1.30 (8H, br s, H12-15), 1.88 (2H, m, H ll), 2.09 (1H, m, H4), 2.24 (1H, m, H4),
2.74 (1H, dd, J  = 9.2, 7.0 Hz, H5), 2.90 (1H, dd, J = 9.7, 4.8 Hz, H5), 4.40 (1H, dd, J  = 9.9,
3.0 Hz, H3), 7.30 (5H, m, H7-9).
13C NMR (68 MHz, CDCI3): 8= (-3.2 (3)), -1.2 (3), 14.2 (3), 22.7 (2), 26.3 (2), (26.8 (2)), 
(27.6 (2)), 29.7 (2), (30.2 (2)), 30.8 (2), (31.5 (2)), 31.7 (2), (32.1 (2)), 32.7 (2), (33.0 (2)),
34.6 (2), 55.2 (0), (76.2 (1)), 78.9 (1), 126.4 (1), 128.6 (1), 128.8 (1), 140.6 (0), (140.8 (0)),
174.0 (0).
(Entries in brackets refer to minor isomers.)
LRMS (Cl mode, NH3): m/z = 405 [(M+TMS)+, 40%], 350 [(M+NH4)+, 17], 333 [(M+H)+, 
20], 243 [(M+H-HOTMS)+, 100].
4-(1 '-Phenylmethyl)-3-(trimethy lsilyl)-3-(n-hexyl)-2-oxetanone (7.5.15.7):
Example (Table 7.5.15, entry 13):
The general procedure was followed with phenylacetaldehyde (7.1.3.4) (93 mg, 0.77 mmol); 
ketene 6.2.12.2 (173 mg, 0.87 mmol); catalyst 6.4.16.3 (2.0 mL of 0.0767 M in toluene, 0.15
184
mmol, 0.20 eq); chromatography (petrol:Et2 0  = 100:0 —> 99:1); total yield: 73%, cis'.trans = 
82:18.
IR (film): v = 2956 (s), 2930 (s), 2857 (m), 1802 (s), 1254 (s), 1112 (m), 1090 (m), 1070 (m), 
847 (s) cm-1.
*H NMR (270 MHz, CDC13): d= 0.35 (9H, s, H9), 0.95 (3H, t, J = 7.0 Hz, H15), 1.37 (8H, 
br s, HI 1-14), 1.93 (2H, m, H10), 3.05 (1H, dd, J = 14.5, 2.7 Hz, H4), 3.27 (1H, dd, / =  14.5,
10.9 Hz, H4), 4.62 (1H, dd, J = 10.9, 2.7 Hz, H3), 7.30 (5H, m, H6-8).
13C NMR (68 MHz, CDCI3): 5= -1.1 (3), 14.2 (3), 22.7 (2), 26.3 (2), 29.7 (2), 30.7 (2), 31.7
(2), 39.2 (2), 55.7 (0), 79.9 (1), 127.1 (1), 128.8 (1), 129.0 (1), 137.4 (0), 173.8 (0).
LRMS (Cl mode, NH3): m/z = 391 [(M+TMS)+, 15%], 318 [(M+H)+, 10], 229 [(M+H- 
HOTMS)+, 100].
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General Procedure for C2-Symmetric Ligands
Arx  NH2 
Ar^NH2
Ar,S 0 2CI
Et3N, DMAP 
CH2CI2
To a solution of the diamine in dry CH2Cl2(5  mL/mmol), under nitrogen at rt, was added 
triethylamine (3 eq) and DMAP (10 mol%). The solution was stirred at rt and a solution of 
the sulfonyl chloride (2 eq) in CH2CI2 was added dropwise. The reaction stirred at rt for 1 h 
then poured into CH2CI2/I N HC1 (1:1). The aqueous layer was extracted with CH2CI2 and 
the combined organic layers were washed with brine, dried (MgSC>4), filtered and 
concentrated in vacuo to a solid foam which was purified by flash chromatography eluting 
with ether/petrol mixtures.
The general procedure was followed with (S , S) diamine 7.5.14.4 (257 mg, 1.21 mmol); 
triethylamine (0.52 mL, 3.73 mmol); DMAP (20 mg, 0.16 mmol) and (+)-10- 
camphorsulphonyl chloride (611 mg, 2.44 mmol); chromatography (petrol:Et2 0  = 50:50 —> 
0:100); yield: 37%, white solid foam.
mp: 90-110°C.
[a]D = +30.6° (c = 0.575, CHCI3).
IR (CH2C12): v=  3297 (m), 1745 (s), 1266 (s) cm"1.
iHNMR (270 MHz, CDCI3): 8 = 0.72 (6H, s), 0.88 (6H, s), 1.40 (2H, ddd, 7=  12.2, 9.2, 3.7 
Hz), 1.75 (2H, ddd, J  = 13.8, 9.1, 4.3 Hz), 1.94 (4H, m), 2.35 (2H, t, J = 4.3 Hz), 2.19 (1H, 
m), 2.24 (1H, m), 2.29 (1H, m), 2.37 (1H, m), 2.46 (2H, d, J=  14.8 Hz), 3.19 (2H, d, J=  15.0 
Hz), 4.92 (2H, m), 6.27 (2H, m), 7.1-7.4 (10H, m).
(5,S)-(+)-iV,A-fi/s-((+)-10-camphorsulfonyl)- 
1,2-diphenylethyIenediamine (for 7.5.18.9):
13C NMR (75 MHz, CDCI3): 8= 19.5 (3), 19.8 (3), 25.3 (2), 27.0 (2), 42.8 (1), 42.9 (2), 48.5
(0), 51.3 (2), 58.7 (0), 63.0 (1), 127.7 (1), 128.1 (1), 128.7 (1), 139.2 (0), 216.5 (0).
LRMS (ES, +ve): m/z = 1303 [(2M+Na)+], 663 [(M+Na)+].
186
esulfonyl)-l,2-diphenylethylene 
diamine (for 7.5.18.4):
(S,S)-(-)-N,N -I?/s-(2,6-dimethyl-4-te/*-butylbe
> u
The general procedure was followed with (S, S) diamine 7.5.14.4 (264 mg, 1.24 mmol) in 
CH2CI2 (6 mL); triethylamine (0.57 mL, 4.09 mmol); DMAP (24 mg, 0.20 mmol) and 4-tert- 
butyl-2,6-dimethylbenzenesulfonyl chloride (648 mg, 2.48 mmol); chromatography 
(petrol:Et2 0  = 90:10 —» 60:40); yield: 90%, white solid foam.
See 1233A experimental for characterisation data.
The general procedure was followed with (5, 5) diamine 7.5.14.4 (l.OOg, 4.71 mmol); 
triethylamine (2.0 mL, 14.35 mmol); DMAP (60 mg, 0.49 mmol) and 3,5-bis- 
(trifluoromethyl)benzenesulfonyl chloride* (2.95g, 9.42 mmol); chromatography 
(petrol:Et2 0  = 80:20 —> 50:50); yield: 94%, white solid foam.
* prepared according to the procedure of: R. V. Hoffman Org. Synth. 1981, 60, 121.
mp 155-8°C.
[a]D = -54.8°C (c = 1.025, CHCI3).
IR (CH2C12): v = 3377 (s), 3051 (s), 2954 (s), 1266 (s) cm '1.
!H NMR (270 MHz, CDCI3): 8= 4.93 (2H, dd, J = 5.0, 2.5 Hz, H5), 6.90 (10H, m, Hl-3),
7.75 (2H, s, H9), 7.81 (2H, dd, J = 4.6, 2.3 Hz, NH), 7.99 (4H, s, H7).
13C NMR (75 MHz, CDCI3): 8=  62.7 (1), 120.4 (0), 124.4 (0), 125.7 (1), 127.2 (1), 128.0
(1), 128.4 (1), 128.6 (1), 132.2 (0), 132.7 (0), 134.5 (0), 143.5 (0).
(SyS)-(-)-A/vr/-jBw-(3,5-^w-(trifluoromethyl)benzene 
sulfonyl)-l,2-diphenylethylenediamine (for 7.5.18.1)
This compound has been reported in the literature but no data was given.221
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2 1
(i?^)-(+)-A^^V/-Bw(2,4,6-triiso-propylbeni 
sulfonyl)-l,2 -diphenylethylenediamine 
(for 7.5.18.3):
11
The general procedure was followed with (R , R) diamine 7.5.14.4 (530 mg, 2.50 mmol); 
triethylamine (1.0 mL, 7.17 mmol); DMAP (30 mg, 0.25 mmol) and 2,4,6-triiso- 
propylbenzenesulfonyl chloride (1.53g, 5.05 mmol); chromatography (petrol:Et2 0  = 95:5 —» 
80:20); yield: 82%, white solid foam.
mp 90-100°C.
[a]D = +96.5°C (c = 1.1, CHCI3).
IR (CH2H2): v = 2932 (s), 2859 (s), 2800 (s), 1741 (s), 1473 (s), 1375 (s), 1255 (s), 1137 (s), 
1007 (s), 967 (m), 837 (s), 778 (s) cm-1.
NMR (300 MHz, CDCI3): S= 1.05 (12H, d, 7 = 6.8 Hz, H13 or 15), 1.16 (12H, d, J = 6.8 
Hz, H15 or 13), 1.21 (12H, d, /  = 7.4 Hz, HI 1), 2.83 (2H, septet, J = 6.9 Hz, H10), 4.01 (4H, 
septet, J = 6.8 Hz, H12, 14), 4.48 (2H, dd, J = 3.6, 2.1 Hz, H5), 5.76 (2H, m, NH), 6.59 (4H, 
m, Hl-3), 6.92 (6H, m, Hl-3).
13C NMR (75 MHz, CDCI3): S = 23.8 (3), 24.7 (3), 25.1(3), 29.9 (1), 34.3 (1), 62.0 (1),
123.6 (1), 127.6 (1), 127.9 (1), 128.3 (1), 132.9 (0), 137.3 (0), 150.3 (0), 153.0 (0).
188
2__1
(/?yR)-(+)-N^V/-Bis(2,4,6-trimethylbenzene 
sulfonyl)-1,2-diphenylethylenediamine 
(for 7.5.18.2): ~ 10
11
The general procedure was followed with (R , R) diamine 7.5.14.4 (558 mg, 2.63 mmol); 
triethylamine (1.1 mL, 7.89 mmol); DMAP (35 mg, 0.29 mmol) and 2,4,6- 
trimethylbenzenesulfonyl chloride (1.15g, 5.26 mmol); chromatography (petrol:Et2 0  = 90:10 
—> 40:60); yield: 97%, white solid foam.
mp 90-5°C.
[a]D = +58.0°C (c = 1.175, CHC13).
IR (CH2H2 film) v = 3312 (m), 1604 (m), 1456 (m), 1322 (s), 1266 (s), 1156 (s), 1056 (m), 
921 (m), 738 (s) cm-1.
!H NMR (270 MHz, CDCI3): 8= 2.20 (6H, s, H10), 2.44 (12h, s, HI 1, 12), 4.34 (2H, dd, J = 
3.8, 2.0 Hz, H5), 5.78 (2H, dd, J = 3.6, 2.2 Hz, NH), 6.60 (4H, m, H2 or 3), 6.74 (4H, s, H8), 
6.87 (4H, m, H2 or 3), 6.97 (2H, tt, J = 7.0, 1.6 Hz, HI).
13C NMR (75 MHz, CDCI3): 8= 21.0 (3), 22.9 (3), 62.4 (1), 127.4 (1), 127.9 (1), 128.1 (1),
131.8 (1), 133.9 (0), 136.4 (0), 139.1 (0), 142.3 (0).
The general procedure was followed with (S, S) diamine 7.5.20.6 (513 mg, 1.91 mmol); 
triethylamine (1.0 mL, 7.17 mmol); DMAP (20 mg, 0.164 mmol) and 3,5-bis- 
(trifluoromethyl)benzenesulfonyl chloride* (1.22g, 3.90 mmol); chromatography 
(petrol:Et2 0  = 90:10 —» 70:30); yield: 85%, white solid foam.
* prepared according to the procedure of: R. V. Hoffman Org. Synth. 1981, 60, 121. 
mp 95-115°C (not crystallised).
benzenesulfonyl)-l,2-£w-(3,5-dimethyl 
phenyl)ethylenediamine (for 7.5.21.1):
F3
(S JS)-(+)-N JV'-Bis-(3,5-bis-(trif\uoromethy\) p3
[cc]D = +53.0°C (c 1.3, CHCI3).
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JR (CH2H2): v = 3254 (m), 1422 (m), 1360 (s), 1281, 1285 (s), 1164 (s), 1110 (m), 903 (m), 
742 (s) cm-1.
NMR (270 MHz, CDC13): 8= 1.90 (12H, s, H12), 4.77 (2H, dd, /  = 5.1, 2.4 Hz, H5), 6.27 
(4H, s, H3), 6.45 (2H, s, HI), 7.52 (2H, dd, J = 4.9, 2.6 Hz, NH), 7.75 (2H, s, H9), 7.98 (4H, 
s, H7).
13C NMR (75 MHz, CDCI3): 8 = 20.7 (3), 62.3 (1), 120.6 (0), 124.2 (0), 125.6 (1), 125.8 (1),
126.9 (1), 129.9 (1), 134.3 (0), 137.9 (0), 143.6 (0).
(S ,S)-(+)-iV ,/V'-Z?w-(2,4,6-trimethyl 
benzenesulfonyl)-l,2-£w-(3,5-dimethyl 
phenyl)ethylenediamine (for 7.5.21.2): S-NH  HN—S
11
The general procedure was followed with (5, S) diamine 7.5.20.6 (414 mg, 1.54 mmol); 
triethylamine (0.65 ml, 4.66 mmol); DMAP (23 mg, 0.189 mmol) and 2,4,6- 
trimethylbenzenesulfonyl chloride (677 mg, 3.10 mmol); chromatography (petrol:Et20  = 
90:10 —» 60:40); yield: 80%, white solid foam.
mp 94-7°C.
[a]D = -71.6° (c = 0.64, CHCI3).
IR (CH2C12): v = 3054 (m), 2986 (m), 1605 (m), 1422 (m), 1322 (m), 1266 (s), 1156 (m) 
cm-1.
lU NMR (300 MHz, CDCI3): 8= 1.99 (12H, s, H12), 2.21 (6H, s, H10), 2.42 (12H, s ,H ll) , 
4.31 (2H, dd, J  = 4.0, 1.9 Hz, H5), 5.56 (2H, dd, J = 3.7, 1.9 Hz, NH), 6.22 (4H, s, H3), 6.60 
(2H, s, HI), 6.75 (4H, s, H8).
13C NMR (75 MHz, CDCI3): 8= 21.0 (3), 21.1 (3), 22.8 (3), 62.0 (1), 125.4 (1), 129.4 (1), 
131.7 (1), 134.2 (0), 136.1 (0), 137.4 (0), 139.1 (0), 142.0 (0).
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General Procedure for Non-C2-Symmetric Catalysts
(i) Et3N, DMAP 
Ar- NH2 (ii) Ar1S 0 2CI
Ar^^NH2 (iii) Ai^SC^CI
To a solution of the diamine in dry CH2CI2 (5 mL/mmol), under nitrogen at rt, was added 
triethylamine (3 eq) and DMAP (10 mol%). The solution was stirred at rt and a solution of 
the first sulfonyl chloride (1 eq) in CH2CI2 was added dropwise. After 1 h at rt the second
poured into CH2CI2/I N HC1 (1:1). The aqueous layer was extracted with CH2CI2 and the 
combined organic layers were washed with brine, dried (MgSC>4), filtered and concentrated 
in vacuo to a solid foam which was purified by flash chromatography eluting with 
ether/petrol mxtures.
The general procedure was followed with (S , S) diamine 7.5.14.4 (218 mg, 1.03 mmol); 
triethylamine (0.44 mL, 3.16 mmol); DMAP (10 mg, 0.08 mmol); 2,4,6-tri/sc>- 
propylbenzenesulfonyl chloride (318 mg, 1.05 mmol) and triflic anhydride (305 mg, 1.08 
mmol). NOTE: the reaction was cooled to -70°C before addition of the triflic anhydride then 
warmed slowly to rt. Chromatography (petrol:Et2 0  = 50:50 —» 0:100); yield: 64%, white 
solid foam.
sulfonyl chloride was added as for the first and the reaction stirred at rt for a further 1 h then
(S,S)-(-)-iV-2,4,6-Triwo-propylbenzenesuIfonyl-Ar'- ^  ^  (jj \7  8
trifly l-l,2-diphenylethylenediamine (for 7.5.26.1): F3C— NH HN— ^
16 2 1
11
13
IR (CH2CI2): vmax = 1265 (s) cm-1.
[a]D = -54.7° (c = 0.655, CHCI3).
19F NMR (282 MHz, CDCI3): 5=25.0 (ref.: C6F6 50).
lU NMR (270 MHz, CDCI3): 5= 0.90 (6H, d, J = 6.8 Hz, HI 1), 1.22 (6H, d, J = 6.8 Hz, H13 
or 15), 1.26 (6H, d, J  = 6.8 Hz, H15 or 13), 2.86 (1H, septet, J = 6.9 Hz, H10), 3.99 (2H, 
septet, J  = 6.9 Hz, H12, 14), 4.23 (1H, dd, J = 10.2, 7.7 Hz, H5), 4.89 (1H, dd, J = 10.2, 6.9 
Hz, H20), 5.25 (1H, d, J = 7.5 Hz, C5 NH), 6.50 (2H, d, J = 7.1 Hz, H8), 7.05 (11H, m, HI- 
3, 16-18, C20NH).
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13C NMR (75 MHz, CDC13): 8 = 23.5 (1), 23.7 (1), 23.9 (3), 25.2 (3), 29.9 (3), 34.2 (1), 62.2 
(1), 63.1 (1), 119.0 (0)*, 123.8 (1), 127.07 (1), 127.13 (1), 128.3 (1), 128.5 (1), 128.8 (1),
128.9 (1), 131.8 (0), 136.2 (0), 137.4 (0), 150.2 (0), 152.0 (0).
* Jc-F = 130 Hz
17,
—NH HI
(S,S)-(-)-N-2,4,6-Triiso-propylbenzenesulfonyl- 
iV'-pentafluorobenzenesulfonyl-l, 2-diphenyl 
ethylenediamine (for 7.5.26.2):
The general procedure was followed with (5, S) diamine 7.5.14.4 (421 mg, 1.98 mmol); 
triethylamine (0.84 mL, 6.03 mmol); DMAP (15 mg, 0.12 mmol); 2,4,6-triiso- 
propylbenzenesulfonyl chloride (601 mg, 1.98 mmol) and pentafluorobenzenesulfonyl 
chloride (528 mg, 1.98 mmol); chromatography (CH2CI2); yield: 36%, white crystalline 
solid. Recrystallised from CH2CI2 (250 mg in 5 mL) overlaid with petrol (2 mL). This 
solution was stood at rt for 1 h after which time the crystals were filtered and dried @0.5 
mmHg @ 100°C to give white needles.
mp: 225°C.
[a]D = -89.5° (c = 0.4, CH2Cl2 ).
IR (CH2C12): vmax = 1265 (s) cm-1.
!H NMR (300 MHz, CDCI3): 8 = 1.02 (6H, d, J = 6.7 Hz, HI 1, 13 or 15), 1.22 (6H, d, J =
6.9 Hz, H ll, 13, or 15), 1.23 (6H, d, J = 6.6 Hz, H ll, 13 or 15), 2.85 (1H, septet, J=  6.9 Hz, 
H10), 3.99 (2H, septet, J = 6.7 Hz, H12, 14), 4.48 (1H, dd, J = 10.3, 6.7 Hz, H5), 4.83 (1H, 
dd, J = 10.3, 6.6  Hz, H20), 5.49 (1H, d, J = 6.7 Hz, C5 NH), 6.60 (1H, d, J  = 6.7 Hz, C20 
NH), 6.95 (12H, m, Hl-3, H8 , 16-18).
13C NMR (75 MHz, CDCI3): 8= 23.7 (1), 23.8 (1), 24.4 (3), 25.2 (3), 30.0 (3), 34.3 (1), 61.7
(1), 63.0 (1), 123.8 (1), 127.5 (1), 127.6 (1), 128.2 (1), 128.4 (1), 128.5 (1), 128.7 (1), 132.4
(0), 135.7 (0), 136.2 (0), 150.3 (0), 153.5 (0).
NB: C6F5: signals very weak.
19F NMR (282 MHz, CDCI3): 8= 1.77 (2F, m); 14.50 (IF, tt, J  = 20.7, 6.5 Hz); 26.01 (2F, 
ddd, J = 27.8, 12.0, 7.9 Hz) (ref.: C6F6 8 0).
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LRMS (ES, +ve): m/z = 731 [(M+Na)+], 1439 [(2M+Na)+].
Anal. Calcd for C35H37F5N2O4S2: C, 59.31; H, 5.26.; N, 3.95; S, 9.05. Found: C, 59.27; H, 
5.16; N,3.71; S, 9.30.
16 2
(S,S)-(-)-iV-2,4,6-Trns0-propylbenzenesulfonyI- 
iV'-2,4,6-trimethylbenzenesulfony 1-1,2-diphenyl
ethylenediamine (for 7.5.26.3): 28
13
11
The general procedure was followed with (5,5) diamine 7.5.14.4 (257 mg, 1.21 mmol); 
triethylamine (0.52 mL, 3.73 mmol); DMAP (10 mg, 0.08 mmol); 2,4,6-trnso- 
propylbenzenesulfonyl chloride (368 mg, 1.22 mmol) and 2,4,6-dimethylbenzenesulfonyl 
chloride (267 mg, 1.22 mmol); chromatography (petrol:Et2 0  = 50:50); yield: 79%, white 
solid foam.
[a]D = -80.0° (c = 0.4, CHCI3).
IR (CH2C12): vmax = 1265 (s) cm-1.
*H NMR (300 MHz, CDCI3): 8=  1.03 (6H, d, J = 6.8 Hz, H15), 1.18 (6H, d, J = 6.6  Hz, 
H13), 1.20 (6H, d, 7=  6.8 Hz, H ll), 2.21 (3H, s, H28), 2.48 (6H, s, H27), 2.84 (1H, septet, 7 
= 6.8 Hz, H10), 4.00 (2H, septet, 7 = 6.8 Hz, H12, 14), 4.42 (1H, dd, 7 = 10.1, 6.3 Hz, H5), 
4.46 (1H, dd, 7 = 9.9, 4.7 Hz, H20), 5.66 (1H, d, 7= 6.1 Hz, C5 NH), 6.15 (1H, d, 7 = 4.6 Hz, 
C20 NH), 6.56 (2H, d, 7 = 7.0 Hz, ), 6.65 (2H, d, 7 = 7.0 Hz), 6.74 (2H, s, Hl-3, 16-18), 
6.82-6.98 (6H, m, Hl-3, 16-18), 7.00 (2H, s, Hl-3, 16-18).
13C NMR (75.47 MHz, CDCI3): 8=  20.9 (3), 22.8 (3), 23.7 (3), 23.8 (3), 24.6 (3), 25.2 (3),
30.0 (1), 34.3 (1), 62.3 (1), 62.5 (1), 123.6 (1), 127.5 (1), 127.6 (1), 127.7 (1), 127.9 (1),
128.0 (1), 128.3 (1), 131.7 (1), 132.7 (0), 134.2 (0), 136.6 (0), 136.9 (0), 139.1 (0), 142.1 (0), 
150.2(0), 153.1 (0).
LRMS (ES, +ve): m/z = 1345 [(2M+Na)+, 100), 683 [(M+Na)+, 36], 662 [(M+H)\ 20%].
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(S,S)-(-)-iV-2,4,6-Triwo-propylbenzenesulfonyl- 
iV'-2,6-dimethyl-4-te/f -butylbenzenesulfonyl- _  
1,2 -diphenylethylenediamine (for 7.5.26.4): 2,
- NH HN— *
28
27
13
The general procedure was followed with (S, S) diamine 7.5.14.4 (386 mg, 1.82 mmol); 
triethylamine (0.77 mL, 5.52 mmol); DMAP (24 mg, 0.20 mmol); 2,4,6-trb\se>- 
propylbenzenesulfonyl chloride (551 mg, 1.83 mmol) and 4-terf-butyl-2,6- 
dimethylbenzenesulfonyl chloride (478 mg, 1.83 mmol); chromatography (petrol:Et2 0  = 
95:5 —» 60:40); yield: 79%, white solid foam.
mp: 95-100°C.
[a]D = -89.9° (c = 0.585, CHC13).
TR (CH2C12): vmax = 3308 (m), 3054 (m), 2966 (s), 2871 (m), 1600 (m), 1456 (m), 1422 (m), 
1321 (m), 1265 (s), 1150 (s) cm"1.
*H NMR (300 MHz, CDCI3): S=  1.06 (6H, d, J = 6.7 Hz, H15), 1.19 (6H, d, J = 6.7 Hz, 
H13), 1.21 (6H, d, J = 6.7 Hz, HI 1), 1.24 (9H, s, H29), 2.51 (6H, s, H27), 2.84 (1H, septet, J 
= 6.9 Hz, H10), 4.01 (2H, septet, J  = 6.9 Hz, H12, 14), 4.45 (2H, m, H5, 20), 5.68 (1H, m, 
C20 NH), 6.11 (1H, m, C5 NH), 6.59 (4H, t, J = 6.9 Hz, H8 , 23, 25), 6.82 (2H, t, J = 6.9 Hz, 
Hl-3, 16-18), 6.95 (8H, m, Hl-3, 16-18).
13C NMR (75 MHz, CDCI3): 5=  23.3 (3), 23.78 (3), 23.81 (3), 24.6 (3), 25.2 (3), 30.0 (1),
31.1 (3), 34.3 (1), 34.6 (0), 62.2 (1), 62.4 (1), 123.6 (1), 127.5 (1), 127.6 (1), 127.7 (1), 127.9
(1), 128.0 (1), 128.1 (1), 128.3 (1), 132.9 (0), 134.1 (0), 136.4 (0), 137.0 (0), 138.8 (0), 150.3
(0), 153.1 (0), 154.9 (0).
LRMS (ES, +ve): m/z = 725 [(M+Na)+, 100%].
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l-N H
30. 31
(S,S)-(-)-iV-2,4,6-T riiso-propylbenzenesulfonyl- 
A'-2,4,6-trimethylbenzenesulfonyl-l,2-ftis-(3,5- 
dimethylphenyl)-ethylenediamine: _
11
13
The general procedure was followed with (S , S) diamine 7.5.20.6 (366 mg, 1.36 mmol); 
triethylamine (0.63 mL, 4.52 mmol); DMAP (24 mg, 0.20 mmol); 2A,6-triiso- 
propylbenzenesulfonyl chloride (412 mg, 1.36 mmol) and 2,4,6-trimethylbenzenesulfonyl 
chloride (303 mg, 1.38 mmol); chromatography (petrol:Et2 0  = 90:10 —> 70:30); yield: 41%, 
white solid foam.
mp: 90-94°C.
[oc]D = -90.5° (c = 0.705, CHCI3).
IR (CH2C12): v = 3310 (m), 2962 (s), 1602 (m), 1463 (m), 1424 (m), 1327 (m), 1265 (s), 
1154(s) cm-1.
!H NMR (270 MHz, CDCI3): 8= 1.04 (6H, d, J = 6.8 Hz. Hll) ,  1.16 (6H, d, J = 6.8 Hz, 
H13), 1.20 (6H, d, /  = 6.8 Hz, H15), 1.96 (12H, s, H29-32), 2.20 (3H, s. H28), 2.43 (6H, s, 
H27), 2.84 (1H, septet, J = 7.2 Hz, H12), 3.95 (1H, septet, J = 7.2 Hz, H14), 4.37 (2H, m, 
H5, H20), 5.38 (1H, d, /  = 5.3 Hz, C5 NH), 5.82 (1H, d, J  = 4.3 Hz, C20 NH), 6.19 (4H, d, J 
= 12.4 Hz, H3, 18), 6.58 (2H, d, J = 6.9 Hz, HI, 16), 6.73 (2H, s, H8), 7.02 (2H, s, H23, 25).
13C NMR (75 MHz, CDCI3): 8= 21.0 (3), 21.1 (3), 21.2 (3), 22.7 (3), 23.7 (3), 24.7 (3), 25.0
(3), 30.0 (1), 34.3 (1), 61.6 (1), 62.1 (1), 123.6 (1), 125.4 (1), 125.6 (1), 129.3 (1), 129.5 (1),
131.6 (1), 133.1 (0), 134.5 (0), 136.2 (0), 136.7 (0), 137.3 (0), 137.6 (0), 139.1 (0), 141.8 (0), 
150.2 (0), 152.8 (0).
LRMS (ES, +ve): m/z = 717 [(M+H)+, 55%], 734 [(M+NH4)+, 65], 739 [(M+Na)+, 55].
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